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Abstract  
Asparagine (N)-linked glycosylation is a common post-translational modification that 
regulates the structure and function of secretory and membrane proteins in eukaryotes. This 
process is catalysed by the multiprotein complex oligosaccharyltransferase (OTase), which 
glycosylates selected asparagine residues in nascent polypeptides as they enter the 
endoplasmic reticulum (ER) through the translocon. N-glycosylation is crucial in protein 
folding, and the precise glycans present on mature glycoproteins are often vital for their 
biological functions. Two isoforms of OTase exist in Bakers’ yeast Saccharomyces 
cerevisiae, determined by the presence of either of the homologous proteins Ost3p or Ost6p. 
Previous studies have identified that efficient glycosylation of some specific sites requires 
Ost3p, while others require Ost6p. Ost3p and Ost6p have thioredoxin-like ER soluble 
domains with grooves adjacent to their redox active sites, and our recent in vitro assays have 
shown that Ost3p and Ost6p can bind stretches of hydrophobic polypeptide with 
complementary characteristics to these peptide-binding grooves. A model of Ost3/6p function 
has been proposed based on this in vivo and structural data in which we hypothesize that 
Ost3p and Ost6p transiently bind nascent polypeptide to increase the glycosylation efficiency 
of selected asparagines.  
In the first part of the thesis, we tested a key prediction of this model using yeast genetics and 
glycoproteomics and established that this peptide-binding activity of Ost3/6p is 
physiologically relevant in N-glycosylation in vivo, suggesting that nascent polypeptide binds 
directly to the grooves in Ost3/6p. Further, we identified the precise sites of interaction 
between the Gas1p substrate nascent polypeptide and the Ost3/6p peptide binding groove in 
vivo, using a combination of site-directed mutagenesis and mass spectrometry 
glycoproteomics. Finally, using our in vitro peptide binding assay, we demonstrated and 
validated that a stretch of Gas1p we identify as interacting with Ost3/6p in vivo also 
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interacted with Ost6p in vitro. Together, this study advances our understanding of Ost3/6p 
function in which they transiently bind stretches of nascent polypeptide substrate proximal 
and N-terminal to specific glycosylation sites, which inhibits local protein folding and 
thereby increases glycosylation efficiency. 
In the second part of the thesis, we investigated the in vitro interactions between substrate 
polypeptide and Ost3/6p by peptide affinity chromatography and Selected Reaction 
Monitoring (SRM) Mass Spectrometry. We developed SRM-MS for improved relative 
quantification and sensitivity for detection in conjunction with peptide affinity 
chromatography. We show that Ost3p and Ost6p bind distinct subsets of peptides from a 
yeast cell wall glycoprotein substrate, with Ost3p binding peptides rich in aromatic acids and 
Ost6p binding peptides rich in aliphatic amino acids. Our data supports a model of Ost3/6p 
function in which they transiently bind complementary hydrophobic stretches of nascent 
polypeptide substrate to optimally inhibit protein folding, thereby increasing glycosylation 
efficiency at nearby asparagine residues.  
In the third part of the thesis, we developed another improved analytical method for site-
specific glycosylation analysis using PNGase F to label glycosylation sites with an 
asparagines-aspartate conversion that creates a new endoproteinase AspN cleavage site, 
followed by proteolytic digestion, and detection of peptides and glycopeptides by liquid 
chromatography electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS). This 
approach will be useful in site-specific glycosylation analysis in many model systems and 
clinical application. Overall, these two novel analytical methods introduced in the second and 
the third part of this thesis will provide advanced knowledge for improved detection and 
quantification of glycosylation sites in vivo and peptide interactions in vitro. 
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In the fourth part of the thesis, we used a novel strategy for engineering glycoprotein stability 
to determine the detailed function of Ost3p and Ost6p in vitro. The ER lumenal domain of 
Ost3p has a single glycosylation sequon, while Ost6p has no glycosylation sequons and 
contains a cluster of acidic amino acids at the position corresponding to the Ost3p sequon. 
We showed that incorporation of targeted like-charged amino acids at N-glycosylation 
sequons in Ost3/6p increases in vitro stability and activity. Optimal stabilization through 
minimal number of local point mutations in Ost3p glycosylation sequon showed increased in 
vitro binding of peptides and these peptides are complementary to the characteristics of the 
peptide binding groove of Ost3, a key determinant of transient nascent polypeptide tethering 
by Ost3p, consistent with the function of Ost3p and Ost6p in modulating N-glycosylation 
substrate selection by OTase activity in vivo. 
In summary, this thesis has made a significant contribution towards our understanding the 
molecular mechanisms of glycosylation site selection by OTase activity, the connectivity 
between glycoprotein folding and N-glycosylation in the endoplasmic reticulum, and opens 
up potential applications in synthetic glycobiology such as engineering of glycosylation sites 
and OTases. Our data provides advance information towards solving the model of the 
mechanisms by which Ost3/6p increase the efficiency of site-specific N-glycosylation. Here 
we detailed the mechanism of this regulatory system through mapping the precise sites of 
interactions between Ost3/6p and Gas1p nascent polypeptide which was not previously 
identified. This is a novel insight into the mechanisms of co-translocational polypeptide 
modification in the endoplasmic reticulum. 
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1.1 Glycosylation 
Protein glycosylation is the most common modification that regulates the structure and function of 
secretory and membrane proteins in eukaryotes (Herscovics and Orlean, 1993). This covalent 
addition of a carbohydrate molecule to a side chain of a polypeptide is an indispensable process in 
biology. Glycosylation aids in altering the properties of proteins, changing their stability, solubility 
and physical structure (Wormald and Dwek, 1999, Varki, 1993). In addition, the carbohydrate 
moieties function as recognition signals that stimulate protein targeting and influence cell-cell 
interactions and development of the organism (Herscovics and Orlean, 1993). Studies have shown 
that abnormalities in glycan expression are implicated as causative or incidental factors in relatively 
rare congenital diseases, widespread acquired diseases and cancer (Moremen et al., 2012, Ohtsubo 
and Marth, 2006, Schachter, 2000, Sell, 1990).  
Glycosylation encompasses different types of glycans, including N-glycans, and O-glycans that are 
typically attached to cellular proteins (Ohtsubo and Marth, 2006). N-glycans are attached to 
asparagine (Asn) residues of proteins in sequons (Asn-X-Ser/Thr; X ≠ Pro), and help in protein 
folding in the endoplasmic reticulum (ER) (Schwarz and Aebi, 2011). O-glycans are linked to 
subset of serines and threonines in the Golgi (Schachter, 2000, Yan and Lennarz, 2005b). The final 
glycan structures on both N- and O-linked glycans are diversified during protein traffic through the 
Golgi. Many different glycosyltransferases carry out a similar basic reaction in which a sugar is 
transferred from an activated donor substrate to an acceptor molecule, usually another sugar residue 
that is part of an oligosaccharide under construction (Ohtsubo and Marth, 2006). These final glycan 
structures can affect protein function in diverse ways (Ohtsubo and Marth, 2006). This review 
focuses on the biosynthetic events of the N-glycosylation pathway as well as the function of 
oligosaccharyltransferase (OTase) subunits Ost3p and Ost6p in yeast Saccharomyces cerevisiae. 
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1.2 Asparagine (N)-linked glycosylation pathway 
Asparagine (N)-linked glycosylation is a well-ordered process that involves the covalent attachment 
of oligosaccharides to selected target Asn residues (Helenius and Aebi, 2004). There are three main 
stages in the N-glycosylation mechanism: 1) the build up of a lipid-linked oligosaccharide (LLO) 
which is catalyzed by a series of glycosyltransferases encoding the asparagine-linked glycosylation 
(ALG) genes, 2) the transfer of the oligosaccharide to selected Asn residues of polypeptide chains 
and 3) the trimming, maturation and generation of glycan diversity in the Golgi (Figure 1.1) 
(Breitling and Aebi, 2013).  
The biosynthesis of the LLO begins at the cytoplasmic surface of the ER membrane where dolichol-
phosphate (Dol-P) lipid carrier acts as the glycosyl acceptor for N-acetylglucosamine (GlcNAc). 
The GlcNAc-phosphate is first added to Dol-P from nucleotide-activated UDP-GlcNac by the 
Alg7p glycosyltransferase encoded ALG7, to form the anhydride dolichyl-pyrophospate-GlcNAc 
(Dol-PP-GlcNAc) (Figure 1.1) (Breitling and Aebi, 2013). The presence of ALG7 is essential in 
yeast and can be blocked by a drug called tunicamycin to prevent N-glycosylation pathway and 
cellular processes (Rine et al., 1983, Elbein, 1984, Kukuruzinska and Robbins, 1987, Breitling and 
Aebi, 2013).  A second GlcNAc residue is then added to Dol-PP-GlcNAc by a protein complex 
encoded by ALG13 and ALG14, to form Dol-PP-GlcNAc2 (Bickel et al., 2005). Recent studies 
suggested that Alg7p, Alg13p and Alg14p assemble a complex that targets UDP-GlcNAc as the 
common substrate for efficient glycosylation by passing on LLO intermediates to consecutive active 
sites without diffusion (Noffz et al., 2009). Alg14p is thought to function as the key organizing 
subunit in this complex formation that interacts with Alg13p and, in addition, recruits Alg7p into 
the complex (Lu et al., 2012). 
The following stages of LLO biosynthesis on the cytoplasmic surface involve the attachment of 
mannose (Man) residues from GDP-Man as a donor substrate to the Dol-PP-GlcNAc2 (Figure 1.1) 
(Breitling and Aebi, 2013). The addition of the first Man to Dol-PP-GlcNAc2 is catalyzed by the 
ALG1 - encoded ß-1,4 mannosyltransferase to generate Dol-PP-GlcNAc2Man (Couto et al., 1984). 
Alg2p steps in next and transfers the two branching Man residues, first the α-1,3- and then the α-
1,6-linked Man to the Dol-PP-GlcNAc2Man to form the lipid-linked GlcNAc2Man3 pentasaccharide 
(O'Reilly et al., 2006, Kämpf et al., 2009, Breitling and Aebi, 2013). The precise mechanism of the 
two different branching Man reactions performed by Alg2p is still poorly understood. The Dol-PP-
GlcNAc2Man3 structure is recognized as a substrate for Alg11p, which extends the LLO by 
recruiting two α-1,2- linked Man residues to initiate the formation of lipid-linked GlcNAc2Man5 
heptasaccharide (Cipollo et al., 2001, O'Reilly et al., 2006). The formation of Dol-PP-
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GlcNAc2Man5 is the final product of ALG pathway on the cytoplasmic surface of the ER membrane 
(Figure 1.1) (Helenius and Aebi, 2004, Weerapana and Imperiali, 2006, Breitling and Aebi, 2013).  
 
 
Figure 1.1: An overview of the N-linked glycosylation pathway is in the ER. Details are discussed 
in the text. The biosynthesis of lipid-linked oligosaccharide (LLO) is catalyzed by a series of 
glycosyltransferases encoded by asparagines-linked glycosylation (ALG) genes. The glycans begin 
to be built up at the cytoplasmic surface of the ER membrane by the addition of N-
acetylglucosamine (GlcNAc)-phosphate to dolichol-phosphate (Dol-P) from nucleotide-activated 
UDP-GlcNAc. After the addition of a second GlcNAc residue to Dol-PP-GlcNAc, five mannoses 
(Man) are attached from GDP-Man to the LLO. After translocation into ER lumen, four additional 
Man and three glucose (Glc) residues are added to form a complete oligosaccharide 
(Glc3Man9GlcNAc2). The completed oligosaccharide is then transferred en bloc to asparagine side 
chains of nascent polypeptides by the oligosaccharyltransferase (OTase) multiprotein complex 
(Breitling and Aebi, 2013). 
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Dol-PP-GlcNAc2Man5 is then translocated across the ER membrane by an ATP-independent bi-
directional ‘flippase’, Rft1p (Figure 1.1) (Helenius et al., 2002). Then four additional Man and three 
glucose (Glc) residues are added, eventually yielding a full-length lipid-linked oligosaccharide Dol-
PP-GlcNAc2Man9Glc3 (Figure 1.2) (Helenius and Aebi, 2004, Breitling and Aebi, 2013). Unlike the 
glycosyltransferases acting on the cytoplasmic surface, the lumenal enzymes utilize the Dol-P-
bound sugar substrates Dol-P-Glc and Dol-P-Man to elongate the LLO (Figure 1.1) (Breitling and 
Aebi, 2013). For example, Alg12p in α-1,6 linkage (Burda et al., 1999, Cipollo and Trimble, 2002) 
only initiates the c branch of the LLO when Alg9p has completed the b branch by capping one α-
1,2-linked Man residue (Burda et al., 1999). Alg9p finally completes the c branch by the addition of 
α-1,2-linked Man residue (Burda et al., 1999, Frank and Aebi, 2005). Once the mannosylation of 
the LLO is completed, signalled by the presence of the complete b and c branches (Burda et al., 
1999), Alg6p steps in to initiate the final glucosylation steps of the a branch (Reiss et al., 1996). 
Alg8p subsequently adds the second α-1,3-linked Glc residue to the LLO and the completion of the 
LLO is obtained by the attachment of α-1,2-linked Glc, catalysed by Alg10p (Burda and Aebi, 
1998). This α-1,2-linked Glc residue represents an important final step in a linear assembly pathway 
of the branched oligosaccharide, ensuring the transfer of this completed oligosaccharide to proteins 
(Burda and Aebi, 1999). Absence of this terminal Glc residue impaires glycan recognition by OTase 
and correlates with a reduced N-glycosylation site occupancy in glycoprotein substrates (Breitling 
and Aebi, 2013). The result is an overall hypoglycosylation of the N-glycoproteome (Hülsmeier et 
al., 2007).  
 
 
 
Figure 1.2: Structure of the mature N-glycan 
normally transferred to protein by OTase. The N-
glycan structure consists of 14 carbohydrate 
residues. It contains two N-acetylglucosamines 
(GlcNAc, black squares), nine mannoses (Man, 
grey circles), and three glucoses (Glc, black 
circles). Linkage information is indicated between 
carbohydrate residues. The different residues are 
labelled with the genes encoding the 
glycosyltransferase that catalyzes the transfer of 
the respective residue. The structure of the glycan 
has three branches labelled a, b, and c (Breitling 
and Aebi, 2013). 
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The completed oligosaccharide Glc3Man9GlcNAc2 (Figure 1.2) is subsequently transferred to the 
amide group of selected Asn residues with the consensus sequence Asn-Xaa-Ser/Thr (where Xaa is 
not Pro) of the polypeptide as it emerges into the ER lumen (Figure 1.1). This reaction is catalyzed 
by the oligosaccharyltransferase (OTase) (Kelleher and Gilmore, 2006, Mohorko et al., 2011, 
Schwarz and Aebi, 2011, Schulz, 2012).   
 
1.3 N-glycans in glycoprotein folding in the ER 
N-glycosylation is cotranslational; it occurs as the protein is being synthesized and it can affect 
protein folding (Helenius and Aebi, 2004). N-glycans assist in protein folding in the ER by their 
hydrophilic bulk lowering the entropy of the protein unfolded state and acting as nucleation sites for 
local folding of nascent glycopolypeptide chains (Helenius and Aebi, 2004, Schulz, 2012). N-
glycans can also trigger a signalling pathway for particular proteins not folded correctly, and help to 
transport these to the ER resident thiol oxidoreductase ERp57 through the lectins calnexin and 
calreticulin (Oliver et al., 1999, Schulz, 2012).  
Following the covalent linkage of the oligosaccharide from the dolichol-linked pyrophosphate 
donor to selected Asn side-chain, a series of processing reactions occurs. Firstly, the glycosidases 
(Glucosidases I and II) present in the lumen of the ER are responsible for the removal of all 3 
glucose (Glc) sequentially (Helenius and Aebi, 2004). The presence or absence of Glc residues is 
crucial during glycoprotein folding as an indication that the glycoprotein is either properly folded 
and ready for release from the ER, or is not correctly folded and is to be reglucosylated by ER α-
glucosyltransferase (Helenius and Aebi, 2004). The α-glucosyltransferase scans for improperly 
folded proteins in the ER and adds a Glc to their N-glycans. This allows glycoproteins to again be 
targeted to ERp57 to be refolded into proper conformation, or alternatively for glycoproteins to be 
eventually deglucosylated and degraded by the proteosome. The protein chaperones calnexin and 
calreticulin bind preferentially to Glc1Man9GlcNAc2 and retain the glycoprotein in the ER for 
folding (Varki, 1993). Once protein folding is completed, glycoproteins traffic to the Golgi 
apparatus where further modifications in the form of trimming and addition of sugars occurs 
(Helenius and Aebi, 2004). The resulting N-linked oligosaccharides are diverse. Each has a 
common core region (GlcNAc2Man3) linked to Asn and originating from the dolichol-linked 
intermediate (Helenius and Aebi, 2004), while the terminal regions can be varied in different 
glycoproteins, cells, tissues and organisms.  
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1.4  Oligosaccharyltransferase (OTase) 
In eukaryotic cells, OTase is an integral membrane protein that catalyzes N-linked glycosylation of 
nascent proteins in the lumen of the ER (Kelleher et al., 2003). OTase functions as the ‘gatekeeper’ 
to the secretory pathway, scanning the emerging nascent polypeptide for glycosylation ‘sequons’ 
(Asn-X-Thr/Ser; X≠Pro), and adding an oligosaccharyl moiety (Glc3Man9GlcNAc2) (Figure 1.2) 
from the dolichol-linked pyrophosphate donor to selected Asn side-chain (Dempski and Imperiali, 
2002, Yan and Lennarz, 2005a, Kelleher and Gilmore, 2006). Previous reports have demonstrated 
that glycosylation at Asn in the sequence Asn-X-Thr is approximately 40 times more efficient and 
frequently used than Asn-X-Ser sequons (Kasturi et al., 1995), and in a few cases, the glycosylation 
of Asn in Asn-X-Cys sequons has also been identified (Miletich and Broze, 1990, Zielinska et al., 
2010). However, this is not an adequate predictor of glycosylation, as one-third of Asn in sequons 
in secreted proteins are not glycosylated (Schulz, 2012). It was also recently reported that N-
glycosylation was observed on Asn-X-Val and Asn-Gly motifs (Zielinska et al., 2010). However, 
this result must be treated with extreme caution, given the propensity for non-catalyzed spontaneous 
deamidation (asparagines-aspartate conversion) is especially high at Asn-Gly sequences (Robinson 
et al., 2004, Palmisano et al., 2012). 
While having a high degree of specificity with regard to the completed lipid-linked oligosaccharide 
donor (with structure Glc3Man9GlcNAc2-P-P-dolichol) (Karaoglu et al., 2001), OTase accepts a 
large number of glycosylation sites situated on many different proteins. The large-scale proteomics 
study of the mouse N-glycoproteome allows detailed categorization of glycoproteins and revealed 
that glycosylation sites are preferentially located in surface-exposed loop and turn regions 
(Zielinska et al., 2010). In studies using SWISS-PROT protein sequence data, Apweiler et al. 
(1999) revealed that the majority of the sequon containing proteins in metazoans will be 
glycosylated and that more than half of all proteins in nature are glycoproteins. This indicates the 
structural diversity and sequence of proteins acceptor sites are phenomenally large (Apweiler et al., 
1999). 
1.4.1: OTase Subunits 
In animals, plants and fungi, the OTase is a hetero-oligomeric complex. In yeast Saccharomyces 
cerevisiae, OTase is composed of eight different membrane–bound protein subunits that exist in 
three subcomplexes: Ost1p-Ost5p, Ost2p-Swp1p-Wbp1p, and Stt3p-Ost4p-Ost3p/Ost6p (Figure 
1.3) (Lennarz, 2007, Yan and Lennarz, 2005b). The yeast OTase complex exists in two isoforms 
that differ with respect to either Ost3p or Ost6p (Schwarz et al., 2005, Spirig et al., 2005, Yan and 
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Lennarz, 2005a). Of these eight, five subunits (Ost1p, Ost2p, Stt3p, Wbp1p, and Swp1p) are 
encoded by essential genes and are important for viability (Heesen et al., 1992, Heesen et al., 1993, 
Zufferey et al., 1995, Silberstein et al., 1995b). Although the other genes (Ost3p, Ost4p, Ost5p, and 
Ost6p) are not essential for viability, deletion of any one causes an N-glycosylation defect (Chi et 
al., 1996, Karaoglu et al., 1995, Reiss et al., 1997, Knauer and Lehle, 1999). Thus, OTase requires 
all subunits for maximal enzyme activity (Harada et al., 2009).  
 
Figure 1.3: Yeast oligosaccharyltransferase (OTase) complex consists of eight different subunits. 
The scheme depicts the membrane topology of the individual subunits (amino (N) and carboxyl (C) 
termini) and the number of predicted transmembrane helices for each subunit. The dashed box 
indicates the site where thioredoxin-like folds are likely to occur in the ER lumenal domain of 
Ost3/6p, where only one of the respective subunits can be incorporated into a given OTase complex 
(Schulz and Aebi, 2009). 
All of these subunits share high sequence identity and similarity with their human homologs 
(Kelleher et al., 1992, Kumar et al., 1994, Kumar et al., 1995, Breuer and Bause, 1995, Kelleher et 
al., 2003, Kelleher and Gilmore, 1997). Subunits of human OTase share a minimum of 90% 
pairwise sequence identity with the respective homolog in mouse, bovine, canine, rat and golden 
hamster OTase (Mohorko et al., 2011). They are ribophorin I (homolog of yeast Ost1p), ribophorin 
II (homolog of yeast Swp1p), OST48 (homolog of yeast Wbp1p), DAD1 (homolog of yeast Ost2p), 
STT3A/ STT3B (homolog of yeast Stt3p), MagT1/TUSC3 (homolog of yeast Ost3p/Ost6p) and 
OST4 (homolog of yeast Ost4p). In addition, all of these subunits have been characterized by 
genome-wide searches and have been demonstrated to be assembled together into a multimeric 
complex similar to the yeast OTase (Kelleher et al., 2003). The newly identified subunits KCP2 and 
9 
 
DC2 seem to associate with mammalian OST complexes (Shibatani et al., 2005, Wilson et al., 
2011). However, there is no reported evidence about the functional roles of KCP2 and DC2 in the 
glycosylation process. In the following, we will describe the different subunits of the human OTase 
in more detail. 
1.4.1.1: Stt3 
Stt3 is the largest and most highly conserved transmembrane protein subunit of the eukaryotic 
OTase (Spirig et al., 1997, Mohorko et al., 2011). In lower eukaryotes, archaea and some bacteria, 
N-glycosylation is catalyzed by a single protein OTase, homologous with Stt3p (Castro et al., 2006, 
Izquierdo et al., 2009, Nasab et al., 2008). This reveals that Stt3p is the catalytic subunit because of 
its direct influence in the catalytic process (Burda and Aebi, 1999, Kelleher et al., 2003, Nilsson et 
al., 2003, Yan and Lennarz, 2005b). Although there is small or no similarity between the glycan 
structures transferred to the acceptor protein in eukaryotes, archaea and bacteria, the OTase 
catalytic domains are structurally and functionally related. The membrane topology of all Stt3 
proteins consists of an N-terminal hydrophobic domain with thirteen transmembrane spans followed 
by a soluble C-terminal domain that is located in the lumen of the ER in eukaryotes or in the 
periplasm of gram-negative bacteria (Kelleher and Gilmore, 2006). The first X-Ray structure of a 
full length bacterial Stt3 homolog, the PglB from Campylobacter lari, revealed that the 
transmembrane domain is essential both for peptide binding and catalysis (Figure 1.4) (Lizak et al., 
2011). This structure provides a molecular explanation for sequon recognition and suggestions for 
the catalytic mechanism in N-linked protein glycosylation (Lizak et al., 2011).  
The structure of the PglB is anchored in the bacterial inner membrane via 13 transmembrane helical 
segments while a bulky globular domain faces into the periplasm (Lizak et al., 2011). Two cavities 
are found at the junction between the transmembrane and globular domains, and the acceptor 
peptide was found to be positioned across one of the cavities with its Asn side chain extending 
through a hole into the adjacent cavity, which is presumed to bind the LLO donor (Lizak et al., 
2011). The nature of the interactions between the peptide acceptor and the active site cavity, the 
indirect catalytic role of a protein-bound divalent cation, and the conformational change in a loop 
region required for product release all provide novel insights into the mechanism of glycan transfer 
(Imperiali and Hendrickson, 1995). The additional subunits required for eukaryotic OTase activity 
presumably act to facilitate coupling to the Sec61 protein translocation pore and to bind recognized 
substrate polypeptide nearby glycosylation sequons in unfolded protein segments either during 
protein translocation into the ER or after translocation is completed (Chen and Helenius, 2000). 
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Figure 1.4: Surface representation of the bacterial OTase PglB. Cartoon in semi-transparent grey, 
with ribbons (transmembrane and periplasmic domains in blue and green respectively). There are 
two cavities at opposite sides of PglB indicated by dashed lines, providing access for substrates. 
The cavities are connected by a tunnel that harbours the acceptor asparagine (Lizak et al., 2011). 
 
In humans, there are two isoforms of the catalytic subunit (Stt3A and Stt3B), and either Stt3A or 
Stt3B is incorporated into the human OTase complex (Kelleher et al., 2003, Mohorko et al., 2011). 
It has been established that Stt3A and Stt3B have different acceptor substrate preferences in vivo 
(Wilson and High, 2007). Wilson and High (2007) performed small interfering RNA knockdown 
experiments to investigate glycosylation sites of different membrane proteins in Stt3A- or Stt3B-
deficient HeLa cells. The deletion of Stt3B results in hypoglycosylation of certain membrane 
proteins where as knocking down Stt3A causes complete loss of both the Stt3A and Stt3B isoforms 
and substantial reduction in N-glycosylation (Wilson and High, 2007). Interestingly, the differences 
between OTase harbouring either Stt3A or Stt3B were described more in a recent study (Ruiz-
Canada et al., 2009) at the level of individual glycosylation sites in distinct substrates: Stt3B was 
observed to target sites glycosylated posttranslationally, and Stt3A catalyzed cotranslational 
glycosylation (Ruiz-Canada et al., 2009). This indicated that the actions of Stt3A or Stt3B differ 
with respect to substrate specificity as well as in the physical manner in the processing of 
polypeptide entering the ER lumen. 
 
Cytosol 
Periplasm 
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1.4.1.2: Ribophorin I 
Ribophorin I is a highly abundant ER membrane protein (Marcantonio et al., 1984, Kreibich et al., 
1978), together with OST48, were the first identified subunits of the mammalian OTase complex 
before the discovery of Stt3 (Kelleher et al., 1992). It was first thought that ribophorin I recruits a 
preassembled oligosaccharide from a membrane bound lipid donor to an acceptor Asn residue 
within a nascent polypeptide, but later studies clearly assigned the role to the Stt3 subunits (Yan and 
Lennarz, 2002, Nilsson et al., 2003). The membrane topology of ribophorin I consists of a single, 
predicted transmembrane helix; a large, lumenal domain; and a smaller, C-terminal cytosolic 
domain (Mohorko et al., 2011).   
Cross-linking studies performed between ribophorin I and ribosomes led to insights into other 
possible functions of ribophorin I. Antibodies against the C-terminus of the ribophorin I cytosolic 
domain inhibit the ribosome from entering the ER membrane channel and thus block protein 
translocation (Yu et al., 1990). This indicated that ribophorin I may be involved in targeting the 
ribosome to the ER membrane (Yu et al., 1990).  In addition, ribophorin I interacts with a subset of 
polypeptide substrates and presents them to the catalytic subunit Stt3 to facilitate efficient 
glycosylation of these proteins (Wilson and High, 2007, Wilson et al., 2008).  
A protein sequence comparison revealed that human ribophorin I subunit is 28% identical to the 
yeast Ost1p (Silberstein et al., 1995b).  The expression of the Ost1p is important for vegetative 
growth of haploid yeast, and mutant Ost1p demonstrated that Ost1p is required for N-linked 
glycoslation of proteins in vivo and for oligosaccharide transfer to acceptor peptides in vitro 
(Silberstein et al., 1995b). 
1.4.1.3: Ribophorin II 
Ribophorin II is an integral transmembrane glycoprotein of the rough ER that is highly conserved in 
mammals, and human ribophorin II shares >90% sequence similarity with ribophorin from mice, rat 
and pig (Crimaudo et al., 1987, Mohorko et al., 2011). The structure of ribophorin II is predicted to 
have a large N-terminal lumenal domain followed by a hydrophobic transmembrane domain with 
three α-helices and a small C-terminus region in the cytoplasm (Crimaudo et al., 1987). Both 
cytoplasmic and transmembrane domains of ribophorin II independently contain ER localization 
signals but, in order to mediate retention or strengthen ER localization, the transmembrane domain 
must be accompanied with fifteen amino acids at the lumenal region (Fu et al., 2000).  
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The expression of ribophorin II has also been implicated in drug resistant human breast cancer cells 
as a potential candidate predictive marker (Honma et al., 2008, Kurashige et al., 2012). Recently, 
Honma et al (2008) reported that downregulation of ripophorin II efficiently induced apoptosis in 
docetaxel-resistant human breast cancer cells in the presence of docetaxel, and silencing of 
ribophorin II inactivates glycosylation of the P-glycoprotein and decreased membrane localisation, 
thereby sensitising cancel cells to docetaxel (Honma et al., 2008). P-glycoprotein is indispensable in 
conferring drug resistance, and stable membrane bound P-glycoprotein requires complete 
glycosylation (Honma et al., 2008). 
1.4.1.4: OST48 
OST48, the third originally identified OTase subunit, was co-isolated from canine pancreas 
microsomal membranes (Kelleher et al., 1992). Canine OST48 and its homolog, Wbp1p, from the 
yeast Saccharomyces cerevisiae are found to be 25% identical in sequence (Silberstein et al., 1992). 
Like the ribophorins, OST48 is also highly conserved in mammals and human OST48 shares more 
than 90% sequence identity with other mammalian OST48 proteins (Yamagata et al., 1997) 
(Mohorko et al., 2011).  
Human OST48 has 456 residues and the first 42 are predicted to have a signal sequence, followed 
by a large, ER lumenal domain. A single transmembrane helix constitutes OST48 as a type I 
membrane protein with a very small C-terminal cytosolic domain consisting of only nine residues 
(Mohorko et al., 2011).  Interestingly, the C-terminal cytosolic domain of OST48 in canine was 
reported to interact with another OTase subunit, DAD1 (defender against apoptotic death) that may 
represent a fourth subunit of the mammalian OTase complex (Fu et al., 1997). Studies investigating 
these interactions among its subunits using yeast two-hybrid system have determined the interaction 
between lumenal domain of OST48 with ribophorin I and ribophorin II respectively but no direct 
interaction was observed between  ribophorin I and ribophorin II (Fu et al., 1997). Knockdown of 
OST48 and DAD1 by small interfering RNA (siRNA) results in destabilization of both OTase 
complex isoforms (Roboti and High, 2012). 
 
 
 
 
13 
 
1.4.1.5: DAD1 
DAD1 (defender against apoptotic cell death), a highly conserved OTase subunit, was initially 
discovered as a negative regulator of apoptosis in a temperature-sensitive mutant hamster cell line 
(tsBN7) (Nakashima et al., 1993). Rapid degradation of the DAD1 protein from a tsBN7 cells after 
shift to the restrictive temperature triggers apoptosis suggesting that DAD1 acts as cell death 
suppressor (Nakashima et al., 1993). The membrane topology of DAD1 consists of a small, 113-
residue polypeptide with two predicted transmembrane spanning helices in the middle of the protein 
and both termini located in the cytoplasm (Mohorko et al., 2011). DAD1 protein is an authentic 
homolog of the yeast Ost2 protein and they share 40% sequence identity (Silberstein et al., 1995a). 
The extensive sequence homology between DAD1 and Ost2p and the in vivo and in vitro evidence 
demonstrating that Ost2p is an essential subunit of the yeast OTase complex suggested that DAD1 
is a possible fourth subunit of the vertebrate complex (Silberstein and Gilmore, 1996, Sanjay et al., 
1998). 
DAD1 is a tightly associated subunit of the OTase both in the intact membrane and in the purified 
enzyme (Kelleher and Gilmore, 1997).  It has been shown that the amino terminal domain of DAD1 
interacts with C-terminus of OST48 (Fu et al., 1997). Interestingly, crosslinking experiments 
indicated that DAD1, OST48 and ribophorin II constitute a structural unit within the OTase core 
enzyme (Kelleher and Gilmore, 1997, Sanjay et al., 1998). They interact directly with each other 
(Fu et al., 1997, Kelleher and Gilmore, 1997), and it has been suggested that the resulting 
subcomplex assists in transferring the LLO donor to the catalytic Stt3 subunit (Beatson and Ponting, 
2004, Kelleher et al., 2007). A mutation in the DAD1 subunit leads not only to the degradation of 
DAD1, but also destabilizes the other three subunits (Sanjay et al., 1998). This indicated that DAD1 
is an essential component of the OTase complex and that its loss causes the rapid degradation of 
OST48 and also to a lesser extent of the ribophorins (Sanjay et al., 1998). The degradation of the 
OTase subunits eventually leads to complete loss of the N-glycosylation activity.  
1.4.1.6: OST4 
Human OST4 contains a very short lumenal domain with one transmembrane span followed by a 
cytoplasmic region of approximately ten residues. Mammalian OST4 has been tentatively identified 
in association with the purified canine OTase complex and it shows clear sequence identity to 
Ost4p, the smallest structural membrane protein of yeast OTase (Kelleher and Gilmore, 2006). In 
the yeast OTase complex, Ost4p regulates the incorporation of the two functionally equivalent, but 
mutually exclusive, subunits, Ost3p and Ost6p (Spirig et al., 2005). Point mutations in the C-
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terminus of the transmembrane segment of Ost4p destabilize the interactions between Ost4p, Ost3p 
and Stt3p, causing severe growth defects in yeast (Kim et al. 2000, Kim et al., 2003).  
Recently, Dumax-Vorzet et al (2013) provides an important role of OST4 that acts co-translational 
N-glycosylation by stabilising Stt3a-OTase isoforms. OST4 is assembled into native OTase 
complexes containing either the catalytic Stt3a or Stt3b isoforms. Knockdown of OST4 or Stt3A 
destabilizes the native OTase complexes and results in severe defect in N-glycosylation (Dumax-
Vorzet et al., 2013).  
1.4.1.7: MagT1/TUSC3 
The human homologs of the yeast OTase subunits Ost3p and Ost6p are human MagT1 (IAP) and 
TUSC3 (N33) (MacGrogan et al., 1996, Kelleher et al., 2003). Human MagT1 and TUSC3 share 
70% sequence identity and similar predicted membrane topology, containing an N-terminal lumenal 
domain followed by a transmembrane domain with four transmembrane helices (Kelleher et al., 
2003, Mohorko et al., 2011). Based on sequence identity, Fetrow and co-workers proposed that 
MagT1 and TUSC3 also contain oxidoreductase activity (Fetrow et al., 2001) which correlates with 
later studies by Schulz (2009) on the lumenal domain of the yeast Ost6p.  The important feature of 
the yeast Ost6p is a thioredoxin-like fold for the lumenal domain and revealed oxidoreductase 
activity for this domain which will be elaborated further in 1.5.2.  
Recently, Mohorko (2014) solved the structures of N33/TUSC3-substrate complexes revealing the 
mode of substrate binding and that N33/TUSC3 may bind different substrate peptides in opposite 
orientations. Their structural and biochemical data show that N33/TUSC3 prefers peptides bearing a 
hydrophobic residue two residues away from the cysteine forming the mixed disulfide with 
N33/TUSC3 (Mohorko et al., 2014). Their results are parallel to our previously reported results 
showing that the thioredoxin-like domain of yeast Ost3p and Ost6 could form transient mixed 
disulfide bonds with cysteines in a model substrate glycoprotein, consistent with the function of 
N33/TUSC3 in modulating N-glycosylation for a subset of human glycoproteins by slowing 
glycoprotein folding (Mohd Yusuf et al., 2013).  
Previous studies have reported that disruption of either Ost3p or Ost6p produces a minor defect in 
N-glycosylation (Karaoglu et al., 1995) and deletion of both OTase subunits results in severe 
underglycosylation of soluble/ membrane bound glycoproteins (Knauer and Lehle, 1999). Schulz 
and Aebi (2009) have also identified a number of specific glycosylation sites that are not efficiently 
glycosylated with lack of either Ost3p or Ost6p. Recently, Molinari et al. (2008) and Garshasbi et 
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al. (2008) reported mutations in the two OTase subunit genes encoding the human Ost3p/6p 
homologs (MagT1 and TUSC3) that can result in nonsyndromic mental retardation (NSMR). These 
data provide an association of NSMR with the congenital disorders of glycosylation syndromes 
which emphasize the crucial role of glycosylation activity in higher brain functions and cognitive 
development (Eklund and Freeze, 2006, Freeze, 2006). There were also other reports that revealed 
that TUSC3 inactivation leads to cancer development (Bova et al., 1993, Pils et al., 2006). In 
addition, the loss of functional MagT1 results in an inherited T-cell immunodeficiency (Li et al., 
2011). At present, however, the precise role of glycosylation in NSMR and cancer is obscure and 
remains to be defined, but given the regulatory activities of yeast Ost3p and Ost6p, it is possible 
that human OTase MagT1 and TUSC3 also assist glycosylation of a subset of protein substrates 
required for correct human development and may be involved in cancer.  
As many proteins require MagT1/TUSC3 for efficient glycosylation, the biology of affected cells 
and tissues would be altered in unpredictable and complex ways. MagT1 and TUSC3 have also 
been linked with magnesium transport. Previous studies have shown that expression of either 
TUSC3 or MagT1 can rescue growth in yeast lacking ALR1, encoding the major yeast magnesium 
transporter (Zhou and Clapham, 2009). Magnesium is a important metal ion that participates in 
many intracellular biochemical functions (Quamme, 2010).  
Recent studies involving patients with a deficiency in MagT1 have shown that MagT1 is an 
important regulator of free intracellular magnesium, where magnesium functions as a second 
messenger in immune signalling activation of T-cell (Li et al., 2011). This indicates that MagT1 is 
required for T-cell activation, a finding which may help to open up potential treatment strategies for 
patients suffering from psoriasis, rheumatoid arthritis, or inflammatory bowel disease. 
Together, this suggested that both human MagT1 and TUSC3 are associated with Mg
2+
 transport. 
However, TUSC3 has been detected physically associated with OTase, and lack of TUSC3 causes 
changes in protein glycosylation. While at least a fraction of MagT1 is present on the cell surface 
(Zhou and Clapham, 2009, Li et al., 2011), both TUSC3 and MagT1 share sequence characteristics 
with Ost3p and Ost6p that are important for their role in N-glycosylation. In the next section, we 
will explore the key characteristics and important roles of yeast Ost3p and Ost6p, which is our main 
focus in this project. This will focus on their different protein substrate binding specificities (Schulz 
and Aebi, 2009, Schulz et al., 2009, Jamaluddin et al., 2011) that will help us test our hypothetical 
model (Figure 1.6) of Ost3/Ost6p function in N-glycosylation. 
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1.5 Ost3p and Ost6p 
1.5.1: Ost3p and Ost6p define isoforms of OTase 
The two best characterized accessory subunits of OTase are Ost3p and Ost6p. The sequence identity 
between Ost3p (UniProtKB number P48439; encodes the 34 kDa OTase subunit) and Ost6 
(UniProtKB number Q03723; encodes the 37 kDa OTase subunit) is low, with 46% amino acid 
sequence homology and 21% sequence identity (Knauer and Lehle, 1999). However, based on the 
hydrophobicity plots of the paralogues Ost3p and Ost6p, both subunits contain similar N-terminal 
lumenal domains in the ER followed by four predicted transmembrane helices. 
Two isoforms of OTase exist in yeast, determined by the presence of either Ost3p or Ost6p. The 
thioredoxin-like domain of Ost3p and Ost6p is likely to be located in the ER lumen (Figure 1.3) 
(Schulz and Aebi, 2009). Ost3p is thought to assemble into a more abundant form of the yeast 
OTase complex than Ost6p (Spirig et al., 2005). The function of Ost6p-complex was found to be 
crucial for cell wall integrity and temperature stress (Schwarz et al., 2005). Recently, genetic studies 
in the model plant Arabidopsis led to the discovery of an ER N-glycosylation pathway that requires 
the Ost3/6p subunits to allow Arabidopsis to tolerate abiotic stress, and also that the protein 
underglycosylation due to Ost3/6p deficiency results in the onset of ER stress (Farid et al., 2013). 
These findings indicated that changes in gene expression of subunits of the OTase complex and N-
glycosylation activity are critical in response of an organism to a stressful environment. Ost3p and 
Ost6p can in part displace each other in the complex when overexpressed, suggesting a dynamic 
regulation of the complex formation (Schwarz et al., 2005). 
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1.5.2: Molecular mechanisms of Ost3p and Ost6 function 
Previous studies predicted that the ER lumenal domains of Ost3p and Ost6p contain a thioredoxin-
like fold and CxxC active-site motif (Fetrow et al., 2001). Thioredoxin-like folds are present in 
proteins with disulfide oxidoreductase activity and in the ER, generally catalyze disulfide bond 
formation and isomerisation during protein oxidative folding (Sevier and Kaiser, 2002). Recently, 
Schulz and Aebi (2009) established that the two OTase isoforms containing Ost3p or Ost6p differ in 
their protein substrate-specific activities at the level of individual glycosylation sites. Furthermore, 
in another experiment it was discovered that a specific peptide can transiently bind to the peptide-
binding groove of the lumenal domain of Ost6p (Ost6L), but only when the CxxC active site of 
Ost6L is oxidized (Schulz et al., 2009). An interesting feature of the active-site loop of Ost6L is that 
it forms a peptide-binding groove when the CxxC is oxidized and becomes flexibly disordered 
when the CxxC is reduced (Schulz et al., 2009). The groove is a key candidate for a peptide-binding 
site, as it contains slightly basic and hydrophobic regions, an acidic patch, and encompasses several 
residues that could accommodate different substrate polypeptides (Figure 1.5) (Schulz et al., 2009). 
The structural and biochemical analyses of yeast Ost6L demonstrate the functional equivalence to 
the recently solved structures of N33/TUSC3-substrate complexes, in that the main function of 
these thioredoxin-like OST subunits is to increase glycosylation efficiency for a subset of 
glycosylation sequons in disulfide bonded glycoproteins (Mohd Yusuf et al., 2013, Mohorko et al., 
2014). Interestingly, Mohorko and co-workers (2014) observed that the peptide-binding pocket of 
N33/TUSC3 shows no specific recognition of glycosylation sequons that could prevent the access 
of the catalytic OST subunit. This suggest a possible mechanism by yeast Ost3/Ost6 and 
N33/TUSC3 delays oxidative substrate folding through mixed disulfide formation and thereby 
increases the probability of sequon recognition and glycosylation by the catalytic subunit Stt3A/B 
as a nascent polypeptide chain passes the OTase complex during cotranslational translocation. 
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Figure 1.5: Peptide-binding groove 
of S. cerevisiae Ost6p and Ost3p. 
Surface representation of (A) top and 
(B) side views of the ER lumenal 
domain of oxidized Ost6p (Ost6L; 
PDB code 3G7Y) with residues lining 
the peptide-binding groove coloured 
by hydropathy (black, hydrophobic to 
white hydrophilic); blue, basic; and 
yellow, cysteine. (C) Sequence 
alignment of sections of S. cerevisiae 
Ost6p and Ost3p, with surface-
exposed residues in the Ost6p peptide 
binding groove and residues of Ost3p 
mutated in MBP-Ost3Q103K, Q106K 
variant bolded (Jamaluddin et al., 
2011). 
 
 
 
19 
 
Our recent in vitro peptide binding assays have shown that Ost3p and Ost6p can bind stretches of 
polypeptide with complementary characteristics to their peptide- binding grooves (Jamaluddin et 
al., 2011). For example, the features of the peptides that interact with the groove of Ost6p are 
enriched with hydrophobic and acidic amino acid residues which perfectly complement the peptide-
binding groove of Ost6p (hydrophobic base lined by basic residues). We also performed in vitro 
peptide binding assays using variant Ost3p and Ost6p proteins, which indeed indicated that the 
Ost6K96Q,K99Q variant abolished peptide binding while the Ost3Q103K,Q106K variant binds to one 
hydrophobic and acidic peptide that also bound to wild type Ost6p (Jamaluddin et al., 2011). This 
demonstrates that mutations made to the groove of Ost3p and Ost6p did affect peptide binding 
activities in vitro. To determine the physiological relevance of these in vitro interactions to in vivo 
N-glycosylation efficiency, it is necessary to investigate the effect of the amino acid residues in the 
peptide-binding grooves of Ost3p and Ost6p in OTase function in vivo.  
The work in this thesis tests aspects of the hypothetical models of Ost3/6p function previously 
developed by Schulz et al. (2009). The central concept of the model in Figure 1.6 is that Ost3/6p 
function by binding nascent polypeptide, which slows protein folding and allows the catalytic site 
of OTase to access flexible nascent polypeptide substrate, which it can glycosylate efficiently 
(Schulz et al., 2009). 
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Figure 1.6: Proposed model of Ost3/6p function in N-glycosylation. (A) Nascent polypeptide 
chains enter through the translocon into the lumen of the ER. (B) Specific stretches of nascent 
polypeptides non-covalently bind at the peptide-binding groove. Translocation of the nascent 
polypeptide continues, with folding inhibited due to Ost3/6p binding constraints. (C) The catalytic 
site of OTase transfers glycan to the asparagine of a glycosylation sequon. (D) The binding is 
transient. Translocation and folding of the glycosylated polypeptide chain continues. (E) 
Glycosylated and folded protein (Schulz et al., 2009). 
 
 
21 
 
1.6 Research aims and significance 
The specific aims of this PhD project are as follows: 
1) Identifying the precise sites of interaction between the Gas1p substrate nascent polypeptide 
and the Ost3/6p peptide binding groove in N-glycosylation in vivo (Incorporated as Chapter 
2) 
 
2) To investigate the in vitro interactions between substrate polypeptide and Ost3p and Ost6p 
by peptide affinity chromatography and Selected Reaction Monitoring (SRM) Mass 
Spectrometry (Incorporated as Chapter 3) 
 
3) Glycosite engineering to investigate the in vitro function of yeast Ost3p and Ost6 variants 
(Incorporated as Chapter 5) 
 
4) Solving the crystal structure of Ost3p or Ost6p bound with a physiological ligand and 
measuring the strength of interaction between them (Incorporated as Chapter 6) 
These specific aims will help us understand the molecular basis of the molecular mechanisms 
underlying glycosylation site selection by OTase activity, and details of the connection between 
glycoprotein folding and N-glycosylation in the endoplasmic reticulum. 
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Chapter 2 
Oligosaccharyltransferase subunits bind polypeptide 
substrate to locally enhance N-glycosylation 
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2.1 Introduction to this publication  
This chapter was published in Molecular and Cellular Proteomics as an original article. A model of 
Ost3/6p function has been proposed based on this in vivo and structural data in which we 
hypothesize that Ost3p and Ost6p transiently bind nascent polypeptide to increase the glycosylation 
efficiency of selected asparagines. In this paper, we tested a key prediction of this model using yeast 
genetics and glycoproteomics and established that this peptide-binding activity of Ost3/6p is 
physiologically relevant in N-glycosylation in vivo, suggesting that nascent polypeptide binds 
directly to the grooves in Ost3/6p. Further, we identified the precise sites of interaction between the 
Gas1p substrate nascent polypeptide and the Ost3/6p peptide binding groove in vivo, using a 
combination of site-directed mutagenesis and mass spectrometry glycoproteomics. Finally, using 
our in vitro peptide binding assay, we demonstrated and validated that a stretch of Gas1p we 
identify as interacting with Ost3/6p in vivo also interacted with Ost6p in vitro. Together, this study 
advances our understanding of Ost3/6p function in which they transiently bind stretches of nascent 
polypeptide substrate proximal and N-terminal to specific glycosylation sites, which inhibits local 
protein folding and thereby increases glycosylation efficiency. 
 
2.2 Declaration on authorship 
In accordance with The University of Queensland, the methods, results and discussion are presented 
in the form of a publication style in the peer-reviewed journal. This article was published in 
Molecular and Cellular Proteomics. The contributions of all authors are mentioned in Section 2.3 
 
2.3 Published peer-reviewed article 
 “Oligosaccharyltransferase subunits bind polypeptide substrate to locally enhance N-
glycosylation” 
Jamaluddin MF, Bailey UM, Schulz BL. Oligosaccharyltransferase subunits bind polypeptide 
substrate to locally enhance N-glycosylation. Mol Cell Proteomics. 2014, 13(12):3286-93. 
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Contributions: 
This paper describes a model in which the Ost3p or Ost6p alternately bind to nascent proteins from 
the translocon thereby holding a "loop" of polypeptide in readiness for glycosylation. The 
Ost3p/Ost6p dichotomy enables the same OTase to preferentially glycosylate different sets of 
substrates, based on the partnering of peptides N-terminal to the glycosylation site with a binding 
groove in either Ost3p or Ost6p which show different binding characteristics. 
This work presented here was done under the supervision of Dr Benjamin Schulz. 
Dr Benjamin Schulz, Dr Maja Bailey and I planned experiments; Dr Maja Bailey and I performed 
in vivo yeast analyses; I performed in vitro peptide binding assays; Dr Benjamin Schulz, Dr Maja 
Bailey and I performed mass spectrometry; Dr Benjamin Schulz, Dr Maja Bailey and I wrote the 
manuscript. All authors read and approved the manuscript. 
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Summary 
Oligosaccharyltransferase is a multiprotein complex that catalyses asparagine-linked 
glycosylation of diverse proteins. Using yeast genetics and glycoproteomics we show that 
transient interactions between nascent polypeptide and Ost3p/Ost6p, homologous subunits of 
oligosaccharyltransferase, modulate glycosylation efficiency in a site-specific manner in vivo. 
These interactions are driven by hydrophobic and electrostatic complementarity between amino 
acids in the peptide-binding groove of Ost3p/Ost6p and the sequestered stretch of substrate 
polypeptide. Based on this dependence, we use in vivo scanning mutagenesis and in vitro 
biochemistry to map the precise interactions that affect site-specific glycosylation efficiency. We 
conclude that transient binding of substrate polypeptide by Ost3p/Ost6p increases glycosylation 
efficiency at asparagines proximal and C-terminal to sequestered sequences. We detail a novel 
mode of interaction between translocating nascent polypeptide and oligosaccharyltransferase in 
which binding to Ost3p/Ost6p segregates a short flexible loop of glycosylation-competent 
polypeptide substrate that is delivered to the oligosaccharyltransferase active site for efficient 
modification. 
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Introduction 
Asparagine (N)-linked glycosylation is an essential post-translational modification of secretory 
and membrane proteins in eukaryota which also occurs in archaea and some bacteria (1). 
Oligosaccharyltransferase (OTase) is an integral membrane protein that catalyzes N-
glycosylation of nascent polypeptides in the lumen of the endoplasmic reticulum (ER) (2). 
Eukaryotic OTase is physically associated with the translocon (3) and transfers oligosaccharide 
from a dolichol-pyrophosphate carrier onto asparagine side-chains of substrate polypeptides (2). 
The efficiency of glycosylation of asparagine residues is dramatically increased if they are 
present in glycosylation “sequons” (N-x-T/S; x≠P), the peptide recognition motif of the catalytic 
site of OTase (4). After transfer of glycan to protein the presence of N-glycosylation assists 
efficient glycoprotein folding in the ER intrinsically and by locally recruiting the disulfide 
isomerase ERp57 through the lectins calnexin and calreticulin (5). Correctly folded glycoproteins 
are free to traffic through the Golgi, where further modification and extension of glycan 
structures can occur (6). The precise glycan structures present on mature glycoproteins are often 
vital for their biological functions including in the immune response, embryonic development 
and cancer (6-8). 
 
OTase in Bakers’ yeast Saccharomyces cerevisiae is a multiprotein complex consisting of eight 
subunits (2). The catalytic site of OTase is located in the Stt3p subunit, while other protein 
subunits whose functions have been investigated are required for the integrity of the complex and 
for regulation of substrate specificity. It has been proposed that the requirement of the Ost1p 
subunit (human Ribophorin I) for efficient glycosylation of a subset of integral membrane 
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proteins (9) is due to direct physical association (10) to retain potential substrates in close 
proximity to Stt3p (11). The details and mechanisms of this association are not known. Ost3p 
and Ost6p are homologous proteins, incorporation of either of which into OTase defines two 
isoforms of the enzyme with distinct protein substrate specificities (Figure 1) (12-14). Efficient 
glycosylation of some asparagine residues requires the isoform of OTase that contains Ost3p 
(Ost3p-OTase), while glycosylation of other asparagines requires the isoform that contains Ost6p 
(Ost6p-OTase) (15). A model of Ost3p/Ost6p function in N-glycosylation site selection has been 
proposed (16), in which their ER-lumenal peptide-binding grooves transiently tether nascent 
polypeptide non-covalently or through mixed disulfides, inhibiting local protein folding and 
increasing the efficiency of glycosylation of nearby asparagine residues. Aspects of this model, 
including mixed-disulfide formation (17) and non-covalent peptide binding (18), have been 
tested in vitro. While it has been established that Ost3p-OTase and Ost6p-OTase have different 
polypeptide substrate preferences in vivo (12-15,19), the physiological relevance and details of 
any interactions between Ost3p/Ost6p and substrate polypeptide are unclear.   
 
Here, we use in vivo yeast genetics, glycoproteomics and in vitro biochemistry to identify the 
precise sites of interaction between Ost3p/Ost6p and substrate polypeptides that impact the 
efficiency of N-glycosylation at diverse asparagines. Based on these data, we present a model in 
which transient binding of nascent polypeptide by Ost3p/Ost6p isolates newly translocating 
polypeptide from pre-translocated polypeptide, resulting in the formation of a short flexible loop 
of glycosylation-competent polypeptide substrate in close proximity to the active site of OTase 
for efficient modification. 
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Experimental Procedures 
Cloning and mutagenesis. DNA encoding OST3 or OST6 including 1 kb up and downstream 
were amplified using PCR and cloned into the YEp352 vector using BamHI and SalI restriction 
enzymes, giving pOST3 and pOST6. DNA encoding GAS1 including 1 kb up and downstream 
was amplified by PCR and cloned into the pRS415 vector using BamHI and SacI restriction 
enzymes, giving pGAS1. The thioredoxin-like ER lumenal domain of Ost6p and the mature 
soluble domain of Gas1p cloned as maltose binding protein (MBP) fusion proteins (pMAL-
Ost6L and pMAL-Gas1, respectively) were used as described (18). Variants with amino acid 
replacements (pOST3Q103K,Q106K, pOST6K96Q,K99Q, pGAS1K34Q, pGAS1R47Q, pGAS1R76Q, 
pGAS1K82Q,K83Q, pGAS1R90Q, pGAS1K105Q, pMAL-GAS1R90Q) were constructed as described 
(20). 
 
Yeast strains. The OST3 and OST6 genes were genomically knocked-out in BY4742 (MATα 
his3∆1 leu2∆0 lys2∆0 ura3∆0) using homologous recombination of transformed PCR products 
to produce strain ∆ost3/∆ost6 (MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 ∆ost3::KanMX 
∆ost6::HisMX). Yeast strain ∆ost3/∆ost6 was transformed with YEp352, pOST3, pOST6, 
pOST3Q103K,Q106K or pOST6K96Q,K99Q to produced yeast expressing only a single isoform of 
OTase (Fig. 1) (14). To determine the precise sites of interaction between Gas1p nascent 
polypeptide and the Ost6p peptide binding groove in vivo, pGAS1, pGAS1K34Q, pGAS1R47Q, 
pGAS1R76Q, pGAS1K82Q,K83Q, pGAS1R90Q or pGAS1K105Q were transformed into strain 
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∆ost3/∆ost6 pOST6 or ∆ost3/∆ost6 pOST6K96Q,K99Q. Yeast cells were grown to mid-log phase at 
30°C in minimal medium (0.67% yeast nitrogen base and 2% glucose with appropriate 
supplements to allow growth). 
 
Cell Wall Protein Sample Preparation. Analysis of site-specific glycosylation occupancy of cell 
wall glycoproteins was performed as described (15). Briefly, cells were mechanically lysed and 
insoluble cell wall material was reduced/alkylated and exhaustively washed. The resulting cell 
wall fraction is highly enriched in glycoproteins covalently linked to the cell wall polysaccharide 
through glycophosphatidylinositol remnants or alkaline sensitive linkages. N-glycans were 
released with endoglycosidase H (Endo H), leaving a single N-acetylglucosamine (GlcNAc) 
monosaccharide on previously glycosylated asparagines, and proteins were digested with trypsin. 
Peptides and glycopeptides were desalted with C18 ZipTips. Strains were analysed in biological 
triplicate from independent transformants. Peptides and deglycosylated peptides were detected 
with LC-ESI-MS/MS.	  
 
Peptide affinity chromatography. MBP-Ost6L, MBP-Gas1 and MBP-Gas1R90Q were expressed in 
E.coli carrying plasmids pMAL-OST6L, pMAL-GAS1 or pMAL-GAS1R90Q, respectively, and 
purified by amylose-agarose affinity chromatography as described (18). MBP-Gas1 and MBP-
Gas1R90Q were eluted in column buffer (20 mM Tris HCl pH 7.4, 200 mM NaCl, 1mM EDTA) 
with 1% SDS, while MBP-Ost6L was retained on the amylose-agarose resin. MBP-Gas1 and 
MBP-Gas1R90Q were reduced, alkylated, precipitated and digested with AspN as described (21). 
Residual AspN was inactivated by addition of EDTA to 1 mM. Peptide affinity chromatography 
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was performed as described (18). Briefly, peptides from equal amounts of MBP-Gas1 and MBP-
Gas1R90Q in column buffer were combined and applied to amylose-agarose beads containing 
bound MBP-Ost6L, with the Ost6p CxxC motif either oxidized, or reduced by prior incubation 
with DTT. Peptides were washed from the affinity matrix by sequential gravity flow washing 
with column buffer and wash fractions collected. Peptides in the load and wash fractions were 
then detected by LC-ESI-MS/MS. 
 
Mass Spectrometry and Data Analysis. Peptides were analysed by LC-ESI-MS/MS using a 
Prominence nanoLC system (Shimadzu) and TripleTof 5600 mass spectrometry with a 
Nanospray III interface (AB SCIEX) as described (21,22). Glycosylation occupancy was 
measured at previously identified glycosylation sites (15,21) using unmodified and GlcNAc-
modified versions of the same peptide. This identification used ProteinPilot (AB SCIEX) 
searching the LudwigNR database with standard settings: Sample type, identification; Cysteine 
alkylation, acrylamide; Instrument, TripleTof 5600; Species, S. cerevisiae with common 
contaminants; ID focus, biological modifications; Enzyme, trypsin or AspN; Search effort, 
thorough ID. False discovery rate analysis using ProteinPilot was performed on all searches and 
peptides identified with greater than 99 % confidence and a local false discovery rate of less than 
1 % were included for further analysis. The glycosylation occupancy at a given sequon was 
defined by the abundance as measured by peak intensity of the GlcNAc-modified peptide as a 
fraction of the sum of the GlcNAc-modified and unmodified versions of the same peptide (15). 
For in vitro peptide affinity chromatography analysis, the relative enrichment of each peptide in 
each wash fraction was determined as described (18) by the ratio of the abundance of each 
peptide. Interactions with the peptide-binding groove of Ost6p were determined for each peptide 
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by the log of the relative abundance of each peptide in each wash fraction between the oxidized 
and reduced versions of Ost6p. Experiments were performed in biological triplicate. 
 
 
Results and Discussion 
Ost3p and Ost6p peptide binding controls glycosylation  
In vitro, Ost3p and Ost6p can transiently bind selected peptides with complementary 
characteristics to their peptide-binding grooves (16). The Ost6p groove is hydrophobic and lined 
by basic residues (K96 and K99), and binds peptides enriched in hydrophobic and acidic 
residues. Point mutations removing these basic residues in Ost6p (Ost6K96Q,K99Q) abolish in vitro 
peptide binding, while addition of basic residues in place of the natively neutral residues at the 
equivalent positions in the Ost3p groove (Ost3Q103K,Q106K) allows binding of a hydrophobic and 
acidic peptide that also binds to wild type Ost6p (18). This demonstrates that mutations to the 
groove of Ost3p and Ost6p affect peptide binding in vitro. To investigate the physiological 
relevance of these in vitro interactions to in vivo site-specific N-glycosylation efficiency, we 
constructed yeast strains expressing only a single isoform of OTase, wild type Ost3p-OTase, 
Ost6p-OTase, or variants of each with point mutations at their peptide-binding grooves 
(Ost3Q103K,Q106K or Ost6K96Q,K99Q). We then used mass spectrometry to measure site-specific 
glycosylation occupancy of cell wall glycoproteins from these cells. As this method analyses 
mature glycoproteins in the yeast cell wall that have successfully folded and trafficked from the 
ER, it likely underestimates the affect of deleterious mutations to OTase (15,16). The analysis 
used Endo H to release N-glycans, leaving a single GlcNAc “tag” on previously glycosylated 
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asparagines. LC-ESI-MS/MS analysis could then detect GlcNAc-modified (glycosylated) and 
unmodified (non-glycosylated) forms of the same peptide to measure site-specific glycosylation 
occupancy at many different asparagines. For example, this approach detected both GlcNAc-
modified and unmodified forms of peptide V91-K105 from Gas1p, which contains a potential 
glycosylation site at N95 (Fig. 2A,B).  
 
We first compared yeast with only Ost3p-OTase or with only Ost6p-OTase. Consistent with 
previous reports (12,14,15), this analysis confirmed that certain asparagines required Ost3p-
OTase for efficient glycosylation equivalent to wild type cells, while others required Ost6p-
OTase. For example, glycosylation occupancy at N95 in Gas1p was significantly lower in yeast 
with only Ost6p-OTase compared to yeast with only Ost3p-OTase, indicating a requirement for 
Ost3p-OTase for efficient glycosylation at this site (Figure 2C,E). Equivalent analyses were 
performed in biological triplicate for the other robustly detected glycosylation sites in cell wall 
glycoproteins (Figure 3A column pOST3:pOST6, Table S1). This showed that efficient 
glycosylation at N253 in Gas1p required Ost6p-OTase, as has been previously reported (15). In 
contrast, Ost3p-OTase was required for efficient glycosylation at: N79 in Sag1p; N40, N57 and 
N95 in Gas1p; N177 in Crh1p, N304 and N328 in Ecm33p, N491 in Plb2p and N60 in Gas5p. 
While qualitatively consistent, our analysis here showed a stronger requirement for Ost3p-OTase 
than previous reports (15). Indeed, all asparagines that were glycosylated in wild type cells 
required the presence of either Ost3p or Ost6p for efficient glycosylation (Table S1), 
highlighting the importance of Ost3p/Ost6p-mediated glycosylation. Further, Gas1p contained 
three sites (N40, N57 and N95) that required Ost3p and one site (N253) that required Ost6p. As 
all of these sites are efficiently glycosylated in wild type yeast (with both Ost3p and Ost6p), this 
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result implies that both Ost3p-OTase and Ost6p-OTase isoforms are located concurrently at the 
same translocon. This is consistent with previous genetic and biochemical studies (13,15,16), 
although split-ubiquitin studies have proposed that Ost3p and Ost6p interact differentially with 
the Sec61 and Ssh1 translocons (23).  
 
We next tested the effect of mutations in the peptide-binding grooves of Ost3p and Ost6p on in 
vivo site-specific glycosylation. For this, we compared site-specific glycosylation occupancy in 
yeast with only Ost3Q103K,106K-OTase to yeast with only Ost3p-OTase; and in yeast with only 
Ost6K96Q,K99Q-OTase to yeast with only Ost6p-OTase. These point mutations did affect in vivo 
glycosylation efficiency at selected sites. For example, glycosylation occupancy at N95 in Gas1p 
was higher in yeast with only Ost6K96Q,K99Q-OTase compared to yeast with only Ost6p-OTase 
(Figure 2C,D), while occupancy at this site was lower in yeast with only Ost3Q103K,Q106K-OTase 
compared to yeast with only Ost3p-OTase (Figure 2E,F). We performed equivalent analyses in 
biological triplicate for the other robustly detected glycosylation sites in cell wall glycoproteins 
(Figure 3A columns pOST6QQ:pOST6 and pOST3KK:pOST3, and Table S1).  N57 and N95 in 
Gas1p and N328 in Ecm33p required Ost3p for efficient glycosylation and were under-
glycosylated with Ost6p (Figure 3A,B,C,E and Table S1). However, this requirement for Ost3p 
was dependent on a neutral Ost3p/Ost6p peptide binding groove, as occupancy at Gas1p N57 
and N95 was increased in the Ost6K96Q,K99Q variant and occupancy at all three sites was 
decreased in the Ost3Q101K,Q103K variant, relative to wild-type proteins (Figure 3A,B,C,E and 
Table S1). In contrast, N253 in Gas1p required Ost6p for efficient glycosylation, and occupancy 
at this site was increased in the Ost3Q101K,Q103K variant (Figure 3A,D and Table S1). These effects 
on site-specific glycosylation occupancy were consistent with growth of the corresponding yeast 
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strains. While the growth defect of Δost3/Δost6 yeast was fully complemented by Ost3p and 
partially complemented by Ost6p, expression of Ost3Q101K,Q103K variant reduced growth relative 
to Ost3p (Figure S1), consistent with inefficient glycosylation at several asparagines in this strain 
(Figure 3). In summary, glycosylation by Ost6p-OTase at sites requiring Ost3p-OTase could be 
increased with point mutation to make Ost6p more like Ost3p, and vice versa. These results 
showed that point mutations that affect in vitro peptide binding by Ost3p and Ost6p also affected 
in vivo site-specific glycosylation occupancy, consistent with nascent polypeptide interacting 
directly with the grooves of Ost3p/Ost6p.  
 
Mapping sites of interaction between substrate and Ost6p 
Efficient glycosylation at N57 and N95 of Gas1p and N328 of Ecm33p required the absence of 
basic lysine residues in the peptide-binding groove of Ost3p/Ost6p (Figure 3A,B,C,E, Table S1). 
This suggested that specific basic amino acid residues in the Gas1p and Ecm33p nascent 
polypeptides caused electrostatic repulsion with Ost6p or Ost3Q101K,Q103K, which had basic 
peptide-binding grooves (Figure 3F). We used this effect to identify the precise sites of 
interaction between the Gas1p substrate nascent polypeptide and the Ost6p peptide-binding 
groove in vivo.  
 
We performed scanning mutagenesis of basic to neutral residues through the Gas1p sequence 
surrounding N57 and N95 and measured the occupancy of Gas1p glycosylation sites in each of 
these variant proteins in cells expressing Ost6p-OTase (see Figure S2). We predicted that 
mutagenesis of specific basic residues in Gas1p would eliminate the electrostatic repulsion and 
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allow binding to the basic peptide-binding groove of Ost6p, which would then increase the 
extent of glycosylation in a site-specific manner. Analysis of these cells showed a large and 
significant increase in occupancy at N95 in Gas1p only with mutation at R90 (Figure 4A,C and 
Table S2). This indicated that R90 in wild type Gas1p limited binding of this stretch of 
polypeptide to wild type Ost6p through electrostatic repulsion with the Ost6p peptide-binding 
groove, and that binding of Gas1p nascent polypeptide proximal to R90 with Ost6p was required 
for efficient glycosylation of N95. In contrast, occupancy at N57 was increased with mutation at 
R47, R76 or R90 (Figure 4A,B and Table S2). We interpreted this result as indicating that 
increased glycosylation of N57 could be achieved through binding at any one of these positions 
in Gas1p to Ost6p, or alternatively that some of these mutations destabilized Gas1p, leading to 
increased glycosylation independent of Ost6p binding. To distinguish between these possibilities 
we analysed the Gas1p variants in yeast with Ost6K96Q,K99Q-OTase. Electrostatic repulsion 
between Ost6p and a section of Gas1p would require that each are positively charged, and point 
mutation to remove the charge on either one or on both would eliminate the repulsion. Therefore, 
increased occupancy with Ost6K96Q,K99Q relative to Ost6p for a particular Gas1p R variant would 
indicate that binding of that position in Gas1p to Ost6p was not required for glycosylation, while 
no change in occupancy would be consistent with that site in Gas1p binding to Ost6p to increase 
site-specific glycosylation occupancy. Analysis of these cells showed that in the Gas1R90Q 
variant, occupancy at N95 did not increase with Ost6K96Q,K99Q compared with Ost6p (Figure 4F 
and Table S3), consistent with the initial scanning mutagenesis (Figure 4A,C and Table S2) and 
with Gas1p nascent polypeptide proximal to R90 binding Ost6p to enhance glycosylation at N95. 
For N57 in Gas1p, occupancy increased with Ost6K96Q,K99Q relative to Ost6p for Gas1R76Q and 
Gas1R90Q but not for Gas1R47Q (Figure 4D,E and Table S3). This indicated that binding near R47 
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of Gas1p to Ost6p was required for efficient glycosylation of N57. Consistent with point 
mutations at R76 and R90 increasing glycosylation of N57 by destabilizing Gas1p, N57 is in a 
surface exposed loop of Gas1p in contrast to N95, which is relatively inaccessible (24) (Figure 
S3). Together, the data showed that transient binding to Ost3p/Ost6p of stretches of Gas1p 
nascent polypeptide proximal and N-terminal to N57 and N95 allowed efficient glycosylation at 
these sites (Figure 4G).  
 
In vitro validation of in vivo peptide binding by Ost6p 
To confirm that the increased glycosylation we observed in the Gas1p variants was due to 
increased physical association of stretches of Gas1p with Ost6p we performed in vitro peptide 
binding experiments. We expressed and purified Gas1p and Gas1R90Q as MBP-fusion proteins in 
E. coli and digested the proteins with AspN to obtain unglycosylated peptides similar to nascent 
polypeptide entering the ER lumen, which is the physiological substrate of OTase (Figure 5A). 
Peptides were applied to resin containing bound MBP-Ost6L, with the active-site CxxC motif 
either oxidized or reduced by pre-incubation with DTT. The peptide-binding groove is only 
present when the CxxC motif is oxidized, and peptides do not bind when this motif is reduced 
(16,18). We measured the MBP-Gas1 peptides present in each wash fraction by LC-ESI-MS/MS 
and observed increased retention of the robustly detected Gas1p77-108 peptide from the 
Gas1R90Q variant compared with wild type Gas1p with oxidized (Figure 5D) but not reduced 
(Figure 5C) Ost6p, compared to the load (Figure 5B). This indicated that Gas1R90Q mutation 
increased in vitro interaction with the Ost6p peptide-binding groove (Figure 5E), consistent with 
our in vivo results (Figure 3,4).  
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To gauge the generality of our results, we inspected the sequence N-terminal and proximal to 
glycosylation sites dependent on the presence of basic residues lining the peptide binding groove 
of either Ost3p or Ost6p (Figure 3A) and compared the characteristics of these sequences (Figure 
6). Although Ost3p and Ost6p have different charge preferences, both require the presence of 
short stretches of hydrophobic amino acids in peptides for efficient binding (18,25). The closest 
hydrophobic sequence stretches N-terminal to N57 and N95 in Gas1p and N328 in Ecm33p were 
flanked by basic amino acids, consistent with efficient glycosylation of these sites requiring 
neutral peptide-binding grooves in Ost3p or Ost6p. In contrast, N253 in Gas1p had a 
hydrophobic stretch with acidic amino acids nearby, consistent with its preference for basic 
Ost3p or Ost6p.  
 
Model of Ost3p/Ost6p function in vivo 
Together, our data showed that Ost3p/Ost6p transiently bound hydrophobic stretches of nascent 
polypeptide substrate proximal and N-terminal to specific asparagines to increase their 
glycosylation efficiency. Based on these findings we propose a mechanistic model of 
Ost3p/Ost6p function in N-glycosylation (Figure 7). In this model, short hydrophobic stretches 
of nascent polypeptide exiting the translocon into the ER lumen (Figure 7A) bind to the peptide-
binding groove of Ost3p/Ost6p independent of the location of nearby glycosylation sites (Figure 
7B). This binding is non-covalent (18) or through a mixed disulfide (17) and depends on 
complementarity between the stretch of nascent polypeptide and the peptide-binding groove of 
Ost3p/Ost6p (Figures 4-6). Mutations at the thioredoxin-like CxxC active site motif of 
 16 
Ost3p/Ost6p in vivo in yeast affect glycosylation at only ~10% of sites (16), suggesting the non-
covalent mode of binding is dominant, and mixed disulfides form only when cysteines are 
appropriately positioned in stretches of bound nascent polypeptide. In either mode, this 
sequestration physically separates polypeptide that has already translocated into the ER lumen 
from newly translocating sequence. Continued translocation therefore produces a loop of nascent 
polypeptide with its ends constrained by the translocon exit and the Ost3p/Ost6p groove (Figure 
7C). As OTase is physically associated with the translocon (3), and Ost3p/Ost6p is adjacent to 
Stt3p in the OTase complex (2,26), this configuration produces a flexible loop of nascent 
polypeptide in close proximity to the acceptor peptide binding site of Stt3p. This presents 
asparagines in glycosylation sequons to the active site of OTase in the form of short flexible 
peptides that are optimal substrates for efficient glycosylation (4,27,28) (Figure 7D,E). 
Ost3p/Ost6p peptide binding is transient (16-18) (Figure 7F), allowing continued translocation 
and folding of the glycosylated polypeptide (Figure 7G). Incorporation of Ost3p/Ost6p into 
OTase would therefore enhance glycosylation of diverse proteins, while their distinct peptide-
binding specificities (17,18,25) would further increase the range of efficiently modified 
substrates. 
 
Transient binding of short hydrophobic stretches of nascent polypeptide by Ost3p and Ost6p is 
reminiscent of the activity of co-translational Hsp70 chaperones such as cytoplasmic SSA/SSB 
(29) and ER lumenal Kar2p (BiP) (30), which assist co-translational folding (31,32). As binding 
to Ost3p or Ost6p is independent of the presence of a nearby glycosylation site, all stretches of 
nascent polypeptides with sufficient affinity to either Ost3p or Ost6p are likely transiently 
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sequestered. This may therefore facilitate proteome-wide co-translational folding of proteins 
translocated into the ER, independent of their glycosylation status.  
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Figure Legends 
 
Figure 1. Overview of experimental manipulation of yeast OTase isoforms. (A) OTase in 
wild type yeast has eight subunits, with two isoforms defined by incorporation of either of the 
homologous Ost3p or Ost6p subunits. Yeast with only (B) Ost3p-OTase or (C) Ost6p-OTase 
were constructed by genomic deletion of OST3 and OST6 with overexpression of either Ost3p or 
Ost6p. (D) Yeast with a single variant OTase isoform were constructed by overexpression of 
variant Ost3p or Ost6p, for example Ost3Q103K,Q106K.  
 
Figure 2. LC-ESI-MS/MS identification and relative quantification of glycosylation 
occupancy at N95 in Gas1p. ProteinPilot matched fragmentation of (A) GlcNAc-modified and 
(B) unmodified peptide V91-K105 from Gas1p. Single ion chromatograms corresponding to 
GlcNAc-modified (GlcNAc-N, black) and unmodified (N, gray) peptide V91-K105 from Gas1p 
([M+3H]3+ ions at an m/z of 666.98 and 559.30, respectively) from yeast with only (C) Ost6p-
OTase (∆ost3/∆ost6 pOST6), (D) Ost6K96Q,K99Q-OTase (∆ost3/∆ost6 pOST6K96Q,K99Q), (E) 
Ost3p-OTase (∆ost3/∆ost6 pOST3), or (F) Ost3Q103K,Q106K-OTase (∆ost3/∆ost6 
pOST3Q103K,Q106K), Horizontal gray lines are aligned with the peak height of the unmodified 
peptide in (C) between (C) and (D), and in (F) between (E) and (F).    
 
Figure 3. Ost3p and Ost6p peptide-binding groove variants affect in vivo site-specific 
glycosylation. (A) Relative occupancy at different glycosylation sites (e.g. N79 in Sag1p) in 
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∆ost3/∆ost6 cells with: pOST3 relative to pOST6 (pOST3:pOST6); pOST6K96Q,K99Q relative to 
pOST6 (pOST6QQ:pOST6); and pOST3Q103K,Q106K relative to pOST3 (pOST3KK:pOST3). Ratio is 
mapped from yellow (increase) to blue (decrease) or black (no change), see color key inset. *, 
P<0.05 ANOVA. Occupancy of (B) N57 in Gas1p (C) N95 in Gas1p, (D) N253 in Gas1p and 
(E) N328 in Ecm33p in various yeast strains. Values are mean. Error bars are s.e.m.. *, P<0.05 
ANOVA. (F) Cartoon surface representation of proposed binding of hydrophobic and neutral 
(black) but not hydrophobic and basic (blue) stretches of nascent polypeptide by the basic 
peptide binding groove of Ost6p (PDB ID 3G7Y (16,18)).  
 
Figure 4. Mapping sites of interaction between Ost6p and Gas1p.  (A) Relative occupancy at 
N40, N57, N95 and N253 in Gas1p variants compared to wild type Gas1p expressed in 
∆ost3/∆ost6 pOST6 cells. Colour as in Fig. 3A. *, P<0.05 ANOVA. Occupancy of (B) N57 in 
Gas1p and (C) N95 in Gas1p in various yeast strains. Values are mean. Error bars are s.e.m..*, 
P<0.05 ANOVA. (D) Relative occupancy at N57 and N95 in Gas1p variants expressed in 
∆ost3/∆ost6 pOST6K96Q,K99Q compared to ∆ost3/∆ost6 pOST6. Colour as in Fig. 3A. Occupancy 
of (E) N57 in Gas1p and (F) N95 in Gas1p in various Gas1p variants expressed in ∆ost3/∆ost6 
pOST6 (black) or ∆ost3/∆ost6 pOST6K96Q,K99Q (white). Values are mean. Error bars are s.e.m.. *, 
P<0.05 ANOVA. (G) Position of basic-neutral point mutations (blue) in Gas1p that increased 
occupancy at specific glycosylation sites (green).  
 
Figure 5. Non-covalent peptide binding by Ost6p in vitro. (A) Aligned AspN peptides from 
MBP-Gas1 and MBP-Gas1R90Q detected by LC-ESI-MS/MS. Extracted ion chromatograms of 
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peptide from MBP-Gas1 (solid) and MBP-Gas1R90Q (dashed) in (B) load, and second wash 
fraction with (C) reduced MBP-Ost6 and (D) oxidized MBP-Ost6. (E) Relative enrichment of 
the Gas177-108 versus the Gas1R90Q 77-108 peptide by columns with attached oxidized MBP-Ost6. 
Data are average of triplicates. Error bars indicate range.   
 
Figure 6. Conservation of sequence characteristics at sites of Ost3p/Ost6p interaction. 
Validated and predicted stretches of substrate proteins Gas1p and Ecm33p that bind to Ost3p or 
Ost6p. Underlined, glycosylation sequon. Grey shading, extended hydrophobic sequence. Blue, 
basic amino acid. Red, acidic amino acid. 
 
Figure 7. Mechanistic model of Ost3p/Ost6p function in N-glycosylation. (A) Partially 
translocated and folded nascent polypeptide enters the ER lumen from the translocon. (B) A 
stretch of nascent polypeptide (red) with affinity for Ost3p/Ost6p is sequestered at the peptide-
binding groove. (C) Continued translocation produces a flexible loop of nascent polypeptide kept 
physically separate from previously translocated polypeptide. (D) Glycosylation sequons in the 
loop are presented to the acceptor-binding site of Stt3p in a glycosylation-competent form and 
(E) efficiently glycosylated. (F) Non-covalent or mixed-disulfide binding of nascent polypeptide 
to Ost3p/Ost6p is transient, and (G) translocation and folding continues. Ost3p/Ost6p and Stt3p 
are physically adjacent in OTase (2) but are shown separately for clarity. See text for details.
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Table S1.  Site-specific N-glycosylation occupancy in wild type and Ost3p/Ost6p variant 
expressing yeast strains. 
Strain 
∆ost3/∆ost6 Glycosylation 
site Wild type 
pOST3 
pOST3 
Q103K,Q106K 
pOST6 
pOST6 
K96Q,K99Q 
p 
Sag1p N79 0.35±0.03 0.40±0.04* 0.36±0.08 0.04±0.02 0.02±0.00 0.02±0.04 
Gas1p N40 1.00±0.00 1.00±0.00* 1.00±0.00 0.94±0.01 0.95±0.01 0.62±0.11 
Gas1p N57 0.97±0.01 0.98±0.02* 0.91±0.01* 0.81±0.04 0.89±0.03* 0.32±0.05 
Gas1p N95 0.99±0.01 1.00±0.01* 0.95±0.02* 0.81±0.02 0.89±0.02* 0.25±0.03 
Gas1p N253 0.99±0.01 0.75±0.02* 0.83±0.02* 0.99±0.00 0.98±0.00 0.88±0.06 
Crh1p N177 1.00±0.00 0.99±0.01* 0.99±0.02 0.65±0.02 0.69±0.06 0.27±0.03 
Ecm33p N304 0.97±0.04 0.99±0.02* 0.91±0.09 0.36±0.06 0.41±0.02 0.07±0.08 
Ecn33p N328 0.96±0.06 0.98±0.04* 0.80±0.00* 0.63±0.04 0.71±0.09 0.06±0.01 
Plb2p N491 0.99±0.01 1.00±0.01 1.00±0.01 0.92±0.03 0.95±0.03 0.40±0.18 
Gas5p N60 1.00±0.00 1.00±0.00* 0.96±0.07 0.67±0.08 0.77±0.06 0.07±0.02 
Cwp1p N45 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 
Ccw14p N87 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 
Tos1p N417 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 
*, P<0.05 ANOVA comparing occupancy with pOST3 and pOST6, pOST3Q101K,Q103K to pOST3, or 
pOST6K96Q,K99Q to pOST6. Values show mean. Error shows s.e.m.. n=3. 
 
 
 
  
Table S2.  Site-specific N-glycosylation occupancy in Gas1p variants expressed in 
∆ost3/∆ost6 pOST6 yeast.  
Strain 
∆ost3/∆ost6 pOST6 
 
Glycosylation 
site pGAS1 
pGAS1 
K34Q 
pGAS1  
R47Q 
pGAS1 
R76Q 
pGAS1 
K82Q,K83Q 
pGAS1 
R90Q 
pGAS1 
K105Q 
Gas1p N40 0.84±0.08 0.91±0.02 n.d.# 0.88±0.06 0.80±0.15 0.88±0.09 0.84±0.09 
Gas1p N57 0.71±0.10 0.69±0.17 0.85±0.04* 0.85±0.02* 0.73±0.02 0.85±0.05* 0.64±0.10 
Gas1p N95 0.70±0.10 0.65±0.16 0.75±0.16 0.84±0.09 0.83±0.03 0.95±0.03* 0.73±0.09 
Gas1p N253 1.00±0.00 1.00±0.00 1.00±0.00 1.00±0.00 1.00±0.00 1.00±0.00 1.00±0.00 
*, P<0.05 ANOVA compared to occupancy in wild type Gas1p. Values show mean. Error shows s.e.m.. n=3. #, n.d. 
not detected. 
 
  
Table S3.  Site-specific N-glycosylation occupancy in Gas1p variants expressed in 
∆ost3/∆ost6 pOST6 K96Q,K99Q yeast. 
Strain 
∆Ost3/∆Ost6 Post6K96Q,K99Q 
Glycosylation 
site 
pGAS1 pGAS1R47Q pGAS1R76Q pGAS1R90Q 
Gas1p N40 0.96±0.02 0.94±0.02 0.95±0.01 0.96±0.01 
Gas1p N57 0.81±0.04* 0.85±0.03 0.89±0.01* 0.88±0.03* 
Gas1p N95 0.80±0.03* 0.86±0.03* 0.87±0.01 0.95±0.02 
Gas1p N253 1.00±0.00 1.00±0.00 1.00±0.00 1.00±0.00 
*, P<0.05 ANOVA comparing occupancy with pOST6K96Q,K99Q to pOST6. Values show mean. 
Error shows s.e.m.. n=3. 
 
 
  
!
 
Figure S1. Growth of yeast expressing variant Ost3p or Ost6p. 5-fold serial dilutions of yeast 
cells from wild type with empty vector (WT p) or !ost3/!ost6 cells with p, pOST3, 
pOST3Q101K,Q103K, pOST6, or pOST6K96Q,K99Q were grown on minimal media agar for 1 day at 
30°C.  
  
!
Figure S2. Approach for mapping sites of interaction between protein substrate and Ost6p. 
Model substrate protein Gas1p is efficiently glycosylated at e.g. N95 by (A) Ost3p or (C) Ost6p-
K96Q,K00Q but not by (B) basic Ost6p. Scanning basic-to-neutral point mutagenesis through Gas1p 
  
maps the site of interaction with Ost6p relevant for glycosylation. (D,F,H) Basic residues (blue) 
in Gas1p limit glycosylation by preventing interaction with Ost6p. (E,G,I) Basic-to-neutral 
mutations (black) allow transient binding, but (G) increase glycosylation only at the site of 
interaction that presents glycosylation-competent N95 to Stt3p (see Fig. 4). 
 
  
!
Figure S3. Cartoon of glycosylation sites in mature Gas1p. Gas1p was modelled on the 
structure of Gas2p (PDB ID 2W61) (20). Green, glycosylation sites N57 and N95. Blue, basic 
residues R47, R76 and R90. 
!
!
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Chapter 3 
Selected reaction monitoring Mass Spectrometry for 
targeted peptide multi-analyte affinity chromatography 
defines the peptide-binding activities of yeast 
Oligosaccharyltransferase subunits Ost3p and Ost6p 
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3.1 Introduction to this publication  
In this article, we investigated the in vitro interactions between substrate polypeptide and Ost3p 
and/or Ost6p by peptide affinity chromatography and selected-reaction-monitoring mass 
spectrometry (SRM-MS). We developed and used SRM-MS for improved relative quantification 
and sensitivity for detection in conjunction with peptide affinity chromatography. We show that 
Ost3p and Ost6p bind distinct subsets of peptides from a yeast cell wall glycoprotein substrate, with 
Ost3p binding peptides rich in aromatic acids and Ost6p binding peptides rich in aliphatic amino 
acids. Our data supports a model of Ost3p and Ost6p function in which they transiently bind 
complementary hydrophobic stretches of nascent polypeptide substrate to optimally inhibit protein 
folding, thereby increasing glycosylation efficiency at nearby asparagine residues.  
 
3.2 Declaration on authorship 
In accordance with The University of Queensland, the methods, results and discussion are presented 
in the form of a publication style in the peer-reviewed journal. This article will be submitted to the 
journal Analytical Biochemistry or Journal of Chromatography B Analytical Technology 
Biomedical Life Sciences. The contributions of all authors are mentioned in Section 3.3 
 
3.3 Article to be submitted 
“Selected reaction monitoring Mass Spectrometry for targeted peptide multi-analyte affinity 
chromatography defines the peptide-binding activities of yeast Oligosaccharyltransferase 
subunits Ost3p and Ost6p” 
Jamaluddin MF, Bailey UM, Schulz BL 
Draft ready for submission. 
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Contributions: 
This paper describes a detection method using SRM-MS when coupled to peptide affinity 
chromatography provides significant improvements in sensitivity and quantification that defines the 
peptide binding characteristics of native yeast Ost3p and Ost6p.  
This work presented here was done under the supervision of Dr Benjamin Schulz. 
Dr Benjamin Schulz, Dr Maja Bailey and I planned experiments; I performed in vitro peptide 
binding assays; Dr Benjamin Schulz and I performed mass spectrometry; Dr Benjamin Schulz, Dr 
Maja Bailey and I wrote the manuscript. All the authors contributed to the critical reviewing of the 
manuscript before the submission.  
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Abstract 
Asparagine-linked glycosylation is a common post-translational modification that regulates the 
structure and function of secretory and membrane proteins in eukaryotes. This process is catalysed 
by the multiprotein complex oligosaccharyltranferase (OTase). Two isoforms of OTase exist in the 
yeast Saccharomyces cerevisiae, determined by the presence of either of the homologous proteins 
Ost3p or Ost6p. These accessory OTase protein subunits are not involved in catalysis, but instead 
regulate the protein substrate specificity of OTase. Ost3p and Ost6p have an ER lumenal 
thioredoxin-like domain with peptide-binding grooves that can transiently bind stretches of 
polypeptide. Here, we describe an analytical technique using in vitro peptide affinity 
chromatography and selected-reaction-monitoring mass spectrometry to detect peptides that bind to 
the peptide-binding grooves of Ost3p and Ost6p. We show that Ost3p and Ost6p bind distinct 
subsets of peptides from a yeast cell wall glycoprotein substrate, with Ost3p binding peptides rich 
in aromatic acids and Ost6p binding peptides rich in aliphatic amino acids. Our data supports a 
model of Ost3p and Ost6p function in which they transiently bind complementary hydrophobic 
stretches of nascent polypeptide substrate to optimally inhibit protein folding, thereby increasing 
glycosylation efficiency at nearby asparagine residues. 
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Text 
Introduction 
Asparagine (N)-linked glycosylation is the most prevalent post-translational modification of 
secretory proteins in eukaryotes, and also occurs in archaea and some bacteria [1-3]. In eukaryotic 
cells, oligosaccharyltransferase (OTase) is an integral membrane protein that catalyzes N-
glycosylation of nascent polypeptides in the lumen of the endoplasmic reticulum (ER) [4]. OTase is 
physically associated with the translocon complex [5] and transfers an oligosaccaryl moiety 
Glucose3Mannose9N-acetylglucosamine2 from a dolichol-pyrophosphate donor onto Asn side-
chains in emerging polypeptides [4]. The efficiency of glycosylation of Asn residues dramatically 
increased if they are present in glycosylation “sequons” (Asn-Xaa-Thr/Ser; Xaa≠Pro), the peptide 
recognition motif of the catalytic site of OTase [6]. N-glycosylation is crucial for efficient 
glycoprotein folding in the ER by locally recruiting the disulfide isomerase ERp57 through the 
lectins calnexin and calreticulin [7, 8]. Once proteins are correctly folded, they are free to traffic 
through the Golgi, where further modification and extension of glycan structures can occur [8]. The 
precise glycan structures present on mature glycoproteins are often vital for their biological 
functions such as the immune response, embryonic development and cancer [9-12].  
 
Two isoforms of OTase exist in the yeast Saccharomyces cerevisiae, determined by the presence of 
either of the homologous proteins Ost3p or Ost6p [13-15]. These proteins have an ER lumenal 
thioredoxin-like domain followed by four transmembrane helices. Efficient glycosylation of 
selected Asn residues requires Ost3p, while others require Ost6p [13, 14, 16, 17]. Ost3p and Ost6p 
have thioredoxin-like ER soluble domains with peptide-binding grooves adjacent to their CxxC 
redox active sites [18]. This groove is only present when the CxxC motif is oxidized, and becomes 
flexibly disordered upon reduction [18]. The grooves of Ost3p and Ost6p can transiently bind 
selected peptides with complementary characteristics to these peptide-binding grooves [19]. The 
groove of Ost6p has a hydrophobic base lined by basic residues, and binds peptides enriched in 
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hydrophobic and acidic amino acid resides [19]. Furthermore, the peptide-binding activities of 
Ost3p and Ost6p can be engineered by targeted mutations to their peptide-binding grooves. Point 
mutations removing the basic residues lining the Ost6p groove abolish peptide binding, while 
mutations to insert basic residues in place of the natively neutral residues lining the Ost3p groove 
lead to binding of a hydrophobic and acidic peptide that also binds to wild type Ost6p [19]. These 
studies used matrix-assisted-laser-desorption-ionization time-of-flight mass spectrometry (MALDI-
Tof/Tof-MS) to detect differentially bound peptides [19]. Despite robustly identifying 35 tryptic 
peptides from a model yeast cell wall glycoprotein, Gas1p, and detecting three peptides that bound 
to Ost6p and variant Ost3p, this study was unable to identify any peptides that showed significant 
retention to native Ost3p [19].  
 
Here, we developed and used selected-reaction-monitoring mass spectrometry (SRM-MS) for 
improved relative quantification and sensitivity for detection in conjunction with peptide affinity 
chromatography. We used this method to identify peptides from a model substrate protein, Gas1p, 
that bound to the peptide-binding grooves of both native Ost3p and Ost6p. 
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Materials and methods  
 
Peptide affinity chromatography  
Preparation of reagents for in vitro peptide affinity chromatography experiments was performed as 
previously described [19]. MBP-Ost3p, MBP-Ost6p and MBP-Gas1p were expressed in E. coli and 
purified by amylose-agarose affinity chromatography, and MBP-Gas1p was reduced/alkylated and 
digested with trypsin. After digestion, residual active trypsin was inactivated by incubation with 
PMSF. Peptide affinity chromatography was performed as described [19]. Briefly, tryptic peptides 
from MBP-Gas1p in column buffer (20 mM TrisHCl pH 7.5, 200 mM NaCl, 1 mM EDTA) were 
applied to amylose-agarose beads containing bound MBP-Ost3p or MBP-Ost6p, with the Ost3p and 
Ost6p CxxC motifs either oxidized, or reduced by prior incubation with DTT. Peptides were 
washed from the affinity matrix by sequential gravity flow washing with column buffer, and wash 
fractions collected. Peptides in the load and wash fractions were then detected by LC-SRM-MS.  
 
Mass spectrometry  
Peptides in load and wash fractions were measured by LC-SRM-MS using an ABSCIEX 5500 
QTRAP. Peptides were separated by C-18 LC as described [20]. Scheduled SRM transitions were 
performed according to optimised parameters (Tab 1). The precursor (Q1) to fragment ion (Q3) 
transitions, used to measure one targeted peptide. (Q1) selects the specific parent mass and (Q3) 
selects the specific fragment mass. Peptide retention times were spread over the 30 min LC gradient 
with 120 s SRM detection windows used for acquisition of each transition and a target scan time of 
2 s. All LC-SRM-MS experiments were performed in triplicate. The relative enrichment of each 
peptide in each wash fraction was determined as described [19] by the abundance of the peptide as 
measured by the integrated SRM peak area as a fraction of the total abundance of all detected 
peptides in that fraction. Interactions with the peptide-binding groove of Ost3p and Ost6p were 
determined for each peptide by the log of the relative abundance of each peptide in each wash 
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fraction between the oxidized and reduced versions of Ost3p or Ost6p using a two-sided paired 
student’s t-test with P < 0.005. Peptide characteristics were determined using ProtParam [21]. 
 
Results and Discussion 
 
The Ost3p and Ost6p accessory subunits of yeast OTase assist efficient N-glycosylation at distinct 
subset of glycosylated asparagines [16]. A model of Ost3/6p function proposes that these accessory 
proteins assist N-glycosylation by transiently binding stretches of nascent polypeptide 
complementary to the characteristics of their peptide-binding grooves [18]. In this study we have 
performed peptide affinity chromatography coupled to LC-SRM-MS to identify the characteristics 
of peptides that bind to both native Ost3p and Ost6p.  
 
Previous similar in vitro peptide binding experiments identified stretches of polypeptide that 
interacted with the peptide-binding grooves of Ost6p and variant Ost3p [19]. These studies used a 
model glycoprotein substrate of Ost3/6p, the yeast cell wall glycoprotein Gas1p. Gas1p was 
efficiently expressed and purified as MBP-fusion protein in E.coli in order to obtain unglycosylated 
polypeptide similar to nascent polypeptide entering the ER lumen, which is the physiological 
substrate of OTase. Purified unglycosylated MBP-Gas1p was digested with Trypsin and applied to 
resin containing bound MBP-Ost3p or MBP-Ost6p, with the active-site CxxC motif either oxidized, 
or reduced by pre-incubation with DTT. The peptide-binding groove is only present when the CxxC 
motif is oxidized, and peptides do not bind when this motif is reduced [18]. 
We performed peptide affinity chromatography as previously described [19], and then measured the 
MBP-Gas1p tryptic peptides present in the load and wash fractions by LC-SRM-MS. This rapid, 
sensitive detection and relative quantification proved superior to the previously utilized detection 
with MALDI-Tof/Tof-MS [19]. Of the 38 MBP-Gas1p tryptic peptides robustly detected, 14 
peptides were identified that were retained by affinity columns with oxidized, but not reduced, 
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MBP-Ost6p, indicating that they bound at the peptide-binding groove of Ost6p (Tab. 2). 
Comparison of the biophysical characteristics of peptides that bound or did not bind to the peptide-
binding groove of Ost6p were in agreement with the previously reported ability of Ost6p to 
specifically bind peptides enriched in aliphatic residues (Fig. 1B) [19]. We then tested if LC-SRM-
MS improved detection for peptide affinity chromatography of MBP-Gas1p peptides interacting 
with the Ost3p. Indeed, our LC-SRM-MS approach successfully identified six peptides that were 
retained by affinity matrix with oxidized, but not reduced, MBP-Ost3p, indicating that they bound 
at the Ost3p peptide-binding groove. These peptides that bound to Ost3p were significantly 
enriched in aromatic amino acids (Fig 1D). Notably, the aromatic amino acids in these peptides 
tended to be clustered, fitting the approximate dimensions of the Ost3/6p peptide binding grooves 
[18, 19]. 
 
Ost3p and Ost6p bound distinct sets of tryptic peptides from MBP-Gas1p, as Ost3p bound peptides 
enriched with aromatic residues, while Ost6p bound peptides enriched with aliphatic residues (Tab. 
2, Fig. 1). The crystal structure of Ost6p shows that it possesses a peptide-binding groove with a 
base of aliphatic amino acids (Fig. 2A,B) [18]. Sequence alignment of Ost3p and Ost6p shows that 
Ost3p has an aromatic amino acid Phe102 in place of the aliphatic Val95 in Ost6p (Fig. 2C). Thus, 
binding of peptides enriched with aliphatic residues by the peptide-binding groove of Ost6 
correlates with the aliphatic amino acids forming the base of the groove in Ost6p, while in contrast, 
Ost3p binds peptides rich in aromatic amino acids, correlating with the presence of Phe in its 
peptide-binding groove. That is, the peptides that bound to Ost3p and Ost6p had different physical 
characteristics complementary to the respective characteristics of the peptide-binding grooves of 
Ost3p and Ost6p. This is consistent with the proposed model of Ost3/6p activity, in that different 
stretches of nascent polypeptide would be bound by OTase isoforms containing Ost3p or Ost6p, 
which would enhance glycosylation efficiency of nearby sequons in an OTase isoform-dependent 
manner [16, 18]. Transient tethering of hydrophobic sections of nascent polypeptide would 
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efficiently inhibit local protein folding, as such hydrophobic sections are typically internal to mature 
folded protein domains. This correlates with the requirement of the catalytic site of OTase for 
unfolded protein acceptor substrate [6]. The distinct peptide binding activities of Ost3p and Ost6p 
would broaden the range of this protein folding inhibition, with binding of hydrophobic stretches of 
nascent polypeptide enriched with aliphatic amino acids by Ost6p and aromatic acids by Ost3p. 
This apparent duplication and diversification of OTase substrate specificity is similar to the 
different protein acceptor specificities based on local charge of the single protein OTases in 
Trypanosoma brucei [22, 23], and based on ill-defined characteristics in Leishmania major [24]. 
 
In conclusion, we have made use of sensitive LC-SRM-MS detection for relative quantification 
following multi-peptide affinity chromatography to define the peptide binding characteristics of 
native yeast Ost3p and Ost6p. Use of LC-SRM-MS as a detection method when coupled to peptide 
affinity chromatography provided significant improvements in sensitivity and quantification, and as 
such similar methods may be generically applicable for other peptide or multi-analyte affinity 
chromatography. 
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Table 1:  SRM transitions and instrument parameters. 
Q1 
mass 
(Da) 
Q3 
mass 
(Da) 
Time 
(min) Peptide sequence 
CE 
(volts) 
     
529.31 732.37 14.2 MBP-Gas1.LVIWINGDK.2/y6 23.000 
504.26 787.43 10 MBP-Gas1.GYNGLAEVGK.2/y8 22.000 
462.74 625.29 12.4 MBP-Gas1.VTVEHPDK.2/y5 25.000 
738.36 1057.56 16.6 MBP-Gas1.FPQVAATGDGPDIIFWAHDR.3/y8 41.000 
883.95 1143.63 15.5 MBP-Gas1.FGGYAQSGLLAEITPDK.2/y11 44.000 
634.33 991.5 16.3 MBP-Gas1.LYPFTWDAVR.2/y8 28.000 
946.05 1149.65 22.1 MBP-Gas1.LIAYPIAVEALSLIYNK.2/y10 47.000 
447.26 552.31 11.7 MBP-Gas1.DLLPNPPK.2/y5 25.000 
601.31 785.44 13.7 MBP-Gas1.TWEEIPALDK.2/y7 31.000 
984.15 1222.65 22.1 MBP-Gas1.SALMFNLQEPYFTWPLIAADGGYAFK.3/y12 48.000 
595.36 948.58 20 MBP-Gas1.AGLTFLVDLIK.2/y8 26.000 
949.42 1113.56 13.2 MBP-Gas1.HMNADTDYSIAEAAFNK.2/y10 47.000 
727.01 1021.49 16.4 MBP-Gas1.GETAMTINGPWAWSNIDTSK.3/y9 35.000 
669.38 805.48 14.9 MBP-Gas1.VNYGVTVLPTFK.2/y7 29.000 
713.72 1029.53 14.4 MBP-Gas1.GQPSKPFVGVLSAGINAASPNK.3/y11 35.000 
699.68 730.41 17 MBP-Gas1.EFLENYLLTDEGLEAVNK.3/y7 34.000 
506.31 768.5 10.4 MBP-Gas1.DKPLGAVALK.2/y8 27.000 
668.82 957.5 9.1 MBP-Gas1.SYEEELAKDPR.2/y8 39.000 
704.01 999.5 19.5 MBP-Gas1.GEIMPNIPQMSAFWYAVR.3/y8 34.000 
480.27 688.37 8.5 MBP-Gas1.TAVINAASGR.2/y7 26.000 
625.98 926.53 14.3 MBP-Gas1.ISEFGSDDVPAIEVVGNK.3/y9 30.000 
821.89 984.49 14.5 MBP-Gas1.FFYSNNGSQFYIR.2/y8 41.000 
773.59 1210.55 12.8 
MBP-
Gas1.GVAYQADTANETSGSTVNDPLANYESC[PPa]SR.4/y10 37.000 
374.72 520.31 12.3 MBP-Gas1.DIPYLK.2/y4 21.000 
415.25 602.36 9.4 MBP-Gas1.LNTNVIR.2/y5 28.000 
599.28 805.33 12.1 MBP-Gas1.VYAINTTLDHSEC[PPa]MK.3/y6 39.000 
763.07 1013.57 18 MBP-Gas1.ALNDADIYVIADLAAPATSINR.3/y10 47.000 
850.89 985.5 16.8 MBP-Gas1.DDPTWTVDLFNSYK.2/y8 42.000 
784.35 951.37 12.9 MBP-Gas1.IPVGYSSNDDEDTR.2/y8 35.000 
784.35 1038.4 8.9 MBP-Gas1.IPVGYSSNDDEDTR.2/y9 45.000 
775.81 893.37 12.5 MBP-Gas1.MTDYFAC[PPa]GDDDVK.2/y8 39.000 
884.38 1101.45 16.2 MBP-Gas1.ADFYGINMYEWC[PPa]GK.2/y8 39.000 
748.36 1109.5 17.7 MBP-Gas1.NLSIPVFFSEYGC[PPa]NEVTPR.3/y9 36.000 
640.33 760.38 12.7 MBP-Gas1.YGLVSIDGNDVK.2/y7 33.000 
830.38 954.45 12.5 MBP-Gas1.TLDDFNNYSSEINK.2/y8 42.000 
459.75 718.37 15.6 MBP-Gas1.ISPTSANTK.2/y7 25.000 
604.28 753.36 11.8 MBP-Gas1.YGAYSFC[PPa]TPK.2/y6 32.000 
832.41 1059.52 16.6 MBP-Gas1.EQLSFVMNLYYEK.2/y8 37.000 
865.4 1167.57 12.6 
MBP-
Gas1.SDC[PPa]SFSGSATLQTATTQASC[PPa]SSALK.3/y11 42.000 
700.62 1001.44 16.9 MBP-Gas1.SNSGSSGSSSSSSSSSASSSSSSK.3/y11 34.000 
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Table 2. Binding of tryptic peptides from MBP-Gas1p to Ost3p- or Ost6p-affinity chromatography 
with LC-SRM-MS detection.  
Peptide sequence Log retention (Oxidized/reduced) 
Ost3p Ost6p 
 
LVIWINGDK -0.77 ± 0.01 0.92 ± 0.01* 
GYNGLAEVGK -0.09 ± 0.43 2.61 ± 0.02 
VTVEHPDK -0.38 ± 0.42 -0.25 ± 0.39 
FPQVAATGDGPDIIFWAHDR -0.13 ± 0.33 -0.22 ± 0.02 
FGGYAQSGLLAEITPDK -0.62 ± 0.01 -0.45 ± 0.00 
LYPFTWDAVR -0.82 ± 0.54 0.34 ± 0.01 
LIAYPIAVEALSLIYNK 0.52 ± 0.00 -1.56 ± 0.00 
DLLPNPPK 0.28 ± 0.04 2.51 ± 0.02 
TWEEIPALDK -0.34 ± 0.86 1.76 ± 0.00 
SALMFNLQEPYFTWPLIAADGGYAFK 1.09 ± 0.01 -3.36 ± 0.00 
AGLTFLVDLIK 0.23 ± 0.69 -0.72 ± 0.00 
HMNADTDYSIAEAAFNK -0.05 ± 0.44 0.46 ± 0.16 
GETAMTINGPWAWSNIDTSK 1.10 ± 0.02 -0.59 ± 0.10 
VNYGVTVLPTFK -0.95 ± 0.05 0.34 ± 0.04 
GQPSKPFVGVLSAGINAASPNK -0.22 ± 0.34 -0.66 ± 0.00 
EFLENYLLTDEGLEAVNK 0.30 ± 0.89 0.02 ± 0.61 
DKPLGAVALK -0.15 ± 0.62 2.56 ± 0.01 
SYEEELAKDPR -0.61 ± 0.55 0.66 ± 0.17 
GEIMPNIPQMSAFWYAVR 0.80 ± 0.01 -2.63 ± 0.21 
TAVINAASGR -0.50 ± 0.59 1.88 ± 0.02 
ISEFGSDDVPAIEVVGNK -0.60 ± 0.43 1.71 ± 0.00 
FFYSNNGSQFYIR -0.04 ± 0.78 -0.68 ± 0.01 
GVAYQADTANETSGSTVNDPLANYESC[PPa]SR 0.78 ± 0.18 -0.71 ± 0.09 
DIPYLK 0.23 ± 0.04 1.80 ± 0.01 
LNTNVIR -0.12 ± 0.98 1.60 ± 0.03 
VYAINTTLDHSEC[PPa]MK -0.80 ± 0.34 0.25 ± 0.25 
ALNDADIYVIADLAAPATSINR -0.37 ± 0.93 -0.35 ± 0.00 
DDPTWTVDLFNSYK -0.29 ± 0.25 0.22 ± 0.01 
MTDYFAC[PPa]GDDDVK 0.19 ± 0.10 -0.03 ± 0.69 
ADFYGINMYEWC[PPa]GK 2.77 ± 0.00 -0.18 ± 0.64 
NLSIPVFFSEYGC[PPa]NEVTPR 0.59 ± 0.76 -0.36 ± 0.00 
YGLVSIDGNDVK -0.30 ± 0.22 2.67 ± 0.01 
TLDDFNNYSSEINK 0.72 ± 0.18 2.60 ± 0.00 
ISPTSANTK -0.44 ± 0.29 1.38 ± 0.43 
YGAYSFC[PPa]TPK -0.33 ± 0.92 0.01 ± 0.54 
EQLSFVMNLYYEK 1.62 ± 0.00 -1.19 ± 0.19 
SDC[PPa]SFSGSATLQTATTQASC[PPa]SSALK 0.52 ± 0.87 -0.08 ± 0.85 
SNSGSSGSSSSSSSSSASSSSSSK -0.70 ± 0.00 0.12 ± 0.54 
* Bold, statistically significant binding to oxidized versus reduced, T-test, p<0.005 
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Figure 1. Characteristics of peptides bound (b) or not bound (n) by the peptide-binding groove of 
Ost3p or Ost6p. (A) pI, (B) aliphatic index, (C) Grand average of hydropathy (GRAVY), (D) 
aromatic residues. Values show mean. Error bars show standard error. *, Statistically significant, T-
test P<0.005. 
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Figure 2. Surface representation of the peptide-binding groove of the ER lumenal domain of Ost6p. 
(A) top and (B) side view. Hydrophobic amino acids forming the base of the peptide-binding 
groove are black. Amino acid residues are labelled with their position in Ost6p and the equivalent 
amino acid at the aligned position in Ost3p. (C) Alignment of amino acid residues forming the 
peptide-binding groove in Ost3p and Ost6p. Residues labelled in (a) and (b) are bold. 
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Chapter 4 
Analysis of Congenital Disorder of Glycosylation-Id in a 
Yeast Model System Shows Diverse Site-Specific Under-
glycosylation of Glycoproteins 
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4.1 Introduction to this publication  
This chapter was published in Journal of Proteome Research as an original article. In this study, we 
developed an LC-ESI-MS/MS based analytical method to detect peptides/glycopeptides and 
measure site-specific glycosylation occupancy in alg3 mutant and wild type yeast Sacchromyces 
cervisiae strains. We performed deglycosylation with peptide-N-glycosidase F (PNGase F) 
followed by AspN digestion and observed an increased number of glycosylation sites in both wild 
type and ∆alg3 cells, when compared with PNGase F and trypsin digest. Of the 26 new sites we 
found in this study, 22 were identified using the combination of PNGase F and AspN. This 
approach will be useful in site-specific glycosylation analysis in many model systems and clinical 
application. 
 
4.2 Declaration on authorship 
In accordance with The University of Queensland, the methods, results and discussion are presented 
in the form of a published article in the peer-reviewed journal. This article was published in Journal 
of Proteome Research. The contributions of all authors are mentioned in Section 4.3 
 
4.3 Published peer-reviewed article 
“Analysis of congenital disorder of glycosylation-Id in a yeast model system shows diverse 
site-specific under-glycosylation of glycoproteins” 
Bailey UM, Jamaluddin MF, Schulz BL. Analysis of congenital disorder of glycosylation-Id in a 
yeast model system shows diverse site-specific under-glycosylation of glycoproteins. J. Proteome 
Res. 2012, 11(11):5376-5383. 
 
 
 
 
 
89 
 
Contributions: 
This paper describes an improved analytical method for site-specific glycosylation analysis using 
PNGase F to label glycosylation sites with an asparagines-aspartate conversion that creates a new 
endoproteinase AspN cleavage site, followed by proteolytic digestion, and detection of peptides and 
glycopeptides by LC-ESI-MS/MS.  
This work presented here was done under the supervision of Dr Benjamin Schulz. 
Dr Benjamin Schulz, Dr Maja Bailey and I planned experiments; Dr Maja Bailey and I performed 
in vivo yeast experiments; Dr Benjamin Schulz and Dr Maja Bailey performed mass spectrometry; 
Dr Benjamin Schulz, Dr Maja Bailey and I wrote the manuscript. All the authors contributed to the 
critical reviewing of the manuscript before the submission.  
 
 
 
 
 
 
 
Analysis of Congenital Disorder of Glycosylation-Id in a Yeast Model
System Shows Diverse Site-Speciﬁc Under-glycosylation of
Glycoproteins
Ulla-Maja Bailey, Muhammad Fairuz Jamaluddin, and Benjamin L. Schulz*
School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD 4072, Australia
*S Supporting Information
ABSTRACT: Asparagine-linked glycosylation is a common
post-translational modiﬁcation of proteins in eukaryotes.
Mutations in the human ALG3 gene cause changed levels
and altered glycan structures on mature glycoproteins and are
the cause of a severe congenital disorder of glycosylation
(CDG-Id). Diverse glycoproteins are also under-glycosylated
in Saccharomyces cerevisae alg3 mutants. Here we analyzed site-
speciﬁc glycosylation occupancy in this yeast model system
using peptide-N-glycosidase F to label glycosylation sites with an asparagine-aspartate conversion that creates a new
endoproteinase AspN cleavage site, followed by proteolytic digestion, and detection of peptides and glycopeptides by LC−ESI−
MS/MS. We used this analytical method to identify and measure site-speciﬁc glycosylation occupancy in alg3 mutant and wild
type yeast strains. We found decreased site-speciﬁc N-glycosylation occupancy in the alg3 knockout strain preferentially at Asn-
Xaa-Ser sequences located in secondary structural elements, features previously associated with poor glycosylation eﬃciency.
Furthermore, we identiﬁed 26 previously experimentally unveriﬁed glycosylation sites. Our results provide insights into the
underlying mechanisms of disease in CDG-Id, and our methodology will be useful in site-speciﬁc glycosylation analysis in many
model systems and clinical applications.
KEYWORDS: ALG, alg3, N-glycosylation, oligosaccharyltransferase, mass spectrometry, glycosylation occupancy, PNGase F, CDG
■ INTRODUCTION
Protein N-glycosylation is a common and essential co- and
post-translocational modiﬁcation of membrane and secreted
proteins that in eukaryotes is catalyzed by the multiprotein
complex enzyme oligosaccharyltransferase (OTase).1 The
oligosaccharide Glc3Man9GlcNAc2 is assembled on the lipid
carrier dolicholpyrophosphate and transferred en bloc by OTase
onto selected asparagines, primarily in N-glycosylation sequons
(NX(S/T); X ≠ P) as nascent polypeptide is translocated into
the endoplasmic reticulum (ER).1,2 Further extension and
modiﬁcation of the glycan structures on mature proteins occurs
in the Golgi.3−5 N-Glycans assist protein folding in the ER, and
the speciﬁc glycan structures on mature glycoproteins modulate
protein function in developmental programs, during immune
responses, in cell−cell interactions, and in many other cellular
processes.6−8
A number of the genes that encode for enzymes in the N-
glycosylation pathway have been shown to be involved in
human health and disease.6,9 Many studies have revealed that
alterations in glycan expression are associated as causative or
incidental factors in relatively rare congenital disorders of
glycosylation (CDG), widespread acquired diseases, and
cancer.6,7,9−11 CDGs are conceptually divided into CDG-I,
where the genetic defect is in the ER in the N-glycosylation
pathway before addition of glycan to protein, and CDG-II,
where the defect is in the Golgi. Thus, CDG-I results in
ineﬃcient glycosylation of asparagines, while CDG-II results in
changes to the glycan structures on mature glycoproteins.6
Under-glycosylation is the underlying cause of disease in
CDG-I, resulting in an increase in misfolded glycoproteins and
alterations in their functions through reduced glycosylation of
particular asparagines. However, with over half of all proteins
predicted to be glycosylated, the sequence and structural
diversity of protein acceptor sites is extraordinarily large.12 It is
currently not clear which particular subset of asparagines are
under-glycosylated in CDG-I. However, a study using targeted
SRM-MS showed that transferrin isolated from the blood of
CDG-I patients had lower glycosylation occupancy speciﬁcally
at its second N-glycosylation site.13 Additionally, several familial
mutations in the homologous OTase subunits MagT1 and
Tusc3 have been linked to a form of CDG-I leading to non-
syndromic mental retardation.14−16 Studies using a manipulable
yeast genetic system showed that the yeast homologues of these
proteins are required for eﬃcient site-speciﬁc N-glycosylation
of selected asparagines.17,18 Other CDGs have also been
extensively studied in yeast. Saccharomyces cerevisiae alg mutants
(alg, asparagine-linked glycosylation) are defective in the
biosynthesis of the dolichol-linked Glc3Man9GlcNAc2,
19,20
and the mutations in the human alg homologues causing
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diﬀerent types of CDG can be functionally studied by
heterologous expression in yeast.6 The ALG3 gene is highly
conserved in eukaryotes, and its mutation also results in a
similar phenotype in Arabidobsis thalina.21,22 Knockout mutants
of these ALG genes in S. cerevisiae are generally viable and have
also been used to characterize the pathway of N-glycosylation
in the ER.19
Glycosylation occupancy can be measured semiquantitatively
on many proteins using MS-based methods.17,18,23−25 Tradi-
tionally in these approaches in yeast, Endo H is used as a
deglycosylation agent followed by protease treatment and MS
analysis to identify glycosylated and non-glycosylated peptides.
Enrichment of glycoproteins rather than glycopeptides allows
detection of both glycosylated and non-glycosylated versions of
the same peptide. This allows direct relative quantiﬁcation of
site-speciﬁc glycosylation occupancy, although it entails some
reduction in the enrichment eﬃciency obtainable through
glycopeptide enrichment.25 Endo H cleaves all N-glycans of
wild type yeast, which are all high-mannose structures, and
conveniently leaves previously glycosylated asparagines tagged
with a single N-acetylglucosamine (GlcNAc).17 Glycan release
with Endo H therefore provides a clear distinction between the
glycosylated and unglycosylated versions of the same peptide
with a Δmass of 203.08 Da. However, in S. cerevisiae Δalg3
mutants the incomplete precursor glycan Man5GlcNAc2-PP-
Dol accumulates and Endo H resistant oligosaccharides are
transferred to proteins.26
In this study we chose a yeast Δalg3 strain as a model system
to develop an MS-based method that can measure the
occupancy of speciﬁc glycosylation sites in diﬀerent proteins
in situations where Endo H cannot be used.
■ EXPERIMENTAL SECTION
Yeast Strains
Yeast strains used were BY4741 (MATa his3Δ1 leu2Δ0
met15Δ0 ura3Δ0) and the Δalg3 mutant derivative thereof
(Open Biosystems). Cells were grown to mid-log phase at 30
°C in YPD (2% Bacto peptone, 1% yeast extract, and 2%
glucose).
Cell Wall Protein Sample Preparation
Triplicates of 50 mL of cells grown to mid-log phase were
harvested and lysed with agitation for 1 h at 4 °C using glass
beads (Sigma) in 50 mM Tris HCl, pH 7.5, 1 mM PMSF and
1x Complete protease inhibitor cocktail (Roche). Based on
previously reported methods,17,27 covalently linked cell wall
material was pelleted by centrifugation at 18000 rcf for 1 min
and washed 4 times with ice-cold 50 mM Tris-HCl pH 7.5. The
pellet was resuspended in 50 mM Tris-HCl pH 8.0, 2% SDS, 7
M urea, and 2 M thiourea. Cysteines were reduced and
alkylated by addition of dithiothretiol to 10 mM and incubation
at 30 °C with agitation for 30 min, followed by addition of
acrylamide to 50 mM and further incubation with agitation at
30 °C for 1 h. Noncovalently linked proteins were removed by
washing the 18000 rcf pellet ﬁve times with 1 mL of 50 mM
Tris-HCl, pH 8, 2% SDS, 7 M urea, and 2 M thiourea, followed
by ﬁve washes with 2% SDS. The pellet was resuspended in 100
μL of 1% NP40 and 1x G7 buﬀer (New England Biolabs) and
aliquoted into 50 μL followed by addition of 500 units of
PNGase F (New England Biolabs) and incubated at 37 °C with
agitation for 16 h. The negative control was incubated in the
same buﬀer without PNGase F enzyme. The cell wall proteins
were pelleted at 18000 rcf and washed 5 times in 50 mM Tris-
HCl pH 8.0. The ﬁnal cell wall pellet, equivalent to 12.5 mL of
cell culture, was resuspended in 50 mM NH4HCO3, and
proteins were digested with either trypsin 4 μg/mL (Sigma) or
AspN 1 μg/mL (Promega) at 37 °C for 16 h with agitation.
Mass Spectrometry and Data Analysis
Peptides were desalted using C18 ZipTips (Millipore) and
analyzed by LC−ESI−MS/MS using a Prominence nanoLC
system (Shimadzu) and TripleTof 5600 mass spectrometer
with a Nanospray III interface (AB SCIEX). Approximately 2
μg of peptides was desalted on an Agilent C18 trap (300 Å pore
size, 5 μm particle size, 0.3 mm i.d. × 5 mm) at a ﬂow rate of 30
μL/min for 3 min and then separated on a Vydac EVEREST
reversed-phase C18 HPLC column (300 Å pore size, 5 μm
particle size, 150 μm i.d. × 150 mm) at a ﬂow rate of 1 μL/min.
Peptides were separated with a gradient of 10−60% buﬀer B
over 45 min, with buﬀer A (1% acetonitrile and 0.1% formic
acid) and buﬀer B (80% acetonitrile with 0.1% formic acid).
Gas and voltage setting were adjusted as required. An MS TOF
scan from m/z of 350−1800 was performed for 0.5 s followed
by information-dependent acquisition of MS/MS with
automated CE selection of the top 20 peptides from m/z of
40−1800 for 0.05 s per spectrum. Peptides were identiﬁed
using ProteinPilot (AB SCIEX), searching the LudwigNR
database (downloaded from http://apcf.edu.au as at 27 January
2012; 16,818,973 sequences; 5,891,363,821 residues) with
standard settings: Sample type, identiﬁcation; Cysteine
alkylation, acrylamide; Instrument, TripleTof 5600; Species,
S. cerevisiae with common contaminants; ID focus, biological
modiﬁcations; Enzyme, trypsin or AspN; Search eﬀort,
thorough ID. False discovery rate analysis using ProteinPilot
was performed on all searches. Peptides identiﬁed with greater
than 99% conﬁdence and with a local false discovery rate of less
than 1% were included for further analysis, and MS/MS
fragmentation spectra were manually inspected. Extracted ion
chromatograms were obtained using PeakView 1.1. Relative
quantiﬁcation of site-speciﬁc glycosylation occupancy was
determined for each deamidated (deglycosylated)/unmodiﬁed
(non-glycosylated) tryptic peptide pair without considering
variable response factors of the unmodiﬁed and deamidated
peptides. Occupancy was deﬁned as the ratio of the extracted
ion intensities of the deamidated peptide ion to the sum of the
intensities of the deamidated and unmodiﬁed peptide ions.17
■ RESULTS
Identiﬁcation and Relative Quantiﬁcation of
N-Glycosylation Site Occupancy in Cell Wall Proteins from
Wild Type and Δalg3 Yeast Cells Using PNGase F
Treatment Followed by Trypsin Digestion
We asked whether glycosylation occupancy in the yeast Δalg3
strain showed site-speciﬁc alterations. To eﬃciently detect
multiple glycosylation sites, enrichment of glycoproteins is
required.17,28 Enrichment of yeast cell wall proteins ensures
detection of both glycosylated and non-glycosylated forms of
proteins since the covalent linkage of the proteins to the yeast
polysaccharide cell wall matrix does not rely directly on N-
glycans. Previous methods for analysis of site-speciﬁc N-
glycosylation occupancy in yeast have used glycan release with
Endo H.17,18,23,24 However, the glycan structures on mature
glycoproteins in the yeast Δalg3 mutant are altered, with the
mutant glycan structures engendering the glycoproteins
resistant to deglycosylation with Endo H.29 We therefore
deglycosylated cell wall enriched glycoproteins from Δalg3 and
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wild type yeast strains with the general deglycosylating enzyme
PNGase F, leaving previously glycosylated asparagines “tagged”
with a deamidation (m/z ≈ 1 Da). Deglycosylated covalently
attached cell wall proteins were digested with trypsin, detected
by LC−ESI−MS/MS, and identiﬁed with ProteinPilot (AB
SCIEX). We identiﬁed peptides containing 19 NX(S/T)
sequons as either previously glycosylated peptides modiﬁed
with deamidation or non-glycosylated unmodiﬁed peptides.
This gave a total of 29 peptides (>99% conﬁdence) from 12
diﬀerent proteins (Table 1, Supporting Information). We
measured the relative glycosylation occupancy17 at these 19
sites by measurement of deamidated-peptide/peptide pairs
(Table 2 and Figure 1A and C). We found 10 N-glycosylation
sites that showed decreased levels of glycosylation occupancy in
Δalg3 compared to wild type. Ecm33p_328 showed the most
severe decrease in glycosylation occupancy at 37% (Table 2 and
Figure 1A−D). Some glycosylation sites showed only mild
under-glycosylation, such as Crh1p_177 that showed 96%
occupancy in the Δalg3 mutant (Table 2). We found six sites
that were completely (100%) glycosylated in both Δalg3 and
wild type cells, and three sites were found to be completely
non-glycosylated in both wild type and mutant yeast cells
(Table 2). Two glycosylation sites were mildly under-
glycosylated in wild type cells, Ecm33p_328 (Table 2 and
Figure 1 A and B) and Pry3p_101, and were both found to be
further under-glycosylated in the Δalg3 strain (Table 2). In
summary, we found 16 glycosylation sites that were occupied in
wild type cells, 10 of which were under-glycosylated in the
Δalg3 strain.
Spontaneous deamidation of NG sequences has been
reported to occur during standard proteomic sample
preparation.30−32 It was therefore important to conﬁrm that
the deamidation events we detected were due to PNGase F
catalyzed glycan release, rather than spontaneous chemical
deamidation of non-glycosylated asparagines. Two of the
detected glycosylation sites, Crh2p_310 and Gas1p_40, have
sequons with the sequence NGS/T (Table 1) and would
therefore be prone to spontaneous deamidation. We did not
detect any deamidated peptide corresponding to Crh2p_310 in
negative control samples not deglycosylated with PNGase F. In
the negative control of Δalg3 cells we did detect a weak MS
peak corresponding to ions of deamidated Gas1p_40 peptide,
indicating that some portion of the unglycosylated form of this
peptide underwent spontaneous deamidation during sample
preparation (data not shown). However, no such peak was
detected in the wild type negative control, indicating that this
site is completely glycosylated in wild type and is partially
under-glycosylated in Δalg3 cells. The intensity of the
deamidated Gas1p_40 peptide in the negative control was
very low and was neglected in calculation of relative
glycosylation occupancy at this site, leading to a slight
underestimation of the level of under-glycosylation at
Gas1p_40 in the Δalg3 strain (Table 2). No detectable
Table 1. Peptides Containing N-Glycosylation Sequons Identiﬁed by Mass Spectrometrya
protein name peptide position sequence Asn m/z z Δmass
Gas1p 35−47 FFYSNNGSQFYIR 40 548.5878 3 −0.0001
Gas1p 35−47 FFYSNNGSQFYIR 40 548.2642 3 0.0132
Gas1p 48−77 GVAYQADTANETSGSTVNDPLANYESCSR 57 1031.453 3 0.0056
Gas1p 48−77 GVAYQADTANETSGSTVNDPLANYESCSR 57 1031.123 3 −0.0014
Gas1p 91−105 VYAINTTLDHSECMK 95 599.6099 3 −0.0042
Gas1p 253−271 NLSIPVFFSEYGCNEVTPR 253 1122.536 2 0.0008
Gas5p 50−73 GVDYQPGGSSNLTDPLADASVCDR 60 837.0438 3 0.0022
Gas5p 50−73 GVDYQPGGSSNLTDPLADASVCDR 60 836.7169 3 0.0055
Pst1p 51−65 CDTLVGNLTIGGGLK 57 766.9019 2 −0.0025
Pst1p 51−65 CDTLVGNLTIGGGLK 57 766.4099 2 −0.0023
Ecm33p 318−335 GGANFDSSSSNFSCNALK 328 939.4022 2 0.0002
Ecm33p 318−335 GGANFDSSSSNFSCNALK 328 938.909 2 −0.0023
Pry3p 100−120 YNYSNPGFSESTGHFTQVVWK 101 817.042 3 0.0019
Pry3p 100−120 YNYSNPGFSESTGHFTQVVWK 101 816.7147 3 0.0039
Yjl171 cP 219−240 NSSSIGYYDLPAIWLLNDHIAR 219 840.4252 3 0.0044
Yjl171 cP 219−240 NSSSIGYYDLPAIWLLNDHIAR 219 840.0991 3 0.0102
Plb2p 47−60 NASGLSTAETDWLK 47 747.3575 2 −0.0042
Plb2p 47−60 NASGLSTAETDWLK 47 746.8659 2 −0.0032
Plb2p 185−200 SIVNPGGSNLTYTIER 193 574.6266 3 −0.0051
Plb2p 362−382 YVNNLSQDDDDIAIYAANPFK 365 796.0468 3 0.0061
Plb2p 491−509 NLTDLEYIPPLVVYIPNTK 491 1102.099 2 0.0019
Gas3p 268−288 LNSTFEDAVIPLIFSEYGCNK 269 811.3958 3 0.0039
Gas3p 268−288 LNSTFEDAVIPLIFSEYGCNK 269 811.0667 3 0.0004
Crh1p 175−186 FHNYTLDWAMDK 177 771.3389 2 −0.0023
Crh1p 175−186 FHNYTLDWAMDK 177 770.8482 2 0.0002
Crh2p 23−59 ATFCNATQACPEDKPCCSQYGECGTGQYCLNNCDVR 28 1098.453 4 0.0215
Crh2p 310−326 NGTSAYVYTSSSEFLAK 310 609.288 3 0.0003
Tos1p 412−421 AAVIFNSSDK 417 526.271 2 −0.0071
Yil169 cP 508−532 GEGVLAVDPTETNATPIPVVGYTGK 520 829.1041 3 0.0157
aProteins covalently linked to the yeast polysaccharide cell wall were prepared, glycans were released by peptide-N-glycosidase F, and proteins were
digested with trypsin, detected by LC−ESI−MS/MS, and identiﬁed by ProteinPilot. Deamidated asparagines are bold. Unglycosylated sequons are
underlined. All methionines are oxidized and all cysteines are alkylated. All peptides listed were identiﬁed with >99% conﬁdence.
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spontaneous deamidation of asparagines in other sequons were
detected in any of the negative controls.
Identiﬁcation of N-Glycosylation Sites in Yeast Cell Wall
Proteins with PNGase F Treatment Followed by AspN
Digestion
Deglycosylation with PNGase F and digestion with trypsin
allowed detection and relative quantiﬁcation of site occupancy
in Δalg3 cells. However, the mass shift upon deamidation is ∼1
Da, which in some cases can be diﬃcult to diﬀerentiate from
the normal isotopic distribution of non-deamidated peptides in
the case that the deamidated and non-deamidated versions of
that peptide are not separated by C18 LC prior to MS
detection. This is in contrast to the ready diﬀerentiation of
previously glycosylated asparagines tagged with a Δmass of
203.08 Da in the case of Endo H glycan release. This ambiguity
has the potential to make measurement of site-speciﬁc N-glycan
occupancy diﬃcult. To overcome these diﬃculties and to
further identify speciﬁc N-glycosylation sites showing under-
glycosylation in Δalg3 yeast cells, we therefore treated the cell-
wall glycoproteins with PNGase F followed by digestion with
the protease AspN and detection with LC−ESI−MS/MS.
Deamidation of a previously glycosylated asparagine converts
the amino acid to an aspartic acid that will be recognized as a
cleavage site for AspN. Consequently AspN will cleave at
deamidated asparagines that were glycosylated prior to
treatment with PNGase F. This will allow clear diﬀerentiation
of previously glycosylated asparagines, in contrast to the
diﬃculties of PNGase F/trypsin as described above. Using this
approach we identiﬁed 49 peptides (>99% conﬁdence) that had
been cleaved at a deamidated asparagine in a sequon
(glycosylated) or contained an unmodiﬁed sequon (non-
glycosylated) (Table 3, Supporting Information). The 49
peptides represented 42 NX(S/T) sequons in 14 diﬀerent
proteins (Table 3); 37 of these sequons were identiﬁed as
glycosylated. We found seven sequons that were present in
unmodiﬁed peptides (Table 3). Three of these unmodiﬁed
sequons (Ecm33p_328, Gas3p_350, and Crh2p_96) were
found only in Δalg3 samples and were also detected as peptides
cleaved at the corresponding deamidated asparagine in both
wild type and Δalg3 cells, indicating partial glycosylation at
these three sites in the Δalg3 mutant. Four sequons were
identiﬁed exclusively as non-glycosylated. Two of these
(Ecm33p_209 and Crh1p_177) were only detected from
Δalg3 cells, indicating that these sites are under-glycosylated in
the Δalg3 mutant strain (Table 3). Crh1p_177 was also
identiﬁed in tryptic peptides both as a (deamidated)
glycopeptide and a non-modiﬁed peptide (Table 1), showing
some under-glycosylation at this site (Table 2). In total we
identiﬁed ﬁve glycosylation sites that were under-glycosylated
in the Δalg3 mutant strain using PNGase F followed by AspN
treatment. In addition, we identiﬁed two sequons in non-
modiﬁed peptides, Ccw14p_87 and Tos1p_417, present in
both wild type and Δalg3 positive and negative controls (no
PNGase F treatment), suggesting that these two sequons are
not glycosylated in wild type or the Δalg3 mutant strain (Table
3). AspN cleavage due to spontaneous deamidation of an
asparagine in an NGS sequon was detected at minor levels at
Gas1p_40 in the Δalg3 negative control, indicating that a
portion of this site that was not glycosylated in these cells
underwent spontaneous chemical deamidation. Relative
quantiﬁcation of glycosylation site occupancy was not
performed using AspN peptides due to the inability to directly
compare the deamidated and unmodiﬁed forms of the same
peptide.
Characteristics of Sequons That Showed Decreased
Glycosylation Occupancy in Δalg3 Cells
N-Glycosylation is a general co-translational modiﬁcation
aﬀecting many glycosylation sites on many diﬀerent proteins
within the cell. Only ∼70% of NX(S/T) sequons are
glycosylated in proteins that are translocated into the
ER.17,18,23,24 However, the sequons that were normally
glycosylated in wild type cells were not evenly aﬀected in the
Δalg3 mutant strain: some sites remained eﬃciently glycosy-
lated, while others showed severe under-glycosylation. We
compared the characteristics of glycosylation sites that were
under-glycosylated and sites that showed no change in
glycosylation occupancy in Δalg3 cells (Tables 2 and 4). We
found that sequons that were eﬃciently glycosylated in Δalg3
cells were more likely to be located in loops of folded proteins
(not in secondary structural elements) and contain threonine in
the +2 position (Figure 2).
Identiﬁcation of Novel N-Glycosylation Sites in Yeast Cell
Wall Proteins
In S. cerevisae there are 196 N-glycosylation sequons that have
been directly experimentally shown to be occupied (Uni-
Prot).17,33 The method we describe here used cell wall enriched
proteins that contain a limited number of proteins compared to
a recently described method using ﬁlter-aided sample
preparation (FASP) from whole cell extracts enriched for
glycoproteins with ConA.33 Nonetheless, using our approach
we found in total 54 diﬀerent occupied glycosylation sites
(Tables 1 and 3), 26 of which have not been reported
previously (Table 5), raising the total number of known
occupied N-glycosylation sites in S. cerevisae to 222.
Table 2. Site-Speciﬁc N-Glycosylation Occupancy in Δalg3
Yeast Straina
strain
glycosylation site wild type Δalg3
Gas1p_95 1.00 ± 0.00 1.00 ± 0.00
Gas1p_253 1.00 ± 0.00 1.00 ± 0.00
Plb2p_193 1.00 ± 0.00 1.00 ± 0.00
Plb2p_491 1.00 ± 0.00 1.00 ± 0.00
Crh2p_28 1.00 ± 0.00 1.00 ± 0.00
Crh2p_310 1.00 ± 0.00 1.00 ± 0.00
Gas5p_60 1.00 ± 0.00 0.97 ± 0.05
Crh1p_177 1.00 ± 0.00 0.96 ± 0.01
Gas1p_40 1.00 ± 0.00 0.94 ± 0.05
Gas3p_269 1.00 ± 0.00 0.92 ± 0.04
Pry3p_101 0.96 ± 0.02 0.85 ± 0.02
Pst1p_57 1.00 ± 0.00 0.76 ± 0.12
Plb2p_47 1.00 ± 0.00 0.66 ± 0.17
Gas1p_57 1.00 ± 0.00 0.57 ± 0.11
Yjl171cp_219 1.00 ± 0.00 0.51 ± 0.18
Ecm33_328 0.99 ± 0.01 0.37 ± 0.08
Plb2_365 0.00 ± 0.00 0.00 ± 0.00
Tos1p_417 0.00 ± 0.00 0.00 ± 0.00
Yil169cp_520 0.00 ± 0.00 0.00 ± 0.00
aThe relative N-glycosylation occupancy at a given site was
determined from the abundance of deamidated-modiﬁed and
unmodiﬁed versions of the same sequon-containing peptide as
measured by LC−ESI−MS/MS. Values are the mean of biological
triplicates. Error is SD
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■ DISCUSSION
We developed an LC−MS based analytical method to identify
N-glycosylation sites and successfully determined the relative
glycosylation occupancy at 19 sites using the yeast Δalg3 strain
as a model. Independent of the yeast strain studied,
deglycosylation with PNGase F followed by AspN digestion
increased the number of glycosylation sites that could be
detected in a complex protein sample at one time, when
compared with trypsin digest. It appears that proteins with
multiple N-glycosylation sites become more accessible to digest
with AspN and MS analysis after treatment with PNGase F
compared with Endo H. Of the 26 new sites we found in this
study, 22 were identiﬁed using the combination of PNGase F
and AspN. In total we could detect 54 diﬀerent occupied
glycosylation sites. The approach we describe here is therefore
complementary to standard techniques and increases the
number of N-glycosylation sites that can be detected at the
same time on many diﬀerent proteins.
While most glycosylation sequons were eﬃciently glycosy-
lated in wild type cells, the altered glycan structure in the Δalg3
strain reduces the general glycosylation activity of OTase,
leading to under-glycosylation.26,29 However, glycosylation sites
were not uniformly aﬀected in Δalg3 cells, with the subset of
sites with lower aﬃnity for OTase most strongly aﬀected. We
found 13 speciﬁc glycosylation sites that were under-
glycosylated in the Δalg3 strain compared to wild type cells
(Table 4). The features of these glycosylation sites suggest that
they are the subset of normally modiﬁed sites that are more
diﬃcult for OTase to glycosylate. For instance, these under-
glycosylated sites are enriched in serine at the +2 position
(Figure 2A). NxS sequons are glycosylated ∼40 times less
eﬃciently than NxT sequons,34 because of speciﬁc recognition
of threonine at the +2 position by the peptide acceptor binding
site of OTase.35 Under-glycosylated sites in the Δalg3 strain
were also likely to be present in secondary structural elements
(helices or sheets), whereas eﬃciently glycosylated sites were
more likely present in ﬂexible loops (Figure 2B). Protein
folding competes with glycosylation by OTase because the
peptide acceptor binding site of OTase requires a ﬂexible
stretch of peptide for tight binding.35 As secondary structure
forms early in protein folding, glycosylation sites in secondary
structural elements will have reduced aﬃnity to OTase. The
subset of glycosylation sites both present in ﬂexible loops and
with threonine at the +2 position were eﬃciently glycosylated
(Figure 2C), suggesting a combination of these factors
inﬂuences peptide acceptor binding to OTase and hence
glycosylation eﬃciency.
Incorporation of either of the homologous proteins Ost3p or
Ost6p into OTase results in enzyme isoforms with diﬀerent
protein substrate speciﬁcities at the level of individual
glycosylation sites.17 Six of the 13 sites that show under-
glycosylation in Δalg3 cells have been shown to be under-
glycosylated in yeast cells with double knockout of these
homologous OTase subunits (Δost3/Δost6).17 All six of these
Figure 1. LC−ESI−MS/MS identiﬁcation and relative quantiﬁcation of glycosylation occupancy at Asn328 of Ecm33p from wild type and Δalg3 cells.
Extracted ion chromatograms of the [M + 2H]2+ ions corresponding to deamidated peptide at an m/z of 939.40 (dashed line) and unmodiﬁed
peptide at an m/z of 938.91 (solid line) from wild type (A, B) and Δalg3 (C, D). The glycoprotein -enriched cell wall proteins were treated with
PNGase F followed by trypsin (A, C) or with trypsin (B, D). The ratio of the area under curve for the deamidated peptide to the total of deamidated
and unmodiﬁed peptide gave a relative occupancy of 0.98 in wild type (A) and 0.37 in Δalg (C) in this single measurement. The scale of the
intensity is the same in panels A and B. MS/MS spectra and ProteinPilot matched fragmentation of deamidated peptide (E) and unmodiﬁed peptide
(F) are shown.
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sites were shown to be rescued by overexpression of Ost3p,
although two sites could be rescued by overexpression of either
Ost3p or Ost6p.17 Furthermore, one glycosylation site,
Gas1p_253, was shown to require Ost6p for complete
glycosylation occupancy.17 Interestingly, we found that
glycosylation occupancy of Gas1p_253 was not aﬀected in
Δalg3 cells (Table 2), which express both Ost3p- and Ost6p-
containing OTase isoforms. This emphasizes the importance of
the protein substrate speciﬁcities of OTase isoforms in deﬁning
the characteristics of an eﬃciently glycosylated asparagine.
Our results may be complicated by the ability of many
proteins to fold correctly even without glycosylation at many
Table 3. Peptides Containing N-Glycosylation Sequons Identiﬁed by Mass Spectrometrya
protein name peptide position peptide sequence Asn m/z z Δmass
Gas1p 23−39 D*DVPAIEVVGNKFFYSN.NGS 40 957.4678 2 0.0003
Gas1p 40−53 NGSQFYIRGVAYQA 40 525.5922 3 0.0021
Gas1p 77−94 DIPYLKKLNTNVIRVYAI.NTT 95 711.7537 3 0.0035
Gas5p 150−165 DNVLGFFAGNEVINSV.NTT 166 847.9219 2 −0.0020
Gas5p 166−179 NTTNTATYVKAVVR 166 769.9114 2 −0.0017
Gas5p 319−343 DFENLKNEYSKVSNPEGNGGYSTSN.NYS 344 917.4109 3 0.0007
Ecm33p 45−55 DKISGCSTIVG.NLT 56 575.7883 2 −0.0080
Ecm33p 82−91 NSSSLSSFSA 82 494.2102 2 −0.0135
Ecm33p 202−213 DNLVWANNITLR# 209 714.8843 2 0.0020
Ecm33p 214−226 DVNSISFGSLQTV.NAS 227 683.8457 2 −0.0007
Ecm33p 241−257 NLTQLSKVGQSLSIVSN 241 894.9885 2 −0.0006
Ecm33p 258−266 DELSKAAFS.NLT 267 484.2396 2 −0.0012
Ecm33p 279−286 NNTQLKVI 279 465.7654 2 −0.0020
Ecm33p 287−303 DGFNKVQTVGGAIEVTG.NFS 304 846.4332 2 −0.0007
Ecm33p 323−345 DSSSSNFSCNALKKLQSNGAIQG# 328 809.7242 3 0.0011
Ecm33p 328−345 NFSCNALKKLQSNGAIQG 328 655.6658 3 −0.0031
Pry3p 91−100 DAWYGEISKY.NYS 101 616.2849 2 −0.0005
Yjl171cP 286−299 DLGTGIQSYGYITR.NTT 300 772.392 2 0.0017
Ccw14p 73−91 DAAYSAFKSSCSEQNASLG 87 669.6309 3 0.0022
Plb1p 81−91 DTSLLSTLFGS.NSS 92 570.7927 2 −0.0001
Plb1p 265−276 DGRYPGTTVINL.NAT 277 653.3411 2 −0.0049
Plb1p 492−512 DLEYIPPLIVYIPNSRHSFNG.NQS 513 815.4273 3 0.0064
Plb2p 83−93 DTSLLSTLFSS.NSS 94 585.7971 2 −0.0019
Plb2p 162−170 NWTSVQEIV 162 538.7665 2 −0.0001
Plb2p 493−514 DLEYIPPLVVYIPNTKHSFNG.NQS 515 806.0919 3 0.0063
Plb2p 567−579 NATLPPECTKCFA 567 769.3527 2 −0.0045
Plb2p 615−629 DGIPITALLGSSTSG.NTT 630 694.8669 2 −0.0003
Gas3p 201−211 NRSIPVGYSAA 201 568.2903 2 −0.0009
Gas3p 191−200 DMKQYISKHA.NRS 201 610.8044 2 −0.0078
Gas3p 339−349 D*DFVNLESQLK.NVS 350 654.3276 2 0.0001
Gas3p 350−363 NVSLPTTKESEISS 350 746.8725 2 0.0000
Gas3p 339−363 D*DFVNLESQLKNVSLPTTKESEISS# 350 927.4709 3 0.0145
Gas3p 370−384 DNSAITNIYSGFGTN.NFT 385 787.36 2 0.0000
Gas3p 414−421 DYAVPTTF.NYT 422 457.219 2 0.0005
Crh1p 117−129 NGTGIVSSFYLQS 117 687.3319 2 −0.0017
Crh1p 173−180 DKFHNYTL# 177 519.2554 2 −0.0016
Crh1p 192−200 DGESVRVLS.NTS 201 481.2486 2 −0.0051
Crh2p 82−95 DYSSKLGNANTFLG.NVS 96 743.8612 2 −0.0021
Crh2p 82−100 DYSSKLGNANTFLGNVSEA# 96 993.9658 2 −0.0160
Crh2p 175−189 DLETAQTNFYWESVL.NYT 190 908.4202 2 −0.0105
Crh2p 223−232 DGVVGRTLYK.NET 233 554.3093 2 −0.0044
Crh2p 237−252 NATTQKYQYPQTPSKV 237 927.9626 2 −0.0052
Crh2p 253−260 DISIWPGG.NST 261 422.7143 2 0.0013
Crh2p 282−296 DISNPGYYYAIVNEV.NIT 297 858.9086 2 −0.0016
Crh2p 310−326 NGTSAYVYTSSSEFLAK 310 913.4259 2 −0.0045
Tos1p 222−235 DWSRGSYFVPGSTS.NCT 236 773.3513 2 −0.0016
Tos1p 407−419 DGTLKAAVIFNSS 417 661.8506 2 −0.0011
Pir3p 231−244 NSTLSMSLSKGILT 231 726.8838 2 −0.0011
Pst1p 215−227 DVHSVSFANLQKI.NSS 228 729.3972 2 0.0124
aProteins covalently linked to the yeast polysaccharide cell wall were prepared, glycans were released by peptide-N-glycosidase F, and proteins were
digested with AspN, detected by LC−ESI−MS/MS, and identiﬁed by ProteinPilot. Deamidated asparagines are bold. Unglycosylated sequons are
underlined. *, missed cleavage; #, peptides containing unglycosylated sequons identiﬁed in Δalg3 only. All methionines are oxidized and all cysteines
are alkylated. All peptides listed were identiﬁed with >99% conﬁdence.
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sites, as long as a certain critical level of glycosylation is present.
This will mean that if glycosylation is strictly required at a
particular asparagine for correct protein folding, then that
asparagine will appear to always be glycosylated, even though
most of the nascent polypeptide that is not modiﬁed will be
degraded by the quality control systems of the ER.2 In addition,
glycosylation eﬃciency may depend on factors such as local
folding of the target protein close to the sequon and the protein
substrate speciﬁcities of the particular OTase isoforms
present.17,36 However, in combination this and previous studies
have detected almost every sequon in both glycosylated and
non-glycosylated forms, suggesting that these eﬀects are
relatively minor. Therefore, it is reasonable to imply that sites
that are easier to glycosylate would be expected to show full
occupancy and sites that are more diﬃcult to glycosylate would
be found under-glycosylated.
■ CONCLUSION
Mutations in the human ALG3 gene cause a rare form of CDG
(CDG-Id).37 Reduced OTase activity due to the altered
structure of the lipid-linked glycan substrate in this disorder
is likely to aﬀect N-glycosylation occupancy in a site-speciﬁc
manner, similar to the patterns we observe here in a S. cerevisiae
model system. We predict that glycosylation sites in NxS
sequons and those located in secondary structural elements will
be the most likely to show reduced glycosylation in CDG-Id.
Many diﬀerent diseases and health conditions in addition to the
CDG spectrum are caused by or associated with defects in
glycosylation and consequently decreased levels of N-
glycosylation occupancy at many diﬀerent glycosylation sites
in many diﬀerent proteins. In conjunction with appropriate
glycoprotein or glycopeptide enrichment strategies, the method
we describe here could potentially be further developed to
study human N-glycosylation site occupancy using clinical
tissue, serum, or saliva protein samples, leading to discovery of
new biomarkers for CDG and other disorders and improved
diagnostics.
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Procter, J. B.; Barton, G. J.; Aebi, M.; Ferguson, M. A. Distinct donor
and acceptor specificities of Trypanosoma brucei oligosaccharyltrans-
ferases. EMBO J. 2009, 28 (17), 2650−61.
(24) Nasab, F.; Schulz, B.; Gamarro, F.; Parodi, A.; Aebi, M. All in
one: Leishmania major STT3 proteins substitute for the whole
oligosaccharyltransferase complex in Saccharomyces cerevisiae. Mol.
Biol. Cell 2008, 19 (9), 3758−68.
(25) Zhang, H.; Li, X. J.; Martin, D. B.; Aebersold, R. Identification
and quantification of N-linked glycoproteins using hydrazide
chemistry, stable isotope labeling and mass spectrometry. Nat.
Biotechnol. 2003, 21 (6), 660−6.
(26) Huffaker, T. C.; Robbins, P. W. Yeast mutants deficient in
protein glycosylation. Proc. Natl. Acad. Sci. U.S.A. 1983, 80 (24),
7466−70.
(27) Yin, Q. Y.; de Groot, P. W.; Dekker, H. L.; de Jong, L.; Klis, F.
M.; de Koster, C. G. Comprehensive proteomic analysis of
Saccharomyces cerevisiae cell walls: identification of proteins
covalently attached via glycosylphosphatidylinositol remnants or mild
alkali-sensitive linkages. J. Biol. Chem. 2005, 280 (21), 20894−901.
(28) Schulz, B. L.; White, J. C.; Punyadeera, C. Saliva proteome
research: current status and future outlook. Crit. Rev. Biotechnol. 2012,
DOI: 10.3109/07388551.2012.687361.
(29) Aebi, M.; Gassenhuber, J.; Domdey, H.; te Heesen, S. Cloning
and characterization of the ALG3 gene of Saccharomyces cerevisiae.
Glycobiology 1996, 6 (4), 439−44.
(30) Krokhin, O. V.; Antonovici, M.; Ens, W.; Wildins, J. A.;
Standing, K. G. Deamidation of -Asn-Gly- sequences during sample
preparation for proteomics: Consequences for MALDI and HPLC-
MALDI analysis. Anal. Chem. 2006, 78 (18), 6645−50.
(31) Robinson, N. E.; Robinson, Z. W.; Robinson, B. R.; Robinson,
A. L.; Robinson, J. A.; Robinson, M. L.; Robinson, A. B. Structure-
dependent nonenzymatic deamidation of glutaminyl and asparaginyl
pentapeptides. J. Pept. Res. 2004, 63 (5), 426−36.
(32) Palmisano, G.; Melo-Braga, M. N.; Engholm-Keller, K.; Parker,
B. L.; Larsen, M. R. Chemical deamidation: a common pitfall in large-
scale N-linked glycoproteomic mass spectrometry-based analyses. J.
Proteome Res. 2012, 11 (3), 1949−57.
(33) Breidenbach, M. A.; Palaniappan, K. K.; Pitcher, A. A.; Bertozzi,
C. R. Mapping yeast N-glycosites with isotopically recoded glycans.
Mol. Cell Proteomics 2012, 11 (6), M111.015339.
(34) Kasturi, L.; Eshleman, J. R.; Wunner, W. H.; Shakin-Eshleman,
S. H. The hydroxy amino acid in an Asn-X-Ser/Thr sequon can
influence N-linked core glycosylation efficiency and the level of
expression of a cell surface glycoprotein. J. Biol. Chem. 1995, 270 (24),
14756−61.
(35) Lizak, C.; Gerber, S.; Numao, S.; Aebi, M.; Locher, K. P. X-ray
structure of a bacterial oligosaccharyltransferase. Nature 2011, 474
(7351), 350−5.
(36) Jamaluddin, M. F. B.; Bailey, U. M.; Tan, N. Y. J.; Stark, A. P.;
Schulz, B. L. Polypeptide binding specificities of Saccharomyces
cerevisiae oligosaccharyltransferase accessory proteins Ost3p and
Ost6p. Protein Sci. 2011, 20 (5), 849−55.
(37) Sun, L.; Eklund, E. A.; Chung, W. K.; Wang, C.; Cohen, J.;
Freeze, H. H. Congenital disorder of glycosylation id presenting with
hyperinsulinemic hypoglycemia and islet cell hyperplasia. J. Clin.
Endocrinol. Metab. 2005, 90 (7), 4371−5.
Journal of Proteome Research Article
dx.doi.org/10.1021/pr300599f | J. Proteome Res. 2012, 11, 5376−53835383
98 
 
 
 
 
 
 
Chapter 5 
Sequence-based protein stabilization in the absence 
of glycosylation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
99 
 
5.1 Introduction to this publication  
This chapter was published in Nature Communications as an original article. In this section, I 
briefly describe my role and contribution towards this successful work. I used a novel strategy for 
engineering glycoprotein stability to determine the detailed function of Ost3p and Ost6p in vitro. 
The ER lumenal domain of Ost3p has a single glycosylation sequon, while Ost6p has no 
glycosylation sequons and contains a cluster of acidic amino acids at the position corresponding to 
the Ost3p sequon. The ER lumenal domain of Ost6 is more easily expressed than Ost3 in E.coli and 
shows in vitro peptide binding activity when Ost3 does not. We showed that incorporation of 
targeted like-charged amino acids at N-glycosylation sequons in Ost3/6p increases in vitro stability 
and activity. Optimal stabilization through introducing a minimal number of local point mutations 
at the Ost3p glycosylation sequon allowed increased in vitro binding of peptides. These peptides 
were complementary to the characteristics of the peptide binding groove of Ost3, a key determinant 
of transient nascent polypeptide tethering by Ost3p, consistent with the function of Ost3p and Ost6p 
in modulating N-glycosylation substrate selection by OTase activity in vivo. 
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in the form of a published article in the peer-reviewed journal. This article was published in Nature 
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Sequence-based protein stabilization
in the absence of glycosylation
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Asparagine-linked N-glycosylation is a common modiﬁcation of proteins that promotes
productive protein folding and increases protein stability. Although N-glycosylation is
important for glycoprotein folding, the precise sites of glycosylation are often not conserved
between protein homologues. Here we show that, in Saccharomyces cerevisiae, proteins
upregulated during sporulation under nutrient deprivation have few N-glycosylation sequons
and in their place tend to contain clusters of like-charged amino-acid residues. Incorporation
of such sequences complements loss of in vivo protein function in the absence of glyco-
sylation. Targeted point mutation to create such sequence stretches at glycosylation sequons
in model glycoproteins increases in vitro protein stability and activity. A dependence on
glycosylation for protein stability or activity can therefore be rescued with a small number of
local point mutations, providing evolutionary ﬂexibility in the precise location of N-glycans,
allowing protein expression under nutrient-limiting conditions, and improving recombinant
protein production.
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T
he presence of N-glycans assists protein folding, increases
protein solubility, reduces aggregation and limits proteo-
lysis1–5, while their speciﬁc structures affect glycoprotein
function in development, cancer, inﬂammation and infection3,6.
In eukaryotes, N-glycans are added to selected asparagine residues
in nascent polypeptides co- and post-translocationally in the
lumen of the endoplasmic reticulum (ER) by oligosaccharyl-
transferase (OTase)7–10. N-glycosylation by OTase occurs before
substrate protein folding, as only ﬂexible polypeptide substrate
can bind at its active site11. The presence of Ser or Thr at the
þ 2 position markedly increases glycosylation efﬁciency of
asparagines, due to speciﬁc interactions with the peptide-
binding site of OTase11, and such sequences are termed glyco-
sylation sequons (N-x-S/T; xaP). Asparagines in secondary
structural elements tend to be inefﬁciently glycosylated12,13, as
their reduced ﬂexibility lowers their afﬁnity to the OTase active
site11. N-glycosylation therefore often occurs between secondary
structural elements of folded proteins14. This allows N-glycans to
optimally assist productive protein folding by their hydrophilic
bulk lowering the entropy of the protein unfolded state and acting
as nucleation sites for local folding of nascent glycopolypeptide
chains2. N-glycans can also increase protein stability by making
direct contacts with amino acids in the folded protein15,16,
increasing overall protein solubility17, shielding exposed hydro-
phobic surfaces18 and limiting proteolysis19. In the ER, N-glycans
act as signals to locally recruit ER chaperones to assist in
glycoprotein oxidative folding and are important in glycoprotein
quality control and degradation2,20–22. Although N-glycans are
important for protein folding and function, the precise sites of
glycosylation within a protein are not generally conserved in
homologues.
Here, we study the extent to which peculiar amino-acid
sequences can functionally replace N-glycosylation sites. We
show that clusters of like-charged amino acids in place of
N-glycosylation sequons can impart local protein stability and
improve protein function in the absence of glycosylation.
Results
Sequence analysis of yeast cell wall N-glycoproteins. In the
absence of a nitrogen source and in the presence of a non-
fermentable carbon source, bakers’ yeast S. cerevisiae ceases
vegetative growth and enters sporulation23. This results in large
changes to many aspects of yeast biology including remodelling of
the cell wall. Key enzymes involved in this process are the
GAS family of glucanases/transglycosidases. Gas1p is a major cell-
wall protein during vegetative growth while its functionally
equivalent paralogue Gas2p is predominantly expressed during
sporulation24,25. Gas1p and Gas2p share 45% sequence identity,
conserved secondary structure and identical disulphide bond
connectivity26,27. However, Gas1p has 10 N-glycosylation
sequons while Gas2p has only 1. This prompted us to test if
other sporulation-induced proteins also had few glycosylation
sequons. This analysis showed that glycoproteins upregulated in
sporulation did have fewer glycosylation sequons than their
paralogues expressed during vegetative growth (Fig. 1a). The
nutrient limitations that induce sporulation may provide a
selective pressure for reducing ﬂux through the energetically
expensive N-glycosylation pathway, resulting in loss of
N-glycosylation sequons from sporulation-speciﬁc proteins.
Given the importance of N-glycosylation for protein folding,
we investigated if the equivalent positions of N-glycans in
paralogues that lacked a sequon at that particular site had
compensatory amino-acid sequences. For this, we used a set
of experimentally validated yeast glycosylation sites13,28–30.
Sequence analysis of positions in paralogues corresponding to
these sites showed that they had more acidic amino acids
compared with both validated glycosylation sites and the average
amino-acid composition of the whole protein set (Fig. 1b–d). This
enrichment was only signiﬁcant in the immediate vicinity of the
residues corresponding to the location of the glycosylation sequon
(Fig. 1e–h), although the high sequence diversity in this analysis
precluded the identiﬁcation of more speciﬁc patterns.
Functional complementation of glycosylation sites in yeast.
To test if these clusters of acidic amino acids served to provide
local intrinsic stability to the protein even in the absence of
N-glycosylation, we expressed and puriﬁed the model glycopro-
teins yeast Gas1p and Gas2p as secreted MBP fusions in E. coli
and S. cerevisiae. Given Gas1p has many more N-glycosylation
sequons than Gas2p, we predicted that Gas2p would be more
stable than Gas1p when expressed without N-glycosylation in
E. coli. Circular dichroism (CD) spectroscopy of E. coli-expressed
protein was consistent with MBP-Gas2 containing more helical
secondary structure than MBP-Gas1, while the native glycosy-
lated forms of these S. cerevisiae-expressed proteins showed
equivalent CD spectra (Fig. 2a,b). MS analysis of the disulphide
bond connectivity by non-reducing tryptic peptide mapping
showed that both E. coli-expressed MBP-Gas1 and MBP-Gas2
had incorrect connectivity compared with native protein
expressed in yeast (Supplementary Tables 1 and 2)26,27. To enable
comparison with native glycosylated MBP-Gas1 and MBP-Gas2,
we created disulphide shufﬂed forms of these S. cerevisiae-
expressed proteins. CD spectra of these disulphide shufﬂed forms
of MBP-Gas1 and MBP-Gas2 were similar to their native forms
(Fig. 2a,b). This is consistent with the increased stability and
secondary structure in nonglycosylated MBP-Gas2 compared
with nonglycosylated MBP-Gas1 being local effects that inﬂuence
secondary structure formation. That is, the absence of
N-glycosylation at the 10 glycosylation sites in Gas1p strongly
affected local formation of secondary structural elements, whereas
this affect was not as strong in Gas2p, which with only a single
glycosylation site does not natively rely on N-glycosylation for
stability to the extent of Gas1p.
We next tested if the Gas2p sequences corresponding to Gas1p
glycosylation sites were functionally equivalent in vivo. Yeast cells
with deletion of GAS1 showed reduced growth compared with
wild-type cells, which was complemented by overexpression
of native Gas1p (Fig. 2c). Gas1p is glycosylated at Asn40
(NN40GS)13 and expression of variant Gas1-N40Q lacking this
glycosylation site did not complement loss of GAS1 (Fig. 2c).
While Asn-Gln site-directed mutagenesis is routinely used to test
the importance of particular glycosylation sites in glycoprotein
folding and function, the conformational preferences of Gln are
very different to those of Asn, while His is more similar to Asn31.
Expression of variant Gas1-N40H only partially complemented
loss of GAS1 (Fig. 2c). This lack of complementation indicated
that glycosylation at Asn40 was required for Gas1p function
in the context of the native sequence. However, replacing this
stretch of Gas1p with the corresponding sequence from Gas2p
(39ESGE42; Supplementary Fig. 1a) restored growth, as did point
mutation to insert proximal Asp residues (Fig. 2c), while
retaining the conserved Gly41 (Supplementary Fig. 1b). The
dependency of in vivo Gas1p function on glycosylation at Asn40
could therefore be rescued by a small number of compensatory
point mutations introducing local clusters of negatively charged
residues.
Stabilization of unglycosylated human interferon-b. Animal
glycoproteins are not generally required to be expressed under
such severe nutrient limitations as during yeast sporulation.
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However, human glycoproteins are often expressed for bio-
technological purposes in bacteria that lack glycosylation systems.
Such a protein is the human glycoprotein hormone interferon-b
(IFNb)32. The single N-glycosylation site in human IFNb is
not strictly conserved in orthologues and paralogues (Fig. 3a,
Supplementary Fig. 2), and in these proteins is often replaced by
clusters of acidic amino acids similar to those observed in place of
N-glycosylation sites in yeast proteins (Fig. 1, Supplementary
Fig. 1). To test if such a sequence would increase IFNb stability in
the absence of glycosylation, we expressed and puriﬁed IFNb as
wild type and glycosylation site variant (Asn101Asp) forms from
E. coli and refolded these proteins in vitro. Guanidinium-induced
unfolding equilibria showed that at physiologically relevant pH
7.5 this point mutation increased stability (DDG0  9 kJmol 1,
Fig. 3b). In contrast, at pH 5.0 the DDG0 was negligible (Fig. 3c).
We propose that this is consistent with stabilization of the
IFNbN101D variant at pH 7.5 through reduced entropy of the
unfolded state due to charge-charge repulsion between Asp101
and Glu102 favouring a local turn or extended structure similar to
the structure of Asn101 and Glu102 in folded native IFNb18, or
stabilization of the native state33,34. At pH 5 there is a lower
probability that both these residues will be simultaneously
deprotonated (negatively charged) in a given protein molecule,
consistent with the lack of stabilization in the IFNbN101D variant.
The overall higher stability for both protein forms at pH 5.0 than
at pH 7.5 is likely due to increased distance from the predicted pI
of IFNb (B9.0). This conﬁrmed that local clusters of negatively
charged amino acids could increase protein stability in the
absence of glycosylation in homologues of human IFNb. To
conﬁrm that stable IFNbN101D retained native activity, we
performed a cell culture growth inhibition assay (Fig. 3d).
Stable IFNbN101D showed signiﬁcantly higher speciﬁc activity
than IFNb wild type (Fig. 3d), correlating increased
thermodynamic stability with improved protein function in this
assay. This suggested that it is possible for IFN proteins to have
either N-glycosylation sites or sequence stretches that can play a
similar role in protein folding and stability.
Stabilization at an inefﬁciently glycosylated sequon. Aspar-
agines in sequons generally show macroheterogeneity with not all
of the protein pool glycosylated, and almost all sequons are
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modiﬁed to some extent9. We therefore tested whether essentially
unmodiﬁed sequons could also be subject to sequence-based
stabilization. For this purpose we studied the paralogous yeast
proteins Ost3p and Ost6p, which are accessory subunits of
OTase7,13. The ER lumenal domain of Ost3p has a single sequon
at Asn33, which is not detectably glycosylated35 (Fig. 4a and
Supplementary Fig. 3), while Ost6p has no sequons and contains
a cluster of acidic amino acids at the position corresponding to
the Ost3p sequon (Supplementary Fig. 4). The ER lumenal
domain of Ost6p is more easily expressed than that of Ost3p in
E. coli30 and shows activity in an in vitro peptide-binding assay
when Ost3p does not36. To test if the higher in vitro activity
of Ost6p relative to Ost3p correlated with increased thermo-
dynamic stability of Ost6p, we performed guanidinium-induced
equilibrium unfolding of Ost6 and Ost3 puriﬁed from E. coli. This
showed that Ost6 (DG0¼  79±10 kJmol 1) was more stable
than Ost3 (DG0¼  28±5 kJmol 1) (Fig. 4b,f), consistent with
the presence of clusters of like-charged amino acids in place of an
unused glycosylation sequon increasing thermodynamic stability
and activity. To test this in the context of Ost6p, we introduced a
glycosylation sequon in Ost6 at the equivalent position to the
Ost3 sequon, and tested in vitro stability and peptide-binding
activity. This variant of Ost6 with a glycosylation sequon had
both reduced stability compared with wild-type Ost6 (Ost6D38N
DDG0¼ 20 kJmol 1) (Fig. 4f,g), and essentially eliminated
in vitro peptide-binding activity (Fig. 4l,m). We next tested
whether the stability and in vitro activity of Ost3 could be
increased by targeted point mutation at the unused sequon in
Ost3. We ﬁrst introduced an acidic Asp in place of Asn33, which
increased stability compared with wild-type protein (Ost3N33D
DDG0¼  16 kJmol 1) (Fig. 4c), but did not result in a
detectable increase in in vitro peptide binding (Fig. 4h,i).
However, Ost3p orthologues lack sequons at this position and
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instead typically possess clusters of basic amino acids, while
Ost6p orthologues have acidic residues at this position
(Supplementary Fig. 4). This difference may depend on Ost3p-
and Ost6-speciﬁc charge distributions on a neighbouring a-helix
(Supplementary Fig. 5). We therefore tested two additional
variants with clusters of either acidic or basic like-charge.
While Ost3N33D,K34D (30KLADDSPKK38) was less stable
(DDG0¼ 6 kJmol 1) (Fig. 4d), Ost3N33K (30KLAKKSPKK38)
was more stable than Ost3N33D and wild-type Ost3
(DDG0¼  27 kJmol 1) (Fig. 4e). Optimal stabilization was
therefore achieved through minimal mutations providing a
cluster of like-charged residues. This stable Ost3N33K showed
increased in vitro binding of several peptides (Fig. 4j,k). These
peptides contained aromatic amino acids, complementary to
Phe102 in the peptide-binding groove of Ost3, a key determinant
of transient nascent polypeptide tethering by Ost3 crucial to its
function in modulating OTase activity in vivo30,36. The additional
thermodynamic stability of Ost3N33K therefore enabled its
function to be investigated in this in vitro assay.
Discussion
We show that targeted introduction of like-charged amino acids
at N-glycosylation sequons is a generally applicable technique for
increasing the stability of normally N-glycosylated proteins when
expressed from more efﬁcient expression systems such as E. coli.
The targeted nature of this approach also limits any unanticipated
affects on protein structure or function of non-targeted
mutagenesis. The presence of a sequon rather than a compensa-
tory sequence at a speciﬁc location in a given protein may also
depend on its protein context. For example, experimental1,16 and
computational37 characterization of variants of CD2 adhesion
domain from human (which is glycosylated) and rat (which is not
glycosylated) has shown that gain of glycosylation mutations in
Rat CD2 do not immediately increase protein thermodynamic
stability. However, acquisition of two additional mutations
proximal to the newly glycosylated Asn introduces speciﬁc
glycan–protein interactions, which lead to the formation of high-
occupancy hydrogen bonds and stabilize the glycosylated protein.
Alternatively, while loss of glycosylation mutations in human
CD2 destabilizes the protein, two additional nearby mutations
rescue stability and function38. Experimentally, Asn-Gln site-
directed mutagenesis is commonly used as a proxy for loss of
glycosylation at a given site. Such a mutation may show if
glycosylation at that site is important for protein folding, stability
or activity, in the context of an otherwise unchanged protein
sequence. However, our bioinformatics, in vitro and in vivo
results here show that such a requirement could in general be
easily rescued by evolutionary acquisition of a small number of
stabilizing point mutations. The exact reasons why particular
glycoproteins have N-glycosylation sites at speciﬁc locations are
undoubtedly complex, depending not only on their affect on
global protein stability but also on evolutionary history and the
many roles of N-glycans in inﬂuencing protein function.
Methods
Sequence analyses. Families of yeast glycoproteins with members expressed
predominantly during vegetative growth or sporulation were identiﬁed from
expression data23 and UniProt BLAST with a cutoff of e-4. Sequence analysis was
performed based on a set of experimentally validated occupied glycosylation sites
in S. cerevisiae cell-wall glycoproteins (28 sites in 13 glycoproteins)13,28,29.
Homologues to these from S. cerevisiae were identiﬁed with UniProt BLAST with a
cutoff of e-4, and each of these sets of homologous proteins and glycoproteins were
aligned with ClustalW. For each experimentally validated glycosylation site, aligned
sequences of homologous proteins were identiﬁed that did not contain a
glycosylation sequon at that position (41 sequences). The characteristics of the
amino-acid sequences ﬂanking these sites (glycosylation sites, and corresponding
sequences in homologues lacking glycosylation sites) were determined through a
non-gapped alignment visualized with WebLogo39 and amino-acid composition
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(hydrophilic, hydrophobic, acidic or basic). pI of the amino-acid sequences was
determined with ProtParam40.
Cloning and mutagenesis. DNA encoding the ER lumenal domain of S. cerevisiae
Gas2p as predicted in the UniProt Knowledgebase (position 25 to 531 of Gas2p/
Q06135/YLR343W) was cloned into the pMAL-p2x vector, using PCR primers
incorporating BamHI and HindIII restriction sites, to give pMAL-GAS2. DNA
encoding the GAS1 genomic locus (GAS1/P22146/YMR307W including 1 kb up
and downstream) was cloned into the pRS415 vector to give pRS415-GAS1. Blunt
ended DNA encoding mature MBP-Gas1 or MBP-Gas2 was ampliﬁed using PCR
primers incorporating a C-terminal His-tag, phosphorylated with T4 polynucleo-
tide kinase, and ligated into blunt ended DNA ampliﬁed from pRS415-GAS1
excluding DNA encoding mature GAS1 (ref. 41). This produced pRS415-MBP-
GAS1-His and pRS415-MBP-GAS2-His, which encoded MBP-Gas1-His or MBP-
Gas2-His with the native Gas1p signal sequence under the control of the native
GAS1 promoter and terminator. DNA encoding the mature protein sequence of
IFNb as predicted in the UniProt Knowledgebase (position 22 to 187 of P01574)
with Cys17 changed to Ser32 and with an N-terminal decaHis-tag, optimized for
E. coli protein expression was synthesized and cloned into the pJexpress404
expression vector (DNA 2.0). DNA sequence encoding a C-terminal FLAG-tag was
inserted in S. cerevisiae OST3 on plasmid YEp352 (ref. 42) using site-directed
mutagenesis41 to create pOST3-FLAG. Point mutation of GAS1, IFNb and OST3
were performed by site-directed mutagenesis41.
Cell culture and protein puriﬁcation. BY4741 (MATa his3D1 leu2D0 met15D0
ura3D0) yeast cells and the Dgas1 mutant derivative thereof (Open Biosystems) was
transformed with pRS415, pRS415-GAS1 or variants using standard protocols.
Cells were diluted to equal densities at OD600 nm, serially 10-fold diluted, equal
volumes spotted to minimal media agar plates and incubated at 30oC. TOP10
E. coli cells carrying the plasmids encoding IFNb, Ost6 (pHis10-OST6L43), Ost3
(pHis10-OST3L43) or variants thereof were grown in LB media, and cells carrying
pMAL-Gas1 (ref. 36) or pMAL-Gas2 were grown in LB-glucose media. Media was
supplemented with 100mg l 1 ampicillin. Protein expression was induced by
addition of IPTG to 1mM at an OD600 nm of 0.7. After incubation for 4 h at 37 C
the cells were collected by centrifugation. MBP-Gas1 and MBP-Gas2 were puriﬁed
as previously described36, except that protein was eluted with 10mM maltose.
Yeast cells carrying pRS415-MBP-GAS1-His or pRS415-MBP-GAS2-His were
grown in minimal media at 30 C with shaking and collected at an OD600 nm
of 1.0. Cells were resuspended in 50mM phosphate buffer pH 7.5, 150mM NaCl,
1 protease inhibitor cocktail (Roche) and 1mM PMSF, and lysed by French
Press. Proteins were puriﬁed using TALON resin (Clontech) and eluted in 50mM
phosphate buffer pH 7.5, 150mM NaCl and 250mM imidazole. The TALON resin
eluate was then applied to amylose-agarose beads and puriﬁed as previously
described36, except that protein was eluted with 10mM maltose. Disulphide-
shufﬂed protein was produced by reduction in 6M guanidinium chloride, 50mM
phosphate buffer pH 7.5 with 10mM DTT, buffer exchange into 1M guanidinium
chloride, 50mM phosphate buffer pH 7.5 with 0.1mM CuSO4 and incubation at
25 C for 2 h. Protein was then buffer exchanged into 20mM phosphate buffer pH
7.5, 200mM NaCl and 1mM EDTA. Collected cells expressing IFNb variants were
resuspended in 50mM phosphate buffer pH 7.5, 150mM NaCl, 1 protease
inhibitor cocktail (Roche) and 1mM PMSF, and lysed by French Press. Inclusion
bodies were recovered by sequential centrifugation at 18,000 rcf. The pellets were
washed with 1ml 50mM phosphate buffer pH 7.5 and 150mM NaCl and
re-centrifuged three times. The washed pellets containing inclusion bodies were
resolublized in 6M guanidinium chloride, 50mM phosphate buffer pH 7.5 and
1mM b-mercaptoethanol and incubated at 37 C for 16 h. His-tagged IFNb was
puriﬁed using TALON resin (Clontech) and eluted in 6M guanidinium chloride,
50mM phosphate buffer pH 5.0 and 1mM b-mercaptoethanol. The pH was
adjusted to pH 7.5 with other constituents remaining constant, DTT was added to
20mM and the protein was incubated at 37 C for 1 h. Protein was buffer
exchanged with PD-10 columns (GE Healthcare) into 50mM phosphate buffer pH
7.5 and 6M guanidinium chloride. Cysteines were oxidized to cystine by addition
of 0.1mM CuSO4 and incubation at 25 C for 2 h. Oxidation was quenched by
addition of 1mM EDTA, and oxidized IFNb was buffer exchanged with PD-10
columns into 50mM phosphate buffer pH 7.5 and 25% glycerol at 4 C. Cells
expressing N-terminally His-tagged Ost6, Ost3 or variants thereof were
resuspended in ice cold 50mM Potassium Phosphate, pH 7.5, 150mM NaCl,
10mM Imidazole, 1 complete mini EDTA free protease inhibitor (Roche) and
1mM PMSF, and lysed by French Press. Protein was puriﬁed from clariﬁed whole-
cell extract using TALON resin and eluted with 200mM imidazole. Proteins were
buffer exchanged with PD-10 columns into 50mM potassium phosphate buffer pH
7.0 and 1mM EDTA. Yeast with pOST3 or pOST3-FLAG were grown in minimal
media at 30 C and collected at mid log phase. Proteins were denatured in SDS
sample buffer, incubated for 1 h at 37 C with 1G5 buffer in the presence or
absence of Endo H13, separated by SDS-PAGE, transferred to nitrocellulose
membrane and probed with an a-FLAG antibody.
In vitro protein analysis. CD spectra were obtained using a Jasco J-710
spectrometer (Jasco, Japan) as described44. Free energies of stabilization (DG0)
were determined based on the two-state model of protein folding45 as described30.
To determine the equilibrium transitions, intrinsic tryptophan ﬂuorescence of
proteins was measured in different concentrations of guanidinium chloride in
50mM potassium phosphate pH 7.5 or 5.0, and 150mM NaCl at 25 C. DG0 and
cooperativity were determined from a non-linear least-squares 6 parameter ﬁt to
the data points45, with uncertainty estimates from the corresponding six-parameter
ﬁts. Ost3 and Ost6 peptide-binding afﬁnity chromatography was performed as
described36. Brieﬂy, tryptic peptides from MBP-Gas1p were applied to peptide-
afﬁnity chromatography columns containing MBP-Ost3, MBP-Ost3N33K,
MBP-Ost6 or MBP-Ost6D38N bound to amylose-agarose resin with or without
pre-reduction with DTT. Peptides were eluted with physiological buffer, fractions
collected, and peptides in the load and elution fractions were detected with
MALDI-TOF-MS. Peptide retention was determined by the relative abundance of
each peptide in wash fractions compared with the load, in oxidized relative to
reduced. Reduction of the CxxC motif in Ost6p causes structural changes only at
the peptide-binding groove30, conﬁrming that retained peptides bind at this groove
rather than through other non-speciﬁc interactions36.
Cell culture growth inhibition assay. A total of 4 103 Human MCF-7 breast
tumour cells were cultured in 200 ml of phenol-free media containing 5% charcoal
stripped calf serum in 96-well plates. Equal amounts of either human recombinant
IFNb (ProSpec CYT-234), IFN-bWT, IFN-bN101D or no protein were added to the
cultures with retinoic acid (Sigma) and incubated for 4 days as described46. Cells
were ﬁxed with a ﬁnal concentration of 3.3% (wt/vol) TCA and stained with
Sulforhodamine B (Sigma R2625) as described47, after which the OD was measured
at 490 nm. A control plate to determine initial seeding intensity was included where
cells were ﬁxed 2–3 h after plating. Absorbance with this plate was set as 0%
growth, and growth obtained with untreated cells was taken as 100%.
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5.4 Supplementary Information  
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Supplementary Figure 1. Sequence alignments of S. cerevisiae Gas1p homologs. (a) 
Alignment of Gas1p and Gas2p surrounding the Gas1p Asn40 glycosylation site. The N-
glycosylation site at Asn40 in Gas1p is underlined. Acidic amino acids at the corresponding 
location in Gas2p are bold and highlighted. (b) Multiple sequence alignment of fungal Gas1p 
orthologs surrounding the Gas1p Asn40 glycosylation site. The N-glycosylation site at Asn40 in 
Gas1p is underlined. The conserved Gly41 is bold. 
 
 Supplementary Figure 2. Sequence alignments of human IFN homologs. (a) Multiple 
sequence alignment of human IFN paralogs. The single N-glycosylation site in IFN is 
underlined. Corresponding positions in paralogs with acidic local sequence stretches are bold and 
highlighted, and with a glycosylation sequon is underlined. (b) Multiple sequence alignment of 
selected mammalian IFN orthologs. The single N-glycosylation site in IFN is underlined. 
Corresponding position in an ortholog with a local stretch of acidic amino acids is bold and 
highlighted. 
 
 Supplementary Figure 3. Glycosylation of Ost3p is not detectable in S. cerevisiae. Whole 
cell extracts of S. cerevisiae with plasmids expressing native (OST3) or C-terminally FLAG-
tagged (OST3-FLAG) Ost3p, digested with endoglycosidase H (EndoH +) or not digested (-), 
were separated by SDS-PAGE, blotted to nitrocellulose and probed with -FLAG antibody. 
 
  
Supplementary Figure 4. Multiple sequence alignment of selected fungal Ost3p and Ost6p 
orthologs. (a) Alignment of Ost3p orthologs. The single N-glycosylation sequon in S. cerevisiae 
Ost3p is underlined. Basic local sequence stretches at the corresponding position in orthologs are 
bold and highlighted. (b) Alignment of Ost6p orthologs. The position corresponding to the single 
N-glycosylation sequon in S. cerevisiae Ost3p is underlined in S. cerevisiae Ost6p. Acidic local 
sequence stretches at the corresponding position in orthologs are bold and highlighted. 
 
 Supplementary Figure 5. Charge complementarity between Ost3p glycosylation sequon 
loop and neighboring helix in Ost3p and Ost6p. (a) Cartoon of Ost6p crystal structure (3G7Y) 
25
 showing proximity of Asp38/Asp39, corresponding to the Ost3p glycosylation sequon, and 
His89 on a neighboring helix. (b) Weblogo representation of aligned sequences of this helix in 
fungal Ost6p and (c) Ost3p orthologs. The alignments begin with the Cys corresponding to 
Cys78 in S. cerevisiae Ost6p. *, Position corresponding to His89 in Ost6p. 
 
  
Supplementary Table 1. Disulfide connectivity of MBP-Gas1p expressed periplasmically in E. 
coli. 
m/z z 
M exp 
(Da) 
^ 
sum of 
* 
M calc 
(Da) 
# 
Peptides 
E. coli    
C-C
a 
Yeast  
C-C
b 
1225.7 2 2449.3 
2451.1 - 
2 
2449.1 
SDC445SFSGSATLQTAT
TQASC462SSALK 
445-462 
379-445, 
372-462 
1058.5 3 3172.3 
1478.6 + 
1695.7 -
2 
3172.3 
MTDYFAC216GDDDVK, 
ADFYGINMYEWC234GK 
216-234 
216-348, 
234-265 
1243.3 3 3726.9 
1557.7 + 
2171.0 - 
2 
3726.7 
SYSATTSDVAC348PATG
K, 
NLSIPVFFSEYGC265NEV
TPR 
265-348 
216-348, 
234-265 
^
 Experimental mass of peptides observed in oxidized but not reduced tryptic digest.  
* Sum of calculated peptide masses less two protons.  
# calculated mass of disulfide-linked peptides.  
a
 disulfide connectivity experimentally measured in E. coli.  
b
 native disulfide connectivity previously experimentally measured in yeast. 
 
 
Supplementary Table 2. Disulfide connectivity of MBP-Gas2p expressed periplasmically in E. 
coli. 
m/z z 
M exp 
(Da) 
^ 
sum of 
* 
M calc 
(Da) 
# 
Peptides 
E. coli    
C-C
a 
Yeast  
C-C
b 
1282.2 2 2562.4 
1133.5 + 
1430.6 - 
2 
2562.2 
YEEYFSYLC419SK, 
VDC424SDILANGK 
419-424 419-424 
1003.6 3 3007.7 
825.4 + 
2184.1 - 
2 
3007.5 
HC466PLNDK, 
NVYFNLESLQPLTSESIC
489K 
466-489 
399-466, 
392-489 
^
 Experimental mass of peptides observed in oxidized but not reduced tryptic digest.  
* Sum of calculated peptide masses less two protons.  
# calculated mass of disulfide-linked peptides. 
a
 disulfide connectivity experimentally measured in E. coli. 
b
 native disulfide connectivity previously experimentally measured in yeast. 
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Chapter 6 
Transient protein-protein interaction between substrate 
peptide and yeast Oligosaccharyltransferase subunit 
Ost3/6p increase N-glycosylation  
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6.1 Introduction  
The ER lumenal domain of Ost3/6p proteins is predicted to have a thioredoxin-like fold and a CxxC 
active-site motif (Fetrow et al., 2001). Previous studies by Schulz et al. (2009) have determined the 
crystal structure of Ost6p that not only implicates the predicted thioredoxin-like core fold, but a 
conspicuous loop adjacent to the CxxC active site motif. When the CxxC motif is oxidized, the loop 
creates a potential peptide-binding groove, but when it is reduced, the loop becomes disordered and 
the groove is no longer present (Schulz et al., 2009). As sequence alignment indicates the amino 
acids involved in forming the peptide-binding groove are not conserved in Ost3p and Ost6p 
(Jamaluddin et al., 2011), it is proposed that they would recognize distinct sets of glycosylation 
sites on a nascent polypeptide chain (Jamaluddin et al, Unpublished work reference to Chapter 2 
and 3), and sequentially increase the efficiency of glycosylation (Schulz and Aebi, 2009). 
Here, we attempted to determine the crystal structure of Ost3L in complex with a physiological 
ligand - Gas1p85-97 peptide (NTNVIRVYAINTT), and measure the binding affinity between them. 
The Gas1p85-97 peptide was one of the physiologically relevant sequences determined in Chapter 2. 
It is comprised of a stretch of hydrophobic residues flanked by basic residues, and interacts directly 
with the peptide-binding groove of Ost3p to assist efficient glycosylation in vivo. This serves as a 
key determinant of transient nascent polypeptide tethering by Ost3p, consistent with the function of 
Ost3p and Ost6p in modulating N-glycosylation substrate selection by OTase activity in vivo. We 
also included Ost3N33K in this experiment, as this variant protein is a more stable form than wild-
type Ost3 (Tan et al., 2014), and because this variant form of Ost3 showed increased in vitro 
peptide binding compared with wild-type Ost3. Interestingly, the peptides identified binding to 
Ost3N33K are complementary to the characteristics of the peptide binding groove (Tan et al., 2014). 
This transient binding of cysteine residues and hydrophobic stretches of nascent polypeptide to 
Ost3p/Ost6p is an optimal strategy for inhibiting local protein folding, as such hydrophobic 
stretches normally would be found in the internal part of folded protein domains (Schulz, 2012). 
This fits with the requirement of the catalytic site of OTase for unfolded or flexible protein 
substrate. 
This chapter illustrates different approaches applied to the crystallization of the lumenal domain of 
Ost3p (Ost3L) with and without Gas1p85-97 peptide. In particular, a linker strategy was utilized to 
increase the chance of the Gas1p85-97 peptide binding to Ost3L. Although we were unable to obtain 
crystals of Ost3L-linker-Gas1p85-97 peptide, some initial crystal hits were identified for Maltose-
Binding Protein (MBP)-tagged Ost3L. Furthermore, preliminary results were obtained for the 
binding affinity between Gas1p85-97 peptide and Ost3L. In general, we have piloted different 
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crystallization trials and conditions for setting up kinetic analysis for binding between Ost3/6L and 
their substrate peptides.  
 
6.2 Materials and Methods 
6.2.1 Recombinant DNA constructs 
The DNA sequence corresponding to the respective ER lumenal domains of Ost3p and Ost6p 
(ranging from the signal peptidase cleavage sites to the beginning of the first transmembrane helix) 
as predicted in the UniProt Knowledgebase: residue 23-185 of Ost3p (P48439, YOR085W); 
residues 25-188 of Ost6p (Q03723, YML019W); and the stable form of Ost3N33K (Tan et al., 2014) 
was amplified using PCR primers and performed ligation-independent cloning (LIC) (Section 
6.2.2.) into the pMCSG7 E.coli expression vector, producing pMCSG7-Ost3L, pMCSG7-Ost6L 
and pMCSG7-Ost3N33K, respectively. This pMCSG7 vector contained an N-terminal His6 tag 
followed by a TEV (tobacco etch virus) protease cleavage site (Stols et al., 2002). This TEV 
protease site is crucial for removal of His tag to improve screening and purification of Ost3/6L. For 
Ost3L-Flexible Linker-Peptide Sequence and Ost3N33K-Flexible Linker-Peptide Sequence 
expression in E.coli, we used PCR primers Ost3L Fwd and Ost3-L-P Rvs to introduce peptide 
sequence (NTNVIRVYAINTT) from Gas1p85-97 and flexible linker (GGSGGHMGSGG) directly 
C-Terminal of Ost3L before beginning of the first transmembrane helix, giving pMCSG7-Ost3L-
Linker-peptide and pMCSG7-Ost3N33K-Linker-peptide. We used our existing pHis10-Ost3, pHis10-
Ost6 (Mohd Yusuf et al., 2013); pHis10-Ost3N33K, pHis10-Ost3-Linker-peptide and pHis10-
Ost3N33K-Linker-peptide as a template to generate all our PCR products above. 
For affinity interaction assays between Ost3L/Ost3N33K/Ost6L/Ost6Lvariants versus Gas1p85-97, the 
DNA sequences of Gas1p85-97 which contains our peptide interest sequence NTNVIRVYAINTT 
was amplified using PCR primers incorporating EcoRI and BamHI restriction sites and cloned into 
pGEX2T vector, giving pGEX2T-Gas1p85-97. Variants with amino acid replacements 
(pMCSG7_OST6LK96Q,K99Q) were constructed as described by Imai et al (Imai et al., 1991).  
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Table 6.1: Primers used for Ost3L-/ Ost6L- / Ost3N33K / Ost3L Linker Peptide/ Ost3N33K Linker 
Peptide 
Primers  Sequences 
Ost3L Fwd  5’-TACTTCCAATCCAATGCCATGTCCAGCAACAGACTACTAA 
AGC-3’ 
Ost3L Rvs  5’-TTATCCACTTCCAATGTTAGTCCATAGGTAAGTGTAAAGA 
GAAG-3’ 
Ost3-L-P-Rvs  5’- TTATCCACTTCCAATGTTAAGTGGTATTGATAGCGTAGAC 
ACGGA-3’ 
Ost6L Fwd  5’- TACTTCCAATCCAATGCCACTGCATCCCATAATATAG-3’ 
Ost6L Rvs  5’- TTATCCACTTCCAATGTTATTCCTGAACGTTGAAGGC-3’ 
___________________________________________________________________________ 
 
Table 6.2: Primers used for pGEX2T-Gas1p85-97 
Primers    Sequences 
pGEX2T-PepSeq-EcoRI Fwd 5’- ATCCGTGTCTACGCTATCAATACCACTTAAG 
AATTCATCGTGACTGACTG -‘3 
pGEX2T-PepSeq-BamHI Rvs 5’- AACATTTGTGTTGGATCCACGCGGAACCAGA 
TC-‘3 
___________________________________________________________________________ 
 
6.2.2 Ligation-independent cloning 
Ligation-independent cloning (LIC) was utilized for the directional cloning of PCR products 
without restriction enzyme digestion or ligation reactions (Aslanidis and de Jong, 1990, Haun et al., 
1992). LIC-compatible vectors contain non-complimentary 12-15 base single-stranded overhangs 
that anneal to complementary single-stranded overhangs of the target insert. The primers amplifying 
the target insert have 5’- extensions so that with T4 polymerase treatment, the insert has 
complementary sequence to the prepared LIC vector. 
The PCR products (Section 6.2.1) were analysed by agarose gel electrophoresis and purified using a 
QIAquick Gel Extraction Kit (Qiagen). For the generation of single-stranded overhangs, the PCR 
product (1 µg) was treated with T4 DNA polymerase (1 U, NEB) in the presesne of dCTP (100 
mM). The pMCSG7 vectors were linearized by the blunt restriction enzyme SspI (NEB) according 
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to the procedure described by the manufacturer. After separating the linearized and circular vectors 
by agarose gel electrophoresis, the pMCSG7 vectors were extracted from the agarose gel (using a 
QIAquick Gel Extraction Kit (Qiagen). The linearized vector was treated with T4 DNA polymerase 
(NEB) as described earlier to generate the single-stranded overhangs complementary to the target 
site. The T4 polymerase-treated vectors (15 ng) and PCR products (25-30 ng) were mixed 
(incubated for 30 min) and transformed by heat shock into DH5α competent cells. Positive clones 
were identified with colony PCR using T7 promoter and T7 terminator primers. Positive colonies 
were grown in 5 ml LB media overnight and plasmids were prepared using QIAprep Spin Miniprep 
Kit (Qiagen). 
 
6.2.3 Protein Expression and Purification 
6.2.3.1  Large-scale expression of His-tagged-Ost3L/ His-tagged-Ost3N33K/ His-tagged-
Ost3L-Linker-peptide / His-tagged-Ost3N33K-Linker-peptide 
All proteins were expressed using the autoinduction method. Autoinduction aims to promote high 
density growth and protein expression. Plasmid DNA containing respectively pMCSG7-Ost3L; 
pMCSG7-Ost3N33K; pMCSG7-Ost3L-Linker-Peptide; pMCSG7-Ost3N33K-Linker-Peptide was 
transformed into E.coli DH5α expression strain by heat shock and plated onto ampicilin agar plates, 
which were incubated over-night at 37 ºC.  Next day, a single colony was picked and inoculated 
into 5 ml of LB supplemented with amipicilin (100 µg/ml) and incubated overnight at 37 ºC (230 
rpm) as a starter culture. For autoinduction, the overnight starter culture (2 ml) was inoculated into 
535 ml autoinduction media (Studier, 2005) (ZY medium: 5g of peptone, 2.5g of yeast extract, 1M 
MgSO4, 50x 5052, 20x NPS) containing 100 ug/ml of ampicilin in 2 litre flask. The culture was 
incubated at 37 ºC (230 rpm) until the cell density reached OD600 around 0.6. Subsequently, the 
temperature was decreased to 20 ºC and the cells were grown overnight until an OD600 of 5-10 was 
reached. The cells were harvested by centrifugation at 6.500 g for 20 min at 4ºC and the cell pellets 
were either processed immediately or stored at -80 ºC. Due to time constraints, I selected pMCSG7-
Ost3N33K and pMCSG7-Ost3N33K-Linker-peptide construct as my main priority for polyhistidine 
purification and affinity assay or crystallisation set up.  
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6.2.3.2  Purification of His6-tagged of Ost3N33K and Ost3N33K-Linker-peptide 
The cell pellets were resuspended in the lysis buffer containing ice cold 20 mM Tris-HCl pH 8, 500 
mM NaCl, 1 mM PMSF, 30 mM immidazole, 1x Complete Mini EDTA free protease inhibitor 
(Roche Diagnostics) and 100 µg/ml DNase at the ratio of 5 ml lysis buffer per gram of cell pellets. 
Cells were lysed using a sonicator (Sonifier W-450D; Branson) and the lysates were subject to 
centrifugation at 15,000 g at 4 ºC for 30 mins. The supernatant was collected and injected onto a 
pre-washed HisTrap
TM
 FF 5 ml column (GE Healthcare) with lysis buffer (20 mM of Tris-HCl pH  
8, 500 mM NaCl, 30 mM immidazole) at 2.5 ml/min. The column was washed with 10 column 
volumes of Washing Buffer (20 mM of Tris-HCl pH8, 500 mM NaCl, 40 mM immidazole) at 4 
ml/min to remove unbound bacterial proteins. Bound proteins containing either His-tagged-
Ost3N33K or His-tagged-Ost3N33K-Linker peptide were eluted with 5 column volumes of Elution 
Buffer (20 mM of Tris-HCl pH8, 500 mM NaCl, 250 mM immidazole). All purification steps were 
performed at 4 ºC. The identity and final purity of Ost3N33K and Ost3N33K-Linker peptide were 
confirmed by SDS-PAGE (data not shown).  All the fractions containing the protein of interest were 
pooled and concentrated to 2 ml followed by subsequent dilution to 4 -column volumes of TEV 
cleavage buffer (50 mM Tris-HCl pH 8, 250 mM NaCl and 0.5 mM EDTA) to dilute the 
immidazole concentration. The His6-tag was removed by overnight treatment with TEV protease 
(100 µl, 8 mg/ml) at 4 ºC in the TEV cleavage buffer. After cleavage, the protein was injected onto 
a pre-equilibrated His Trap
TM
 FF 5 ml column (GE Healthcare) to remove uncleaved protein, His6-
tag, the TEV protease (His-tagged) and other contaminating proteins. The flow through was 
collected and concentrated to 5 ml using Amicon-Ultra centrifugal filter devices (10 kDa cutoff) 
and injected on to a HiLoad 26 / 60 Superdex 200 PG column (GE Healthcare) pre-equilibrated 
with the gel filtration buffer (20 mM Tris HCl pH 8, 125 mM NaCl). The peak fractions were 
pooled, concentrated (10-15 mg/ml), snap-frozen as 50 µl aliquots in liquid nitrogen and stored at-
80ºC. 
 
6.2.3.3  Purification of GST-tagged Gas185-97 peptide 
The cell pellets were resuspended in the lysis buffer (5 ml of lysis buffer for 1 gram of cell pellets) 
containing 50 mM Tris HCl pH 8, 125 mM NaCl, 1 mM EDTA and 2 mM DTT. Resuspended cells 
were lysed by sonification (Sonifier W-450D; Branson) at 4 ºC and cell debris was removed by 
centrifugation at 15,000 g for 30 minutes at 4 ºC (Avanti J-26; Beckman Coulter). The soluble 
supernatant fractions were collected and purified by IMAC (immobilized metal affinity 
chromatography) using a 5 ml GST (Glutathione S-transferase) column (GST
TM
 FF 5 ml, GE 
Healthcare), where the soluble fractions were loaded onto the GST column for protein binding at 
122 
 
2.5 ml/min. To remove non-specifically bound bacterial proteins, the GST column was washed 
using the lysis buffer until the absorbance reached a steady state at 4 ml/min. GST-tagged protein 
was eluted by elution buffer containing 10 mM glutathione in the lysis buffer. The identity and final 
purity of GST-tagged Gas185-97 were confirmed by SDS-PAGE. 
6.2.3.4  Purification of MBP-Ost3L 
The cell pellets of MBP-Ost3Lwere resuspended in lysis buffer (50 mM Tris HCl pH 7.5, 150 mM 
NaCl and 1 mM EDTA, 1 mM PMSF and 100 µg/ml DNase) at the ratio of 5 ml lysis buffer per 1 g 
of cell pellets. Then, the cell pellets were lysed at 4 ºC by sonication (Sonifier W-450D; Branson). 
The lysates were centrifugated at 15,000 g for 30 min at 4 ºC (Avanti J-26; Beckman Coulter) and 
the supernatant was collected and applied onto the MBP Trap HP 5 ml column (GE Healthcare) at 
2.5 ml/min. The column was further washed with column buffer (50 mM Tris HCl pH 7.5, 150 mM 
NaCl and 1 mM EDTA) to about 50-100 ml at 4 ml/min to remove non-specifically bound proteins. 
Finally, the MBP-Ost3L protein was eluted with 40 ml of elution buffer containing column buffer 
and 10 mM maltose (D-(+) maltose monohydrate). The fractions containing MBP-Ost3L verified by 
SDS-PAGE were pooled and reduced volume to 5 ml for injecting to HiLoad 26 /60 Superdex 75 
PG column (GE Healthcare). The elution based on the peak fractions from the FPLC were pooled 
together and concentrated (by using 10 kDa cutoff Amicon-Ultra centrifugal filter device) to 5 ml of 
gel filtration. The concentrated protein (77 mg from 5 ml) was snap-frozen as 25 µl aliquots in 
liquid nitrogen and stored at -80 ºC and ready for crystallisation tray setup. 
6.2.4  Crystallization screening and optimization 
For initial crystallization screening, several commercially available sparse matrix screens were set 
up using the Mosquito robot (TTP LabTech, UK) at the UQ ROCX Diffraction Facility. The 
screens used in this study were: Index (Hampton Research), PEGIon (Hampton Research), JCSG+ 
(Molecular Dimensions) and Proplex (Molecular Dimensions). The droplets were set up with equal 
ratio of protein and reservoir solution (100 nl of protein and 100 nl of reservoir solution) and were 
equilibrated against 100 µl of reservoir solution. The plates were stored in an automated imaging 
system (Rock Imager) at 20 ºC and each drop was imaged after 0, 1, 2, 3, 5, 8, 13 and 21 days. The 
conditions of the hits from the initial crystallization screens were optimized in a 24-well plate 
format by varying the precipitant concentrations and the pH values of buffer.  Each droplet 
containing 1 µl of protein and 1 µl of reservoir solution was equilibrated against 500 µl of reservoir 
solution at 18 ºC incubator.  
123 
 
6.2.5  Kinetic analysis of ligand-analyte interaction 
We performed kinetic analysis of ligand-analyte interaction between GST-Gas185-97 peptide and 
purified Ost3N33K (Section 5.2.3.2).  We firstly used anti-GST antibody biosensor to capture the 
ligand: GST-Gas185-97 peptide and then measure its binding to different concentrations of Ost3N33K 
from 300 µM, 200 µM, 150 µM, 100 µM and 0 µM. We also performed reverse analysis using Ni-
NTA biosensor captured His6-tagged Ost3N33K first, and then measured its binding to GST-Gas185-97 
peptide from 672 µM, 67.2 µM and 0 µM. There are five steps in this kinetic analysis: 1) Initial 
Baseline, 2) Loading, 3) Baseline, 4) Association and 5) Dissociation as instructed by manufacturer 
(ForteBio BLItz System). It is essential to hydrate the biosensors for at least 10 min with 
experimental buffer (gel filtration buffer: 20 mM Tris HCl pH 8, 125 mM NaCl) before use. At the 
first step, the biosensor was incubated with 250 µl of experimental buffer to obtain a stable baseline 
for 30 sec. At the Loading step, the biosensor was dipped into the drop holder filled with 4 µl of the 
ligand for 120 secs. Then, the third step is to wash away unbound ligand with 250 µl of 
experimental buffer for 30 sec. During the Association step, the biosensor loaded with ligand was 
dipped into 4 µl of analyte in the drop holder to measure interaction between ligand and analyte. 
Lastly at the Dissociation step, the biosensor was incubated with 250 µl of experimental buffer for 
120 sec. Data was collected in real-time fashion and analysed using 1:1 binding mode. Negative 
controls were also performed to ensure there was no binding between GST and Ost3N33K.  
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6.3 Results 
6.3.1 Rationale of construct design and cloning of pMCSG7-Ost3L/ pMCSG7-Ost3N33K/ 
pMCSG7-Ost3L-Linker-Peptide / pMCSG7-Ost3N33K-Linker-Peptide 
To maximize the chances of successful crystallization using this technique, initial construct design 
is crucial. The length of the flexible linker region consisted of eleven amino acids 
(GGSGGHMGSGG) with minimal hydrophobicity to avoid unnecessary aggregation between the 
protein of interest Ost3L and the peptide sequence (NTNVIRVYAINTT) from Gas1p85-97 peptide. 
Based on the published structure of Ost6L (Schulz et al., 2009),  we used PyMOL to estimate that 
the distance between the C-terminus of Ost3L directly before the beginning of the first 
transmembrane helix and the Ost3L peptide-binding groove was approximately 44.2Å. We predicted 
that a peptide linker of this length should be sufficient to allow Gas1p85-97 peptide to access and bind 
at the targeted Ost3L peptide-binding groove. Due to my limited PhD time, I selected pMCSG7-
Ost3N33K and pMCSG7-Ost3N33K-Linker-peptide construct as my main priority for polyhistidine 
purification and affinity assay or crystallisation set up.  Ost3N33K was preferred than Ost3 wild type 
because Ost3N33K binds strongly to the peptide as shown from Tan et al (2014). 
 
 
Figures 6.1: Scheme expression of the pMCSG7 vector harbouring Os3 or Ost3N33K with and 
without linker peptide. Using the designated primers described above (6.2.1), all PCR product of 
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A) pMCSG7-Ost3L, B) pMCSG7-Ost3N33K, C) pMCSG7-Ost3L-Linker-Gas185-97 peptide and D) 
pMCSG7-Ost3N33K-Linker-Gas185-97 peptide had the correct size insert through ligation-
independent cloning (LIC) (Section 6.2.2.) into the pMCSG7 E.coli expression vector. This 
pMCSG7 vector contained an N-terminal hexahistidine (His) tag followed by a TEV protease 
cleavage site (Stols et al., 2002). This TEV protease site is crucial for removal of His6 tag to 
improve crystallization screening. To make Ost3L-Linker-Gas185-97 peptide and Ost3N33K- Linker-
Gas185-97 peptide expression construct, we used PCR primers Ost3L Fwd and Ost3-L-P Rvs to 
introduce flexible linker and Gas185-97 peptide sequences at the C terminal end of Ost3L. 
 
6.3.2 Purification of Ost3N33K and Ost3N33K-Linker-Gas185-97 peptide 
Here the aim was to achieve the expression and purification of Ost3N33K and Ost3N33K-linker-
Gas185-97 peptide in E.coli BL21(DE3) expression, and performed polyhistidine tag purification, and 
finally TEV cleavage digestion to remove His tag for obtaining the purified protein. For purification 
of Ost3N33K (Figure 6.2a), the distinct bands in lane 1 showed the confirmed purified proteins of 
Ost3N33K using a polyhistidine tagged purification. Lane 2 and 3 indicate clear separation of a band 
from His6 tag after overnight treatment with TEV protease. After cleavage, the protein was injected 
onto a pre-equilibrated His Trap
TM
 FF 5ml column to remove un-cleaved protein, the His6 tag, the 
TEV protease and other contaminating proteins. A small aliquot from the elution was collected and 
ran on the protein gel to check for purified Ost3N33K (Lane 4). The purified protein of Ost3N33K was 
collected and concentrated for crystallization set up and affinity assays.  
For purification of pMCSG7-Ost3N33K-Linker-Gas185-97 peptide (Figure 6.2b), after TEV cleavage, 
the protein was injected into the FPLC to determine protein purity. We collected the elution 
fractions from 1 to 17 from the FPLC and identified the distinct bands fractions 14 - 17 (Label in 
Blue). We pooled and concentrated fractions for crystallization purpose.  
We trialed this purified Ost3N33K (Figure 6.2A) and Ost3N33K-Linker-Gas185-97 peptide (Figure 6.2B) 
which was earlier cleaved from His6 tag in different conditions through several commercially 
available sparse matrix screens but none of them produced any crystals. 
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Figures 6.2a: Purification of Ost3N33K; Lane 1: purification of His6-tagged of Ost3N33K, Lane 2 
and 3: After TEV overnight digestion separating Ost3N33K from His6 Tag and Lane 4: Purified 
Ost3N33K. On the right, it is the cartoon representation of the purification steps for Ost3N33K. The red 
arrows indicated the respective inserts. 
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Figures 6.2b: Purification of Ost3N33K-Linker-peptide; The lanes 14 - 17 (in blue box) were 
corresponding to the peak fractions from the FPLC. These fractions were pooled together and 
concentrated for crystallization.  
 
6.3.3 Purification of MBP-Ost3L 
We used our existing MBP-Ost3L (Jamaluddin et al., 2011) to facilitate crystallization. The cells 
were grown in large scale of 3 litre cell culture using the autoinduction method. The protein was 
purified using affinity to MBP amylose resin followed by injection into FPLC and gel filtration 
(Section 6.2.3.4). Suitable fractions of the elution based on the peak fractions from the FPLC 
(Figure 6.3A) were pooled together and concentrated (by using 10 kDa cutoff Amicon-Ultra 
centrifugal filter device). The concentrated protein (77 mg from 5 ml) was snap-frozen in 25 µl 
aliquots in liquid nitrogen and stored at -80 ºC ready for crystallisation tray setup. 
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Figure 6.3: Gel filtration and Purification of MBP-Ost3L (A) Gel filtration peak fractions profile 
of MBP-Ost3L; fractions 9 - 15 (in red box) of the elution peak fractions from the FPLC were 
pooled together and concentrated. (B) Purification of the MBP-Ost3L construct agreed well with the 
theoretical weights of MBP-Ost3L (61.2 kDa). 
 
 
 
(A) 
(B) 
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6.3.4. Crystallization screening of MBP-Ost3L 
For setting up crystallization screens, a suitable protein concentration (20 mg/ml) was determined 
first using Qubit Protein concentration measurements. Here we utilized two commercially available 
sparse matrix screens which is Index (Hampton Research) and PEGIon (Hampton Research) to 
identify conditions that could induce crystallization. All the screens were set up using the hanging 
drop method with 100 nl protein and 100 nl reservoir solution per drop (Section 6.2.4). A promising 
hit was indentified for MBP-Ost3L protein; crystals formed after 5-8 days of setting up the drop and 
was observed in 4 out of 99 wells in Index plate, reference to 1) Index well no 45 with following 
condition: 25% w/v Polyethylene glycol 3,350 and 0.1 M Tris HCl pH 8.5; 2) Index well no 62: 0.2 
M Trimethylamine N-oxide dihydrate, 20% w/v polyethylene glycol monomethyl ether and 0.1 M 
Tris HCl pH 8.5; 3) Index well no 73: 0.2 M NaCl, 25% w/v Polyethylene glycol 3,350 and 0.1 M 
Tris HCl pH 8.5 and 4) Index well no 90: 20% w/v Polyethylene glycol 3,350 and 0.2 M Sodium 
Formate. For PEGIon plate, 1 hit was indentified for MBP-Ost3L out of 99 wells reference to this 
condition in 0.1 M Tris HCl pH 8 and 28% w/v Polyethylene glycol 4,000 in PEGIon well C9. In 
order to optimize the condition, customized grid screens were designed, in which both the pH and 
precipitant concentration were changed in the higher as well as lower direction from initial 
condition. However, so far I have not been able to reproduce the original crystals. Ost3N33K, 
Ost3N33K-Linker-peptide, pHis10-Ost3-Linker-peptide and pHis10-Ost3N33K-Linker-peptide were 
initially trialed for crystallization in different conditions through several commercially available 
sparse matrix screens but none of them produced any crystals. 
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Figure 6.4: Images of crystals of MBP-Ost3L after 8 days in the A) Index well no 45, B) Index 
well no 62. C) Index well no 73, D) Index well no 90, E) PEGIon well C9. 
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6.3.5. Purification of GST-Gas185-97 and GST pull-down of Ost3N33K protein 
For affinity assay measuring the strength of interaction between Ost3N33K and a short stretch of 
peptide sequence (85NTNVIRVYAINTT97) in Gas1p, we have successfully cloned Gas185-97 in the 
pGEX2T vector and expressed this fusion protein in E.coli strain BL21 (DE3) by the autoinduction 
method in large scale (1litre cell culture). We chose this peptide in relevance to our results in the 
Chapter 2 which showed that this Gas185-97 peptide requires the neutral peptide binding groove of 
Ost3p for efficient glycosylation. The GST-Gas185-97 protein was successfully purified (Figure 6.5: 
Lane 3) using a 5 ml GST column (GST
TM 
FF 5 ml, GE Healthcare) followed by gel filtration 
(Section 6.2.3.3). The GST tag improved the solubility of the peptide so we were able to obtain 6 
mg of purified protein from 1 litre culture. The purity of proteins was analysed by SDS-PAGE 
analysis below. We also performed GST pull down to capture our purified Ost3N33K proteins (Lane 
2) that interact with GST-Gas185-97peptide (Lane 3). Our results showed a weak faint band (red box) 
in lane 6 which suggested there is a binding between GST-Gas185-97 with Ost3N33K peptide binding 
groove. 
 
Figure 6.5: Purification of Ost3N33K and GST-Gas185-97: Lane 1) molecular weight ladder, Lane 
2) Ost3N33K, Lane 3) GST-Gas185-97 peptide, Lane 4) Gas185-97 peptide, Lane 5) GST-Gas185-97 
peptide versus Ost3N33K with 4 times dilution and Lane 6) GST-Gas185-97peptide versus Ost3N33K 
with 1 time dilution.  
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6.3.6. Kinetic analysis of Ost3N33K versus GST-Gas185-97 peptide interaction 
In this experiment we performed kinetic analysis of ligand-analyte interactions where the GST-
Gas185-97 peptide which acts as the ligand was first loaded in biosensors on the BLItz system 
followed by monitoring the association and dissociation of Ost3N33K to the ligand (Figure 6.6). We 
use the high affinity anti-GST antibody on biosensor that binds to our GST-Gas185-97 peptide. The 
aim here is to determine that Ost3N33K can bind to GST-Gas185-97 peptide captured on biosensor. We 
tested using the purified and concentrated Ost3N33K (6 mg/mL) which was cleaved using the TEV 
protease to remove the His6 tag and prepared different concentration of Ost3N33K. In the first run 
(Green colour), we loaded the GST-Gas185-97 peptide on the biosensor and no Ost3N33K being 
replaced by an experimental buffer. Our results showed a clear indication of green signal which 
suggest no binding during association phase observed between 180 to 300 seconds. In the third run 
(Orange colour), we loaded the GST-Gas185-97 on the biosensor and subsequently loaded 300 µM of 
Ost3N33K. As expected, we saw the spectra at the highest peak during association phase with a KD 
affinity of interaction of 0.5 mM. In the subsequent fourth run (Purple colour), fifth run (Grey 
colour) and sixth run (Black colour), we loaded different concentrations of 100 µM, 150 µM and 
200 µM of Ost3N33K to their respective runs versus GST-Gas185-97 peptides (150 nM) on the 
biosensor. From the spectra, we saw a very clear difference and binding during association phase 
when we compared the first run to the increasing concentration of Ost3N33K, indicating specific 
concentration dependent binding between Ost3N33K and GST-Gas185-97 peptide. 
We also performed reverse analysis using the anti Ni-NTA antibody on biosensor to bind to our 
His6-tagged Ost3N33K (Figure 6.7). We performed three runs of experiments with different 
concentrations of our GST-Gas185-97 peptide, and one run (labelled in orange) with GST-Gas185-97 
peptide replaced with the experimental buffer and applied these samples to our Anti-His antibody 
biosensor bound Ost3N33K. For Run 2, we performed ten times dilution of the GST-Gas185-97 peptide 
from Run 1. From the spectra, we saw a very clear difference during association phase when we 
compared the first run and the last run, indicating specific binding between Ost3N33K and the peptide 
with a KD affinity of interaction of approximately 2 Molar. 
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Figure 6.6: Kinetic analysis of GST-Gas185-97 peptide (ligand) versus different concentrations 
consisting of 300 µM (Orange), 200 µM (Black), 150 µM (Grey), 100 µM (Purple) and 0 µM 
(Green) of Ost3N33K (analyte) interactions. Sensorgram displayed the data collected in real time. Y 
axis: binding signal in nanometer (nm) unit; X-axis: analysis time in sec unit. 
 
 
 
Figure 6.7: Kinetic analysis of Ost3N33K (ligand) versus different concentrations consisting of 672 
µM (Green), 67.2 µM (Pink) and 0 µM (Orange) of GST-Gas185-97 peptide (analyte) interactions. 
Sensorgram displayed the run data collected in real time – binding signal was measured in 
nanometers (nm) as a function of time (sec). 
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6.4 Summary 
The main objective in the first part of this chapter was to make protein expression constructs of 
Ost3N33K and Ost3N33K-linker-Gas185-97 peptide in pMCSG7 vector using LIC cloning method, and 
further obtain high yield of purified proteins for crystallographic purposes. As experiments using 
constructs pHis10-Ost3-Linker-Gas185-97 peptide and pHis10-Ost3N33K-Linker-Gas185-97 peptide 
failed to produce any crystals in any commercial crystallization screens (not shown), we questioned 
if either the 10 histidine residues tag or flexible linker or peptide caused aggregation or interfered 
with the formation of protein crystal contacts. Consequently, we used the pMCSG7 vector that 
provides an N-terminal hexahistidine (His) purification tag followed by a TEV protease cleavage 
site (Stols et al., 2002). The TEV protease cleavage site is crucial for the removal of His6 tag to 
reduce the flexibility of proteins and improve chances of obtaining crystals. Our own experiments 
have demonstrated that the expression of pMCSG7 Ost3N33K was successfully obtained. This was 
also established by SDS PAGE results (Figure 6.2A) which confirmed the purification of the cut 
and uncut version of Ost3N33K from the His6tag. The purified Ost3N33K was collected and 
concentrated for crystallization and affinity assays. The commercial crystallization screens were set 
up for both purified Ost3N33K and Ost3N33K-Linker-Gas185-97 peptide with His6 tag removed. 
However, none of these produced crystals. Additionally, these proteins became unstable and 
aggregated during the process of concentration which was not improved by adding 5% glycerol in 
the purification buffer. This caused a major hurdle for obtaining milligram quantities of highly 
purified, soluble protein for crystallization screens. Due to this issue and limited time for my PhD, 
we used our existed MBP Ost3L construct using pMAL vector (Jamaluddin et al., 2011) to produce 
MBP tagged Ost3L for crystallization. The usage of the MBP tag is to improve the solubility of 
protein and chances on crystallization. By doing so we obtained five promising conditions for 
crystallizing MBP-Ost3L protein from two commercial screens: Index and PEGIon (Hampton 
Research). Although we have not been able to reproduce the crystals in the initial grid screens, 
some techniques for promoting crystallization will be utilized in future work such as stripe- or 
macro-seeding.   
The second part of this chapter illustrates kinetic analysis of the binding between Ost3N33K and 
GST-Gas185-97 peptide. The preliminary result indicated a weak binding between Ost3N33K and 
Gas185-97 peptide which is consistent with the proposed mechanistic model of Ost3/6p function in 
which the binding has to be transient to allow translocation and folding of the glycosylated 
polypeptide to precede (Figure 1.6). Further repetition of the kinetic experiments is required to 
ensure statistical integrity. Furthermore, oxidized and reduced controls are very essential to validate 
and confirm that peptides bind to the peptide binding groove, which only present in the oxidized 
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Ost3, rather than non-specifically elsewhere on Ost3. This concept is relevant to previous studies 
that have highlighted the ability of the active-site loop of Ost6L to generate a peptide-binding 
groove during its oxidized state but not in the reduced state (Schulz et al., 2009). We have also tried 
to have a similar peptide sequence synthesized with a fluorophore coupled and measured the 
binding of the peptide to Ost3p using fluorescence anisotropy (not shown). Unfortunately, the 
reaction mixture aggregated, possibly due to the high hydrophobicity of the peptide. This is the 
main reason we chose to proceed with a fusion protein for further studies. Alternatively, we would 
use well-established ELISA assays to determine the binding affinity of Ost3/6L and peptide. For 
this we would need to clone Ost3/Ost6p and variants into the pET-30a vector (Novagen), which 
tags the proteins with an S-tag which can be recognised with horseradish peroxidise (HRP) 
(Kaneshiro et al., 2002). By supplying the HRP substrate that can be catalysed by HRP, the binding 
can be measured by detecting the absorbance change at A420nm (Matsuura et al., 2003, Lange et 
al., 2010, Takeda et al., 2011, Marfori et al., 2012). 
In conclusions, the structure of Ost3 bound to a peptide would allow the precise interactions to be 
known, which could then be tested in vitro and in vivo. The binding affinity assays could be used to 
test these interactions in vitro. Finally, the quantitative comparison of in vitro peptide binding by 
Ost3p and Ost6p would give insights into how these subunits function in vitro, especially 
concerning the balance between their specificity and ability to complement each other. 
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7.1 Conclusion 
Asparagine (N)-linked glycosylation is an abundant post-translational modification of many 
proteins in eukaryotes that is important in diverse biological systems (Schwarz and Aebi, 2011). 
The N-linked glycans perform a multitude of functions at a cellular and organismal level (Mohorko 
et al., 2011). This process is catalyzed by the multiprotein complex oligosaccharyltransferase 
(OTase) (Kelleher and Gilmore, 2006, Mohorko et al., 2011, Schwarz and Aebi, 2011, Schulz, 
2012). Alterations in the biosynthesis of the unique lipid-linked oligosaccharide substrate of OTase 
therefore affect the glycosylation efficiency and functionality of many different proteins and results 
in diverse human diseases (Mohorko et al., 2011). While catalysis is performed by the Stt3p protein 
subunit of OTase (Nilsson et al., 2003, Yan and Lennarz, 2005, Lizak et al., 2011), our knowledge 
about the functions of the additional protein subunits of OTase in the N-glycosylation process are 
not clearly defined. 
In Chapter 2, we established that the homologs Ost3p/Ost6p subunits of yeast OTase directly 
interact with polypeptide substrate to enhance glycosylation of asparagines proximal and C-terminal 
to sequestered sequences. Previous studies have shown that incorporation of either Ost3p or Ost6p 
into OTase results in two enzyme isoforms with different protein substrate preferences in vivo, and 
that in vitro Ost3p/Ost6p transiently bind peptides with complementary characteristics to their 
peptide-binding grooves (Schulz and Aebi, 2009, Schulz et al., 2009, Jamaluddin et al., 2011). In 
this experiment, we performed yeast genetics and glycoproteomics to show that this peptide-binding 
activity of Ost3p/Ost6p is required for site-specific glycosylation by OTase in vivo. This confirmed 
for the first time that there are transient direct physical interactions between nascent polypeptide 
and Ost3p/Ost6p. However, in some cases the presence of basic residues in both nascent 
polypeptide and Ost3p/Ost6p caused electrostatic repulsion, limiting binding and inhibiting 
glycosylation at particular sites. This finding presented us with an experimental tool to probe the 
details of the interactions between nascent polypeptide and Ost3p/Ost6p that impact site-specific 
glycosylation. We performed scanning basic-to-neutral mutagenesis through a model substrate 
protein, and monitored the effect of each mutation on sitespecific glycosylation occupancy. This 
showed that binding of substrate polypeptide to Ost3p/Ost6p enhanced glycosylation at sites 
proximal and C-terminal to the sequestered sequence. We then validated selected physiologically 
relevant peptide substrates in vitro. 
Based on our results from this integrated study using in vivo yeast genetics, glycoproteomics and in 
vitro biochemistry, we presented a model of the mechanisms by which Ost3p/Ost6p increase the 
efficiency of site-specific N-glycosylation. In this model, transient sequestration of stretches of 
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nascent polypeptide by Ost3p/Ost6p at the translocon separates newly translocating polypeptide 
from pre-translocated polypeptide. Glycosylation sequons in the short flexible loops of nascent 
polypeptide formed by this mechanism are therefore presented to the active site of OTase in a 
glycosylation competent form. This is a surprising and novel insight into the mechanisms of 
cotranslocational polypeptide modification in the endoplasmic reticulum. 
In Chapter 3, we developed new methodologies using Selected Reaction Monitoring Mass 
Spectrometry coupled to peptide affinity chromatography which provided significant improvements 
in sensitivity and quantification that defined the peptide binding characteristics of native yeast 
Ost3p and Ost6p. We showed that Ost3p and Ost6p bind distinct subsets of peptides from a yeast 
cell wall glycoprotein substrate, with Ost3p binding peptides rich in aromatic acids and Ost6p 
binding peptides rich in aliphatic amino acids. Our data supports a model of Ost3p and Ost6p 
function in which they transiently bind complementary hydrophobic stretches of nascent 
polypeptide substrate to optimally inhibit protein folding, thereby increasing glycosylation 
efficiency at nearby asparagine residues. In the following Chapter 4, we showed an improved 
analytical method for site-specific glycosylation analysis using PNGase F to label glycosylation 
sites with an asparagines-aspartate conversion that creates a new endoproteinase AspN cleavage 
site, followed by proteolytic digestion, and detection of peptides and glycopeptides by LC-ESI-
MS/MS (Bailey et al., 2012). This approach will be useful in site-specific glycosylation analysis in 
many model systems and clinical application. Overall, these two novel analytical methods will 
provide advanced knowledge for improved detection and quantification of glycosylation sites in 
vivo and peptide interactions in vitro. 
In Chapter 5, we described a novel strategy for engineering glycoprotein stability which we used to 
determine the detailed function of Ost3p and Ost6p using in vitro peptide affinity chromatography. 
In previous studies, we have shown that the ER lumenal domain of Ost6 is more easily expressed 
than Ost3p in E.coli and shows in vitro peptide binding activity when Ost3 does not (Jamaluddin et 
al., 2011). Interestingly, Ost3p has a single glycosylation sequon, while Ost6p has no glycosylation 
sequons and contains a cluster of acidic amino acids at the position corresponding to the Ost3p 
sequon. While N-glycosylation is vital for the folding, stability and function of many glycoproteins, 
it is common that in the homologs of such glycoproteins the precise sites of N-glycosylation are not 
conserved. This suggests that a properties of the sequence in a protein can at least rescue for lack of 
N-glycosylation. Indeed, we successfully showed that incorporation of targeted like-charged amino 
acids at N-glycosylation sequons in Ost3/6p increases in vitro stability and activity (Tan et al., 
2014). When we performed optimal stabilization through a minimal number of local point 
mutations at the Ost3p glycosylation sequon, the resulting protein showed increased in vitro binding 
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of peptides, which were complementary to the characteristics of the peptide binding groove of Ost3, 
a key determinant of transient nascent polypeptide tethering by Ost3p. This is consistent with the 
function of Ost3p and Ost6p in modulating N-glycosylation substrate selection by OTase activity in 
vivo. This compensation would allow flexibility in the evolution of the precise sites of N-
glycosylation in glycoproteins, and could also be used to engineer normally glycosylated proteins so 
that they can be expressed as non-glycoproteins in efficient bacterial expression systems. 
In Chapter 6, we extended our investigation using the best expressing and most stable variants of 
Ost3L from Chapter 5 and performed crystallization trials with a view to obtain a 3D crystal 
structure of Ost3L bound with a physiological substrate peptide. Different strategies were applied to 
the crystallization of Ost3L with and without peptide. Again, the peptide sequences would be 
physiologically relevant sequences as determined from Chapter 2. Although we were unable to 
obtain crystals of Ost3L-linker-Gas1p85-97 peptide, some initial crystal hits were identified for MBP-
tagged Ost3L. We also performed initial experiments to measure the binding affinity between 
Ost3L and peptide and detected weak but specific binding. These preliminary results are in 
agreement with the proposed mechanistic model of Ost3/6p function in N-glycosylation (Figure 1.6) 
in which this binding has to be transient to allow translocation and folding of the glycosylated 
polypeptide to precede (Schulz et al., 2009). 
In summary, this thesis has made a significant contribution towards our understanding of the 
molecular mechanisms of glycosylation site selection by OTase, the connection between 
glycoprotein folding and N-glycosylation in the endoplasmic reticulum, and opens up potential 
applications in synthetic glycobiology such as engineering of glycosylation sites and OTases. Our 
data provides advance information towards solving the model of the mechanisms by which Ost3/6p 
increase the efficiency of site-specific N-glycosylation. Here we detailed the mechanism of this 
regulatory system through mapping the precise sites of interactions between Ost3/6p and Gas1p 
nascent polypeptide which was not previously identified. This data allowed us to present a model, 
in which we propose that short hydrophobic stretches of substrate polypeptide transiently bind to 
Ost3p or Ost6p, leading to the formation of a short flexible loop of new translocated polypeptide. 
Glycosylation sequons in the short flexible loops of nascent polypeptide formed by this mechanism 
are therefore presented to the active site of OTase in a glycosylation competent form. This is a 
novel insight into the mechanisms of co-translocational polypeptide modification in the 
endoplasmic reticulum. Our study also give insights into how the evolution of OTase isoforms has 
increased the substrate range of efficiently glycosylated proteins; how flexibility in the presence and 
position of N-glycosylation sites can allow sequence evolution; and how this processes can be used 
for creating engineered cellular systems for glycoprotein expression and engineering glycoproteins 
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so that they can be expressed even in bacteria that do not glycosylate. These findings will be of 
general interest and utility to a wide variety of researchers across the fields of glycobiology, protein 
biochemistry, structural biology, protein expression, biopharmaceutical development and protein 
evolution. 
 
7.2 Future Directions 
A key feature of the lumenal domain of the Ost3/6 subunits is their peptide-binding groove, which 
in Ost6p is oxidation state dependent, and their oxidoreductase activity (Schulz et al., 2009). In the 
present study, we have addressed primarily the peptide-binding properties of these subunits using 
reverse genetics. However, it would be of interest to know if the mutations introduced into the 
peptide-binding sites also affect the redox potential of the oxidoreductase. If this is the case, the 
oxidation state dependent formation of the peptide binding domain would be affected and this 
would result in altered peptide binding as well. It is evident that such an explanation does not 
explain the effect of mutations in the substrate but it is an alternative explanation for the severe 
phenotype of the Ost3 mutations. 
Another aspect of this study worthy of future investigation would be to investigate and characterize 
the human homologs of Ost3p and Ost6p - MagT1 and TUSC3. While roles of MagT1 and TUSC3 
regulating N-glycosylation or magnesium transport have been proposed, the mechanisms of 
MagT1/TUSC3 involvement is these processes are not clear. We already have the yeast double 
deletion strain (∆ost3/∆ost6) from Chapter 2, which are the yeast homologs of MagT1/TUSC3 
encoding OTase accessory subunits. We could also create a strain with genomic deletion of ALR1, 
encoding the major yeast magnesium transporter. Previous studies have shown that ∆alr1 yeast 
requires magnesium supplementation for growth and ∆ost3/∆ost6 shows inefficient N-glycosylation 
at many sites in diverse glycoproteins (Zhou and Clapham, 2009). We could then test if expression 
of human MagT1 or TUSC3 can rescue either or both of these phenotypes. This would provide 
clear evidence of a direct role for MagT1 and/or TUSC3 in magnesium transport, regulation of N-
glycosylation, or both.  
Alternatively, whole-genome sequencing of patient DNA may reveal mutations in other subunits of 
OTase, and the subsequent characterization of the N-glycoproteome will provide additional 
information to define the molecular function of the different OTase components (Mohorko et al., 
2011). Eventually, this understanding of OTase-mediated catalysis will provide insights for the 
development of drugs that affect the properties of the enzyme. In addition, glycoproteins are also 
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significant as valuable therapeutic products (Lawrence and Betenbaugh, 2002). About 70% of the 
new drug candidates that have been brought to commercialisation are glycosylated proteins 
(Durocher and Butler, 2009). A number of industrially important glycoproteins are used as drugs, 
including erythropoietin, interferon, colony stimulating factors, and blood-clotting factors, and this 
has led to an upsurge in glycosylation engineering. By genetically engineering glycosylation 
pathway in different hosts, this aims to optimise glycoproteins to achieve desirable biological, 
biochemical or physical properties. A detailed understanding of the molecular mechansisms by 
which OTase controls site-specific N-glycosylation will facilitate efficient targeted and systems 
glycoengineering. 
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7.4 Appendix 
 
Other author’s publication work which contributed substantially to a manuscript entitled “Mixed 
disulfide formation in vitro between a glycoprotein substrate and yeast oligosaccharyltransferase 
subunits Ost3p and Ost6p” published in Biochemical and Biophysical Research Communications.  
The full details of publication as follow: 
 
Mohd Yusuf SN, Bailey UM, Tan NY, Jamaluddin MF, Schulz BL. (2013). Mixed disulfide 
formation in vitro between a glycoprotein substrate and yeast oligosaccharyltransferase subunits 
Ost3p and Ost6p. Biochem Biophys Res Commun. 432(3):438-443. 
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Oligosaccharyltransferase (OTase) glycosylates selected asparagine residues in secreted and membrane
proteins in eukaryotes, and asparagine (N)-glycosylation affects the folding, stability and function of
diverse glycoproteins. The range of acceptor protein substrates that are efﬁciently glycosylated depends
on the action of several accessory subunits of OTase, including in yeast the homologous proteins Ost3p
and Ost6p. A model of Ost3p and Ost6p function has been proposed in which their thioredoxin-like active
site cysteines form transient mixed disulﬁde bonds with cysteines in substrate proteins to enhance the
glycosylation of nearby asparagine residues. We tested aspects of this model with a series of in vitro
assays. We developed a whole protein mixed disulﬁde interaction assay that showed that Ost6p could
form mixed disulﬁde bonds with selected cysteines in pre-reduced yeast Gas1p, a model glycoprotein
substrate of Ost3p and Ost6p. A complementary peptide afﬁnity chromatography assay for mixed disul-
ﬁde bond formation showed that Ost3p could also form mixed disulﬁde bonds with cysteines in selected
reduced tryptic peptides from Gas1p. Together, these assays showed that the thioredoxin-like active sites
of Ost3p and Ost6p could form transient mixed disulﬁde bonds with cysteines in a model substrate gly-
coprotein, consistent with the function of Ost3p and Ost6p in modulating N-glycosylation substrate
selection by OTase in vivo.
 2013 Elsevier Inc. All rights reserved.1. Introduction
Asparagine (N-)linked glycosylation is a common co- and post-
translational modiﬁcation that affects the structure and function of
secretory and membrane bound proteins in eukaryotes [1], archaea
[2] and some bacteria [3]. In eukaryotes, nascent polypeptide is N-
glycosylated by the enzyme oligosaccharyltransferase (OTase) after
entry into the endoplasmic reticulum (ER) lumen through the tran-
slocon [4–6]. N-glycans enhance the efﬁciency of glycoprotein
folding in the ER by increasing the solubility of folding nascent
polypeptide and by recruiting the disulﬁde isomerase ERp57
through the lectins calnexin and calreticulin [7–10]. Glycan struc-
tures are modiﬁed during glycoprotein trafﬁc through the Golgi,
and the ﬁnal structures present on mature glycoproteins can play
important roles in regulating protein function [1,11]. Changes in
the structure of glycans attached to proteins are also associated
with numerous diseases [12–15].
OTase catalyses the key step of N-glycosylation, transfer of oli-
gosaccharide from a dolicholpyrophosphate carrier to asparagines
in nascent polypeptides translocated into the ER lumen [16]. OTasell rights reserved.is a multiprotein complex consisting of a catalytic subunit, Stt3p,
and varying numbers of accessory protein subunits in different
organisms [5,17,18]. The acceptor peptide-binding site of Stt3p
speciﬁcally recognizes asparagine residues in glycosylation sequ-
ons (Asn-Xaa-Ser/Thr; Xaa–Pro) [19], substantially increasing the
efﬁciency of glycosylation at these sites [20]. The accessory sub-
units are also important for determining the protein acceptor spec-
iﬁcity of OTase, as several interact with acceptor nascent
polypeptide to inﬂuence N-glycosylation substrate selection [20–
26]. In Saccharomyces cerevisiae, there are two isoforms of OTase
deﬁned by incorporation of either of the homologous proteins
Ost3p or Ost6p [27–29], which have an ER lumenal thioredoxin-
like domain [23,30] followed by four transmembrane helices.
These OTase isoforms have different acceptor protein speciﬁcities
[27,31,32] at the level of individual glycosylation sites [22,23].
A model of Ost3p and Ost6p function in site selection by OTase
has been proposed [23], in which nascent polypeptide transiently
binds to the peptide-binding groove in their thioredoxin domain,
which slows protein folding and presents nearby asparagine resi-
dues to the active site of OTase for efﬁcient glycosylation. This
transient binding of stretches of nascent polypeptide is proposed
to occur through noncovalent interactions and also through the
formation of a transient mixed disulﬁde between a cysteine in
S.N.H. Mohd Yusuf et al. / Biochemical and Biophysical Research Communications 432 (2013) 438–443 439the nascent polypeptide and the active site CxxC motif of Ost3p or
Ost6p [23]. Hydrophobic stretches of polypeptide do bind to the
peptide-binding grooves of both Ost3p and Ost6p in vitro, consis-
tent with this model [33]. The CxxC motif of Ost3p and Ost6p is
also important for glycosylation of a subset of sites in vivo in yeast,
where mutation of the Ost3p or Os6p CxxC cysteines to serines re-
sults in inefﬁcient glycosylation at several asparagines [23]. One
such affected site is Asn253 in Gas1p. Here, we performed a series
of in vitro assays to test if Ost3p and Ost6p were capable of seques-
tering the model substrate polypeptide Gas1p through transient
mixed disulﬁde bonds.Fig. 1. Experimental design for detecting in vitro whole protein mixed disulﬁde
formation with Ost3 or Ost6. (A) Reduced MBP-Gas1 is incubated together with
oxidized Ost3 or Ost6. (B) A cysteine in Gas1 performs nucleophilic attack on the
Ost3/6 cystine and forms a mixed disulﬁde bond. This reaction is reversible [23]. (C)
Alkylation of free cysteines prevents further mixed disulﬁde shufﬂing. (D) Disulﬁde2. Materials and methods
2.1. Protein expression and puriﬁcation
The malE gene was deleted from existing pMAL-c2x-OST3 and
pMAL-c2x-OST6 vectors [33] and replaced with an N-terminal
His10 tag by site-directed PCR mutagenesis [34] leaving the DNA
sequence corresponding to the lumenal domain of Ost3p or Ost6p
as predicted in UniProt Knowledgebase (position 23–185 of Ost3p/
P48439/ YOR085W; position 25–188 of Ost6p/Q03723/YML019W)
to give pHis10-OST3 and pHis10-OST6. TOP10 E. coli cells carrying
pHis10-OST3 or pHis10-OST6 were grown in LB media supple-
mented with 100 mg/L ampicillin. Protein expression was induced
at an OD600 nm of 0.7 by addition of IPTG to a ﬁnal concentration
of 1 mM and incubation for 4 h at 37 C, after which the cells were
harvested by centrifugation. Cells were resuspended in ice cold
50 mM potassium phosphate buffer pH 7.5, 150 mM NaCl,
10 mM imidazole, 1 complete mini EDTA free protease inhibitor
cocktail (Roche) and 1 mM PMSF, and lysed with a One Shot cell
disrupter (Constant Systems). Protein was puriﬁed from clariﬁed
whole cell extracts using TALON resin (Clontech) and eluted in
50 mM potassium phosphate buffer pH 7.5, 150 mM NaCl and
200 mM imidazole. Proteins were buffer exchanged with PD-10
columns (GE Healthcare) into 50 mM potassium phosphate buffer
pH 7.5, 150 mM NaCl and 1 mM EDTA. S. cerevisiae Ost3p, Ost6p
and Gas1p were expressed and puriﬁed from E. coli as maltose-
binding protein fusions (MBP-Ost3, MBP-Ost6 and MBP-Gas1) as
previously described [33]. MBP-Gas1 was eluted in 50 mM
Tris–HCl buffer pH 7.5, 150 mM NaCl, 1 mM EDTA and 0.1% SDS.
MBP-Ost3 and MBP-Ost6 were not eluted but were retained on
amylose–agarose beads as described [33].bonds are reduced with DTT. (E) Trypsin digestion and LC–ESI–MS/MS analysis
allows detection of alkylated or reduced forms of the same cysteine-containing
peptide (boxed). Peptides detected with an alkylated cysteine were originally free
as in (A), and peptides detected with a reduced cysteine originally formed a
disulﬁde bond as in (B). See Section 2 for details.2.2. Whole protein mixed disulﬁde formation analysis
Puriﬁed MBP-Gas1 in 50 mM Tris–HCl buffer pH 7.5, 150 mM
NaCl, 1 mM EDTA and 0.1% SDS was reduced by addition of DTT
to a ﬁnal concentration of 10 mM and incubation at 95 C for
10 min. SDS and DTT were removed from reduced MBP-Gas1 by
buffer exchange using PD-10 columns into 50 mM Tris–HCl buffer
pH 7.5, 150 mM NaCl and 1 mM EDTA. In order to allow the in vitro
formation of mixed disulﬁde bonds between reduced cysteines in
MBP-Gas1 and the oxidized CxxC active site motif of Ost3 or
Ost6, puriﬁed and reduced MBP-Gas1 was incubated with either
puriﬁed Ost3, Ost6 or no additional protein in 50 mM potassium
phosphate buffer pH 7.5, 150 mM NaCl and 1 mM EDTA at 25 C
for 1 h (Fig. 1). Sulﬁde reactivity was quenched by cysteine alkyl-
ation with addition of acrylamide to a ﬁnal concentration of
25 mM and SDS to a ﬁnal concentration of 0.1%, and incubation
for 30 min. Protein was precipitated by addition of four volumes
of 1:1 methanol:acetone, incubation at 20 C for 16 h and centri-
fugation at 18,000 rcf for 10 min. The protein pellet was resus-
pended in 50 lL of 50 mM ammonium acetate, 10 mM DTT and1 lg trypsin (proteomics grade, Sigma–Aldrich) and incubated at
37 C for 16 h.
2.3. Peptide mixed-disulﬁde afﬁnity chromatography
Puriﬁed MBP-Gas1was precipitated by addition of four volumes
of 1:1 methanol:acetone and incubation at 20 C for 16 h. Protein
was resuspended in 50 lL of 50 mM ammonium acetate, 10 mM
DTT and 1 lg trypsin and incubated at 37 C for 16 h. Residual
trypsin activity was inhibited by addition of PMSF to a ﬁnal con-
centration of 1 mM and incubation at 25 C for 30 min, followed
by incubation at 95 C for 5 min. Peptides were desalted using
tC18 Sep-Pak cartridges (Waters) and eluted with 70% acetonitrile
in 50 mM Tris–HCl buffer pH 7.5 with 1 mM EDTA to prevent re-
oxidation of cysteines. Desalted and reduced tryptic peptides from
MBP-Gas1 were applied to puriﬁed MBP-Ost3 or MBP-Ost6 still
Table 1
Identiﬁcation of reduced and alkylated versions of cysteine-containing tryptic
peptides from Gas1p detected by LC–ESI–MS/MS used to measure MBP-Gas1 whole
protein mixed disulﬁde formation with Ost3 or Ost6.
Peptide sequence m/z z Mass Score
G48VAYQADTANETSGSTVNDPLANYESC74SR76 1007.43 3 0.001 17
G48VAYQADTANETSGSTVNDPLANYESC74SR76 1031.11 3 0.004 18
N253LSIPVFFSEYGC265NEVTPR271 724.67 3 0.001 16
N253LSIPVFFSEYGC265NEVTPR271 748.35 3 0.001 10
S338YSATTSDVAC348PATGK353 779.84 2 0.002 15
S338YSATTSDVAC348PATGK353 815.36 2 0.000 17
V91YAINTTLDHSEC103MK105 575.59 3 0.001 15
V91YAINTTLDHSEC103MK105 599.27 3 0.001 17
M210TDYFAC216GDDDVK222 740.28 2 0.003 15
M210TDYFAC216GDDDVK222 775.80 2 0.006 13
Y415GAYSFC421TPK424 568.74 2 0.003 10
Y415GAYSFC421TPK424 604.26 2 0.005 14
Reduced cysteines are bold. Alkylated cysteines are underlined. Peptide numbering
is from sequence of native Gas1p.
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incubated in 50 mM potassium phosphate buffer pH 7.5, 150 mM
NaCl and 1 mM EDTA with gentle agitation at 25 C for 1 h. Re-
duced cysteines were then alkylated by addition of acrylamide to
a ﬁnal concentration of 25 mM and incubation for 30 min. Bead
slurries were transferred to gravity ﬂow columns and the beads
were washed with 25 column volumes of 50 mM Tris–HCl buffer
pH 7.5, 150 mM NaCl and 1 mM EDTA. Peptides bound to MBP-
Ost3 or MBP-Ost6 were eluted with this same buffer containing
in addition 10 mM DTT.2.4. Mass spectrometry and data analysis
Peptide samples were desalted using C18 ZipTips (Milipore)
prior to mass spectrometry analysis. Peptides were analysed by
LC–ESI–MS/MS using a Prominence nanoLC system (Shimadzu)
and TripleTof 5600 mass spectrometer with a Nanospray III inter-
face (AB SCIEX), as previously described [35,36]. Peptides were
identiﬁed using ProteinPilot (AB SCIEX), searching the LudwigNR
database (downloaded from http://apcf.edu.au as at 27 January
2012; 16,818,973 sequences; 5,891,363,821 residues) with stan-
dard settings: Sample type, identiﬁcation; Cysteine alkylation,Table 2
LC–ESI-MS/MS identiﬁcation of tryptic peptides from MBP-Gas1 in load and DTT elution f
Protein Sequence
Load
MBP T371AVINAASGR380
MBP G42YNGLAEVGK51
MBP D322KPLGAVALK331
MBP I343AATMENAQK352
MBP T154WEEIPALDK163
MBP V266NYGVTVLPTFK277
MBP E304FLENYLLTDEGLEAVNK321
MBP F93GGYAQSGLLAEITPDK109
Gas1p Y415GAYSFCTPK424
Gas1p V91YAINTTLDHSECMK105
Gas1p Y303GLVSIDGNDVK314
Gas1p M210TDYFACGDDDVK222
Gas1p A106LNDADIYVIADLAAPATSINR127
Gas1p S338YSATTSDVACPATGK353
Gas1p I194PVGYSSNDDEDTR207
Gas1p T315LDDFNNYSSEINK328
Gas1p D128DPTWTVDLFNSYK141
Gas1p E468IGSMGTNSASGSVDLGSGTESSTASSNASGSSSK502
Elution
Gas1p G48VAYQADTANETSGSTVNDPLANYESC74SR76
All cysteines are reduced and bold. Peptide numbering is from sequence of native E. colacrylamide; Instrument, TripleTof 5600; Species, not limited; ID fo-
cus, biological modiﬁcations; Enzyme, trypsin; Search effort, thor-
ough ID. False discovery rate analysis using ProteinPilot was
performed on all searches. Peptides identiﬁed with greater than
99% conﬁdence and with a local false discovery rate of less than
1% were included for further analysis, and MS/MS fragmentation
spectra were manually inspected. Extracted ion chromatograms
were obtained using PeakView 1.1 (AB SCIEX).3. Results
3.1. Ost6p can form mixed disulﬁdes with a model substrate protein
A key prediction of the proposed model of Ost3p and Ost6p
function in N-glycosylation [23] is that the CxxC active sites in
these proteins are capable of forming transient disulﬁde bonds
with cysteine residues in substrate polypeptides. We tested if
Ost3p and Ost6p had this activity with two complementary
in vitro assays. For these assays we used the thioredoxin-like ER lu-
menal domains of Ost3p and Ost6p, and yeast Gas1p, a model gly-
coprotein substrate, as Asn253 in Gas1p requires the CxxC motif of
either Ost3p or Ost6p for efﬁcient glycosylation in vivo [22,23]. Se-
lected peptides from Gas1p can also transiently bind non-cova-
lently to the peptide-binding groove of both Ost3p and Ost6p
in vitro [33]. We therefore tested if cysteine residues of Gas1p
could form mixed-disulﬁde bonds with the active site cysteines
of Ost3p and Ost6p. We expressed and puriﬁed Gas1p as a peri-
plasmically targeted MBP-fusion protein from E. coli, reduced its
disulﬁde bonds by incubation in SDS and DTT, and desalted the
protein to obtain reduced MBP-Gas1 protein. We then measured
the extent to which each cysteine residue was free, or alternatively
involved in a disulﬁde bond in a cystine (Fig. 1). For this, we ﬁrst
alkylated free cysteines by incubation with acrylamide and then
reduced the disulﬁde bonds with DTT. The MBP-Gas1 protein
was subsequently digested to peptides with trypsin in the presence
of DTT and EDTA to prevent re-oxidation of cysteines. When MBP-
Gas1 protein alone was subjected to this analysis, we identiﬁed six
cysteine-containing peptides from Gas1p, all of which were de-
tected in two forms – with the cysteines either reduced or alkyl-
ated (Table 1). Reduction of MBP-Gas1 was therefore partial,
mimicking incompletely oxidized polypeptide still in the process
of folding, and a likely substrate of OTase. To test if Ost3 or Ost6ractions in peptide mixed-disulﬁde afﬁnity chromatography with MBP-Ost3.
m/z z DMass Score
480.27 2 0.001 14
504.26 2 0.001 10
506.31 2 0.002 15
538.77 2 0.002 16
601.31 2 0.000 14
669.38 2 0.001 12
699.69 3 0.003 23
883.95 2 0.004 23
568.76 2 0.000 15
575.60 3 0.002 16
640.33 2 0.002 18
740.29 2 0.005 18
763.07 3 0.007 27
779.86 2 0.008 25
784.35 2 0.012 17
830.38 2 0.002 22
850.89 2 0.000 18
1065.47 3 0.002 23
1007.44 3 0.010 25
i MBP and native S. cerevisiae Gas1p.
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bated reduced MBP-Gas1 together with either Ost3 or Ost6 and
measured the extent of alkylation at each detectable cysteine in
Gas1. Peptides containing the CxxC active site cysteines of Ost3p
or Ost6p, which are the only cysteines in the ER lumenal domains
of these proteins, were not detected in this analysis. Some cyste-
ines, such as Cys348 in tryptic peptide Ser338-Lys353, showed
no change in the extent of alkylation in the presence or absence
of Ost3 or Ost6 (Fig. 2A–C). However, the extent of alkylation of
some peptides did change. For example, Cys74 in tryptic peptide
Gly48-Arg76 was signiﬁcantly less alklyated when MBP-Gas1 had
been incubated in the presence of Ost6 than when MBP-Gas1
was incubated either alone or together with Ost3 (P < 0.05, ANO-
VA) (Fig. 2D–F). This indicated that during the incubation of Ost6
and reduced MBP-Gas1, Cys74 in some MBP-Gas1 proteins was
not alkylated because it formed a disulﬁde bond with a cysteine
in the CxxC motif of Ost6 (Fig. 1B). Of the six cysteine-containing
Gas1 tryptic peptides, two formed mixed disulﬁde bonds with
Ost6 detectable with this analysis (P < 0.05, ANOVA) but none with
Ost3 (Fig. 1G and H). This showed that the cysteines in the CxxC
thioredoxin-like active site of Ost6 could form mixed disulﬁdes
with cysteines in a physiological substrate polypeptide in vitro.3.2. Ost3p can form mixed disulﬁdes with tryptic peptides from a
model substrate protein
Formation of disulﬁdes between cysteines in whole Gas1 pro-
tein and the active site cysteines of Ost3 or Ost6 may have been
limited by the folding status of the partially reduced MBP-Gas1Fig. 2. In vitro mixed disulﬁde formation between MBP-Gas1 whole protein and Ost3 or
Ser338-Lys353 with Cys348 reduced at an m/z of 779.84 (dashed) or alkylated at anm/z o
(C) MBP-Gas1 with Ost6. Extracted ion chromatograms of the [M+3H]3+ ions correspon
alkylated at an m/z of 1031.11 (full) from incubation of (D) MBP-Gas1 alone, (E) MBP-G
alkylated versions of peptides containing Cys74, Cys265, Cys348, Cys103, Cys216 or Cys4
with (G) Ost3 or (H) Ost6, relative to incubation of MBP-Gas1 alone. Values showmean of
and (H) at a value of 1 are equivalent to no change.protein. Cysteines are commonly associated with hydrophobic re-
gions, are typically buried in folded proteins, and may be inacces-
sible even in a fully reduced protein. Some cysteines may therefore
have not been able to form a disulﬁde with Ost3 or Ost6 in the con-
text of the whole MBP-Gas1 protein (Fig. 1 and 2 and Table 1).
However, interaction between substrate polypeptide and Ost3/6p
in vivo is proposed to occur directly upon entry of the nascent
polypepide from the translocon into the ER lumen [23]. To mimic
this form of nascent polypeptide we tested if reduced tryptic pep-
tides from Gas1 could form disulﬁde bonds with the active site cys-
teines of Ost3 or Ost6 (Fig. 3). We applied reduced peptides to
amylose-agarose beads with pre-bound MBP-Ost3 or MBP-Ost6,
alkylated free cysteines to freeze disulﬁde reactivity, washed away
non-bound peptides and eluted peptides bound through a disulﬁde
to Ost3/6p with DTT. We then detected peptides in the load and
elution fractions using LC–ESI–MS/MS (Table 2). We detected 18
peptides from MBP-Gas1 in the load sample applied to the amy-
lose–agarose beads with MBP-Ost3 or MBP-Ost6 (Table 2). No pep-
tides were detected in the elution from beads with MBP-Ost6.
However, one peptide, Gly48-Arg76, was detected in the DTT elu-
tion from beads with MBP-Ost3 (Table 2). This peptide contained
Cys74, the same residue identiﬁed as forming a mixed disulﬁde
with Ost6 in our whole protein mixed disulﬁde assay (Fig. 2D–F
and H).4. Discussion
S. cerevisiae OTase subunits Ost3p and Ost6p modulate the
acceptor protein substrate range of OTase in vivo [22]. Both pro-Ost6. Extracted ion chromatograms of the [M+2H]2+ ions corresponding to peptide
f 815.36 (full) from incubation of (A) MBP-Gas1 alone, (B) MBP-Gas1 with Ost3, and
ding to peptide Gly48-Arg76 with Cys74 reduced at an m/z of 1007.43 (dashed) or
as1 with Ost3, and (F) MBP-Gas1 with Ost6. Ratios of the intensity of reduced and
21 fromMBP-Gas1 (Gas1p amino acid numbering, Table 1) when incubated together
biological triplicates. Error bars show s.e.m. ⁄P < 0.05, ANOVA. Horizontal lines in (G)
Fig. 3. Experimental design for in vitro peptide mixed-disulﬁde afﬁnity chroma-
tography with Ost3 or Ost6. (A) Reduced MBP-Gas1 tryptic peptides are incubated
together with amylose-agarose beads with bound puriﬁed oxidized MBP-Ost3 or
MBP-Ost6. (B) A cysteine in a Gas1 peptide performs nucleophilic attack on the
Ost3/6 cystine and forms a mixed disulﬁde bond. This reaction is reversible [23]. (C)
Alkylation of free cysteines prevents further mixed disulﬁde shufﬂing. (D) Non-
bound peptides are removed by thorough washing. (E) Reduction with DTT releases
peptides bound to Ost3 or Ost6 through a disulﬁde bond. (F) LC–ESI–MS/MS
analysis allows detection of peptides. See Materials and Methods for details.
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tive site residues are required for efﬁcient in vivo glycosylation of a
subset of glycosylation sites, including N253 in Gas1p [23]. It has
been proposed that the active site cysteines of Ost3p and Ost6p
can form transient mixed disulﬁdes with nascent polypeptide sub-
strate [23]. To test this, we developed two independent in vitro as-says to identify cysteines in S. cerevisiae Gas1p that could form
transient mixed disulﬁde bonds with the thioredoxin-like active
site cysteines of Ost3p or Ost6p. One of these assays tested interac-
tions using Gas1p as a reduced but intact MBP fusion protein
(Fig. 1), and the other used this same protein after it had been di-
gested to peptides with trypsin (Fig. 3). The combination of these
approaches identiﬁed that the Cys74 cysteine residue in Gas1p
could form a mixed disulﬁde bond with both Ost3p and Ost6p
(Fig. 2, Table 2). In addition, the whole protein interaction ap-
proach identiﬁed that Cys421 could form a mixed disulﬁde bond
with Ost6p (Fig. 2). While efﬁcient glycosylation of Asn253 in
Gas1p in vivo requires the CxxC motif of either Ost3p or Ost6p
[23], it is not clear if this requirement is due to the formation of
a mixed disulﬁde bond between Ost3p or Ost6p and either Cys74
or Cys421 in Gas1p, that our analyses here detected could bind
in vitro. Both Cys74 and Cys421 are distant from Asn253 both in
amino acid sequence and in the predicted ﬁnal folded protein
structure of Gas1p [37,38]. It is not clear if the peptides that we de-
tected forming mixed disulﬁdes with Ost3p and Ost6p in vitro also
form such transient bonds in vivo, or if these particular bonds are
key for glycosylation at Asn253 of Gas1p. Although we detected
six peptides from Gas1p that contain cysteine residues (Table 1),
there are eight additional cysteine residues in Gas1p that we did
not detect with our analytic approach. Some of these cysteine res-
idues may also form mixed disulﬁde bonds with Ost3p and/or
Ost6p relevant to N-glycosylation of Asn residues in Gas1p in vivo.
In summary, our results validated a key prediction of the pro-
posed model of Ost3/6p function in N-glycosylation [23]. It has
been previously shown that the CxxC motifs of Ost3p and Ost6p
are important for glycosylation in vivo [23]. Here, we showed that
the ER lumenal domains of both Ost3p and Ost6p could form
mixed disulﬁdes with cysteines in their physiological protein sub-
strate Gas1p, using a peptide and a whole-protein assay. Ost3p and
Ost6p showed differences in their activities in these assays, consis-
tent with their different peptide-binding activities in vitro [33] and
different range of substrates in vivo [22]. The assays we developed
may also be applicable to in vitro identiﬁcation of transient mixed
disulﬁde bonds in other systems.
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